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Abstract 
Since the serendipitous discovery of the first antibiotic, the "wonder drug" penicillin by 
Alexander Fleming, bacteria over time have slowly developed resistance to most antibiotics 
through three well coordinated processes. Firstly, bacteria can evolve their genetic makeup to 
become resistant against antibiotics; Secondly, bacteria can relay the modified antibiotic resistant 
genes to other bacteria and other species through a process called conjugation. Thirdly, bacteria 
quickly give up their individuality to become a part of a team to form surface attached 
multicellular communities known as biofilms. Bacteria residing within biofilms are protected by 
a layer of slime which renders the bacteria one thousand fold more resistant to the action of 
antibiotics. Nearly eighty percent of bacterial infections are associated with biofilms and 
therefore understandably, biofilms are considered as one of the seven most important health 
issues facing mankind in the 21st century.  
The focus of research work presented here is to discover small molecules that can control 
multiple microbial multicellular behaviors. The fundamental approach was to deploy small 
molecules that do not kill the bacteria (nonmicrobicidal), but are able to modulate bacterial 
multicellular behaviors, like biofilm formation and swarming motility, which are not essential for 
bacterial survival but are critical for infections. Consequently, the use of such nonmicrobicidal 
agents is less likely to induce evolution of bacterial genes. The use of two different kinds of 
nonmicrobicidal agents, maltose derivatives and brominated furanones, as modulators of 
different bacterial multicellular behaviors has been demonstrated. 
Rhamnolipids secreted by Pseudomonas aeruginosa are biosurfactants that are known to 
be essential for at least three multicellular behaviors of P. aeruginosa, biofilm formation, biofilm 
dispersion and swarming motility. Maltose derivatives, which are structurally related to
rhamnolipids were synthesized and found to be nonmicrobicidal to the growth of P. aeruginosa, 
Escherichia coli and Staphylococcus aureus. Maltose derivatives were effective at inhibiting the 
initial adhesion, biofilm formation and at dispersing pre-formed biofilm of P. aeruginosa. 
Maltose derivatives were capable of both modulating the swarming motility of wild type P. 
aeruginosa (PAO1) and activating swarming of a nonswarming P. aeruginosa mutant, rhlA. 
Although, the maltose derivatives were able to inhibit the biofilm formation, these agents were 
not effective at either inhibiting the initial adhesion or dispersing the preformed biofilms of both 
E. coli and S. aureus.  
Brominated furanones are known to disrupt bacterial chemical communication process 
known as quorum sensing (QS). Here the mechanism of action of brominated furanones on both 
E. coli and P. aeruginosa was explored. The presence of a methyl substituent either on the 
furanone ring or on the exocylic vinyl bond was identified as an important structural element for 
maintaining nonmicrobicidal action. The protein SdiA of E. coli was found to be critical for 
antibiofilm activities of brominated furanones against E. coli.  The lasI protein on P. aeruginosa 
is a known homologue of the E. coli SdiA protein. It was found that the brominated furanones 
were antagonistic to the las QS system but were agonistic to the rhl QS system of P. aeruginosa. 
The nonmicrobicidal agents presented here, maltose derivative and brominated furanones 
offer new approaches for controlling biofilm and bacteria-related problems. 
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Chapter 1 
Introduction 
1.1. Bacterial multicellular behaviors 
 
1.1.1 Bacteria: “Can’t live with them can’t live without them” 
 
Bacteria are usually regarded as microbes that invade human body causing detrimental 
effects making existence difficult. Contrary to this belief, human survival is indebted to the 
existence of bacteria as some of these bacteria play key role in various life processes. Bacteria, 
within the human body are responsible for carrying out metabolic activities like food digestion 
and vitamin synthesis. Even outside host bodies, bacteria carry out multiple functions that are 
essential for maintaining the global energy cycle. These functions include decomposing dead 
matter, breaking down garbage, bioremediation, nitrogen fixation etc.    
Traditionally, bacteria have been viewed as unicellular organisms that can exist in many 
habitats including air, soil, oceans, rocks and snow. Bacteria are also known to coexist on or 
within other organisms such as plants and animals.  Coexistence of bacteria within humans is 
usually (99%) symbiotic, while sometimes (1%) certain opportunistic or pathogenic bacteria may 
invade the host immune system, causing diseases and infections.  
1.1.2 Bacteria are unicellular social beings 
 
Observance of “teamwork” in bacteria dates back to the 20th century. Notably, Sergei 
Winogradsky identified that bacteria play a crucial role in the global carbon cycle by 
decomposing cellulose.1 Interestingly he also reported that majority of the bacteria resided as 
groups on soil particles rather than existing as isolated cells. 2,3 Sergei Winogradsky’s 
 
 
observation of group behavior in bacteria was later confirmed by Kempner and Hanson in 1968 
by the discovery of quorum sensing in marine Photobacterium fischeri (Vibrio fischeri). Why do 
bacteria switch from unicellular organisms to social beings? While the answer to such a question 
may be complex, the general belief is that the switch is triggered to ensure the survival of the 
microbes in the environment or in-vivo to maintain its virulence. It is argued that, triggering a 
switch to group mode of living would require a coordinated merger of many chemical and 
physical cues in the bacteria.4 In combination, such physio-chemical changes are capable of 
inducing morphological changes that are necessary for social living.  
1.1.3 Quorum sensing as an intelligence system of bacterial social behavior 
 
Quorum sensing is a sophisticated communication system within the bacteria which helps 
them receive and send chemical messages to and from other bacteria.4 Quorum sensing is 
responsible for coordinately controlling the gene expression of the entire community of bacteria 
and hence concerting a unicellular organism into a multicellular community.5 Quorum sensing 
controls many multicellular bacterial behaviors including symbiosis, virulence, antibiotic 
production, biofilm formation and swarming.5 The process of quorum sensing was first observed 
in the marine bacterium Vibrio fischeri by Kempner and Hanson in 1968. These marine 
bioluminescent bacteria were only able to produce light at a specific density of bacteria in the 
liquid culture but not at low density. To explain their observation, Kempner and Hanson 
proposed that there exist inhibitors of luminescence in culture medium and hence when culture 
becomes overpopulated with bacteria, bacteria overpower these inhibitors in the culture.6 But 
later it was shown that the phenomenon of density dependent bioluminescence was not due to 
inhibitors in the medium but was dependent on the concentration of small molecules secreted by 
bacteria, and these small molecules are called autoinducers. The process in which bacteria 
 
 
secrete autoinducers and respond to their accumulation in the environment is called quorum 
sensing and it was first discovered for the V. fischeri (photobacterium) (Figure 1.1).7-9 
Eberhard and co-workers in 1981 first isolated and identified N-(3-oxohexanoyl)-3-
aminodihydro-2(3H)-furanone (AHL) from V. fischeri as a bacterial signaling molecule 
(autoinducer). They further showed that autoinducers stimulated light production in V. fischeri in 
a concentration dependent manner.10  
The circuit of quorum sensing in V. fischeri was first mapped out in 1983 by Engebrecht 
and Silverman.11-13  In V. fischeri, a two component system is involved in quorum sensing 
wherein, luxI gene controls the expression of LuxI type protein (signal synthase) which is 
responsible for production of autoinducer (AI). Initially the concentration of the AI’s is low 
inside and outside the cell wall but as the cell density increases the local concentration of these 
AI’s increases to nanomolar levels. Upon reaching a threshold concentration AI’s strongly bind 
LuxR protein (signal receptor) (controlled by luxR gene) giving maximum activation of LuxR 
(Figure 1.1).14-16 Binding of autoinducer to LuxR protein activates the expression of luxI and 
downstream genes which controls the multicellular bacterial behaviors such as bioluminescence 
in V. fischeri.12, 13 Hence V. fischeri exhibits cell density dependent bioluminescence.  
Another quorum sensing circuit which co-exists in V. fischeri is LuxPQ/LuxS.17 In this 
system LuxS is an autoinducer synthase which produce AI-2.  LuxP is a periplasmic protein 
which binds to AI-2. LuxQ is an inner membrane sensor kinase which detects the binding 
between LuxP and AI-2.18 Activation of LuxQ further regulates the downstream genes. In case of 
V. fischeri AI-2 is furanosyl borate.19   
The initial confinement of quorum sensing to marine bacterium was later modified as it 
was observed in other gram negative as well as gram positive bacteria.20, 21 Variety of 
 
 
structurally different autoinducers exist in nature whose structure is specific for that bacterial 
species. Gram negative bacteria use derivatives of AHLs and gram positive bacteria use oligo 
peptides.22, 23 For example, different gram negative bacteria are able to distinguish their own 
chemical signal from that of others by recognizing the difference in the length of acyl side chain 
of acyl-homoserine lactone (AHL) autinducers.  
Similar to the quorum sensing circuit in V. fischeri other gram negative bacteria are 
known to possess a two component system having homologous LuxI and LuxR-type proteins 
that secrete and bind specific autoinducers (Table 1.1). Later it is also shown that bacteria are not 
only capable of intraspecies but are also capable of interspecies communication. This intra and 
interspecies communication is important in ensuring bacterial survival and propagation in the 
natural environment where hundreds of bacterial species coexist (e.g, human oral cavity).24  
As quorum sensing is the communication between the bacteria through the chemical 
signals which gives them the decision making ability to control their growth, movement and 
biochemical activities, it is an attractive therapeutic target in medicinal field for controlling 
microbes.                                    
                             
Figure 1.1 Quorum sensing circuit of Vibrio fischeri 25 [Reprinted with permission from 
Citation: David R. Spring, (2011) Quorum sensing in gram-negative bacteria: small molecule 
 
 
modulation of AHL and AI-2 quorum sensing pathways. Chem. Rev. (111), 28-67; Copyright : 
2011, American Chemical Society.]  
Table 1.1 Autoinducers secreted by Gram-negative and Gram-positive bacteria. (Adapted and 
modified from review by Spring and co-workers and also by Bassler and co-workers.)5, 25 
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1.1.4 From human perspective social microbes are more harmful than unicellular beings 
 
Multicellularity is an adaptive lifestyle that microbes exhibit and as such is an integrated 
activity of different cells. The coordinated behavior in microbes foresees cellular proliferation, 
manipulates availability of resources and nutrients, shields individual cell against anti-microbials 
and generates cell populations with assigned work and enhanced survivability.  From a human 
standpoint, the culmination of such differentiation and added resistance exhibited by 
multicellular bacteria makes combating such microbes even more difficult task.  
1.2. Quorum sensing controlled multicellular behaviors  
1.2.1. Biofilm formation and its development 
Among quorum sensing controlled processes, the one which is most vital for microbial 
survival and also a significant contributor to the pathogenesis is formation of biofilm. Biofilms 
are surface associated three dimensional hydrated bacterial communities formed by secreted 
networks of extra polymeric substances.26, 27 This communal living gives bacteria an added 
advantage over unicellular existence.  Inside the biofilm, bacteria becomes 1000 fold more 
resistant to the action of antibiotics than the planktonic microbes.28 About 80 % of bacterial 
infections in humans are associated with biofilms.29 Biofilms are serious threats not only in the 
medical sector but also in industrial and agricultural sectors. Common medical conditions 
associated with bacterial biofilms include cystic fibrosis,30-38 catheter infections, tooth decay, 
endocarditis, otitis media, chronic urinary tract disease and whooping cough. In terms of impact 
to the medical and healthcare sectors, increasing rates of antibiotic resistance strains is one of the 
most important consequences of biofilms. 
 
 
Bacteria residing inside the biofilms are phenotypically different than the bacteria in the 
culture of the same species.39 Biofilm formation is a developmental process and each step is gene 
regulated.  First step of biofilm formation is the reversible attachment of bacteria on the biotic or 
abiotic surfaces.40 This initial attachment is governed by Van der Waals forces and at this stage 
bacteria can be easily removed from the surface. In the second step, bacteria use its adhesins 
such as pilli, flagella to adhere irreversibly onto the surface.41 It is also suggested that some 
bacteria also precondition the surface with polymeric substances or proteins they are constantly 
secreting in their milieu and further receptors on the bacterial surface recognize these epitopes.42 
In the third step bacteria start communicating with each other through quorum sensing. When a 
quorum is achieved, bacteria start secreting polysaccharides to create a three dimensional matrix. 
The fourth step in the process is formation of mature biofilms. Mature biofilm is usually a 
mushroom shaped structure consisting of different phenotypes as we move from cap to root of 
the mushroom. Last step of biofilm formation is dispersion of mature biofilm. Dispersion is 
important stage of the biofilm cycle as it allows bacteria to spread and colonize new surfaces.    
 
 
 
 
 
Figure 1.2 Biofilm formation is a developmental process; 1) reversible attachment of cells on the 
surface; 2) irreversible attachment of cells to the surface; 3) start of secretion of polymeric 
substances to form biofilm, controlled by quorum sensing; 4) mature biofilm formation; 5) 
dispersion of bacterial cells from the mature biofilm to colonize new surface.43 [Citation: 
Monroe D (2007) Looking for Chinks in the Armor of Bacterial Biofilms. PloS Biol 5 (11):e308. 
Doi: 10.1371/journal.pbio.0050307; Image Credit: D. Davies; Copyright: © 2007 Don Monroe. 
This is an open-access article distributed under the terms of the Creative Commons Attribution 
License, which permits unrestricted use, distribution and reproduction in any medium, provided 
the original author and source are credited.  
1.2.2 Different ways of controlling biofilm formation 
 
Progression of biofilm formation is associated with many developing stages  (Figure 1.3) 
and therefore, most biofilm treatment strategies target at least one or more developing stages.44  
These strategies include;  
 
 
(1) Arresting switch from unicellular to multicellular lifestyle. Cyclic diguanylate (c-di-
GMP) is a secondary messenger in bacteria and suggested to be crucial for taking environmental 
and physiological signaling inputs.45 Increase in the production of surface adhesive organelles 
while going from planktonic to sessile mode is directly correlated with high levels of production 
of c-di-GMP. Hence this switch from planktonic to biofilm lifestyle can be regulated by 
controlling the production of c-di-GMP in bacteria.46, 47 One example is sulfthiazole compounds 
which are active against the biofilm of Escherichia coli (E. coli ) by interfering with the 
biosynthesis of c-di-GMP.46  
 
(2) Molecular intervention of bacterial adhesion to surfaces. Many biological recognition 
events such as cell-to-cell interactions, bacterial, fungal and viral infections of human host cells 
are mediated through carbohydrate-protein interactions.48, 49 Bacteria in particular use proteins 
known as adhesins to bind carbohydrate epitopes present on host cells.50, 51 Additionally, 
adhesion is also the first step in the colonization of abiotic surfaces by bacteria to form biofilm.52, 
53 Molecular intervention of bacterial adhesion to prevent infection is therefore the cornerstone 
of a therapeutic approach known as anti-adhesive strategy.54 
(3) Blocking bacterial communication through chemical mimics. Another approach to 
prevent biofilm formation is through interference with the quorum sensing pathways of the 
bacteria by limiting communication using small molecules that mimic natural autoinducers (AIs). 
These mimics can bind the receptor protein of the natural AI’s and block the active site for 
natural AI. Many anti-biofilm agents have been discovered based on this strategy. As every 
bacterial species have their own set of autoinducers, a variety of mimicking molecules have been 
discovered and tested for biofilm inhibition. Brominated furanones and indoles are best known 
 
 
for interfering with the quorum sensing system of the E. coli and inhibiting formation of 
biofilm.55-58 2-Aminobenzimidazole derivatives have been shown to inhibit biofilm formed by   
Pseudomonas aeruginosa (P. aeruginosa).59, 60 Derivatives of naturally occurring acyl 
homoserine lactones have been synthesized and shown to effectively inhibit formation of biofilm 
by binding to the receptor protein more efficiently than the natural autoinducers.61-63   
(4) Increasing the antibiotic efficiency by reactivating the metabolic activity. 
The bacteria residing within the biofilm formed by P. aeruginosa in the cystic fibrotic lungs are 
many fold more tolerant to the action of antibiotics. Hence, completely eradicating the pathogen 
from the lungs of the cystic fibrosis patients is difficult. It has been shown that limiting iron 
levels could be a potential strategy to disintegrate biofilm of P. aeruginosa.64 Further researchers 
used FDA approved iron chelators along with antibiotics to inhibit such antibiotic resistant 
biofilms of P. aeruginosa. Synergistic effect of antibiotic and iron chelators was able to disperse 
almost 90% of the biofilm.65  
(5) Creating surfaces that resist biofouling. Initial attachment of bacteria on the surface can be 
avoided by making the surface bioinert. If bacterial adhesins do not recognize the surface it will 
not be possible for bacteria to attach on to the surface. Luk and coworkers have reported bio-
inert surfaces that resist adhesion of microbes. They reported that polyol terminated alkanethiol 
self-assembled monolayers (SAMs) on gold surfaces resisted the attachment of E. coli for almost 
21 days.66 Progress has been made in creating bioinert medical devices like catheters by coating 
them with antiseptics to avoid adherence of antibiotic resistant bacteria like Staphylococcus 
aureus (S. aureus) or P. aeruginosa in critically ill patients.67  
(6) Strategies to disperse preformed biofilms. Strategies that disperse preformed biofilms are 
more clinically relevant than strategies that prevent biofilm formation. Many small molecules 
 
 
that mimic autoinducers not only inhibit the biofilm formation but have also been shown to 
disperse preformed biofilms.68 Compounds like nitric oxide (NO) have been reported to disperse 
P. aeruginosa biofilm.69 Collins and coworkers have reported the use of bacteriophages that 
expresses biofilm degrading enzymes to disintegrate the biofilm of E. coli.70, 71   
 
Figure 1.3. Five developmental stages of biofilm formation and different strategies to disrupt 
each step of biofilm formation.44 [Citation: Bordi and de Bentzmann (2011) Hacking into 
bacterial biofilms: a new therapeutic challenge. Annals of intensive care, 2011, 1: 19. 
doi:10.1186/2110-5820-1-19; Image Credit: de Bentzmann; Copyright: © 2011 Bordi and de 
Bentzmann; licensee Springer. This is an open-access article distributed under the terms of the 
Creative Commons Attribution License, which permits unrestricted use, distribution and 
reproduction in any medium, provided the original author and source are cited. 
1.2.3 Swarming 
 
When bacteria come in contact with the surfaces, apart from aggregating into sessile 
colonies of biofilms, sometimes they rapidly move on the surface through a multicellular process 
known as swarming. Both biofilm formation and swarming are surface associated multicellular 
 
 
bacterial behaviors that are inversely regulated.72, 73 The reasons as to why bacteria choose one 
multicellular behavior over another are probably central to its survival. Swarming is a flagella 
driven coordinated rapid movement of bacteria on semisolid surface.74, 75 In laboratory set up this 
phenomenon is observed on agar plates containing nutrient medium. Some bacterial species like 
Vibrio parahaemolyticus and Proteus mirabilis can swarm on 1.5 to 3% of agar gel (hard agar) 
but some bacteria like (E. coli, P. aeruginosa and Bacillus subtilis) swarm on medium agar gels 
(0.5 to 0.8 % agar).76 Below 0.5 % of agar, bacteria swim inside the agar through the water 
channels and this motility is a unicellular behavior. Swarming is just not a locomotive type of 
motion but it is lifestyle adaptation in response to the environmental cues and nutrient conditions 
and hence it is highly influenced by quorum sensing.74 Bacteria swarming on medium agar gels 
usually synthesize biosurfactants to propagate their motility on the surface,77 but there are 
exceptions like E. coli and salmonella which do not produce biosurfactants.78               
1.3 Need of new therapeutic approaches and non-microbicidal agents to control 
multicellular behaviors of bacteria 
 
All the bacterial multicellular behaviors induce high degree of antibiotic resistance in the 
microbes.29, 76 Since the first introduction of antibiotics, bacteria over time have evolved 
sophisticated resistant strains against almost all the available antibiotics.79-81 Microbicidal agents 
like antibiotics cause selection pressure on the bacteria to evolve their genetic makeup and 
develop resistance against such agents. Bacterial strains that are resistant to most of the 
antibiotics are called multi-drug resistant (MDR) strains or colloquially as “superbugs”.82 
Shutting down multicellular behaviors (swarming and biofilm formation), with the use of only 
antibiotics, of such superbugs is a very difficult task and nearly impossible. Hence scientific 
community continuously seeks new strategies to overpower these resistant superbugs without 
 
 
killing them.82, 83 As a consequence, scientifically there is an urgency to find alternative non-
microbicidal strategies that can control bacterial group behaviors.  The central theme of this 
thesis is therefore presenting alternative nonmicrobicidal strategies to control multicellular 
behaviors of both gram negative (P.  aeruginosa and E. Coli) and gram positive (S. aureus) 
bacteria. 
1.4 A brief introduction of the following chapters  
 
Chapter 2.  Inhibition of Pseudomonas aeruginosa adhesion, biofilm formation and dispersion 
of preformed biofilm by maltose derivatives 
Chapter 3. Swarming activation and phenotypic bifurcation of nonswarming P. aeruginosa 
mutant by maltose derivatives 
Chapter 4. Maltose derivatives inhibit the biofilm formation of Escherichia coli and 
Staphylococcus aureus 
Chapter 5.  Biofilm inhibition activities and mechanism of action of brominated furanones 
against Escherichia coli and Pseudomonas aeruginosa 
 
 
 
 
 
 
 
Chapter 2 
Inhibition of Pseudomonas aeruginosa Adhesion, Biofilm Formation 
And Dispersion of Preformed Biofilm by Maltose Derivatives 
 
 Overview  
Microbial biofilm formation is associated with many medical conditions and causes huge 
expenses to industrial setups. Treating biofilms formed by bacteria poses many key challenges 
including the problem of inducing drug resistance in microbes due to the use of microbicidal 
agents that kill the planktonic bacteria. Contrary to this, nonmicrobicidal agents are less likely to 
invoke drug resistance in microbes. Here we demonstrate the use of twelve nonmicrobicidal 
maltose derivatives to efficiently inhibit and disperse the biofilms formed by an opportunistic 
pathogen, Pseudomonas aeruginosa. Maltose derivatives possessing bulky hydrocarbon groups 
had higher potency than derivatives with n-alkyl aliphatic chains, with the most potent agents 
exhibiting a half-maximal inhibitory concentration for biofilm inhibition (IC50) and dispersion 
(DC50) of 23 µM and 31µM, respectively. These maltose derivatives also reduced the initial 
adherence of Pseudomonas aeruginosa on polystyrene surfaces. Unlike many other anti-biofilm 
agents reported by others, these maltose derivatives do not interfere with the quorum sensing 
pathways of Pseudomonas aeruginosa. Many bacterial biological recognition events are known 
to be mediated by protein-carbohydrate interactions and we believe that, the action of these 
maltose derivatives could be a consequence of such a recognition process, wherein a putative 
receptor protein exists for a natural ligand that structurally resembles such maltose derivatives. 
 
 
 
2.1 Background and Significance 
 
2.1.1 Detrimental effects of Pseudomonas aeruginosa and its biofilm  
 
Pseudomonas aeruginosa is a gram negative, rod shaped opportunistic pathogen 
associated with many medical conditions.84 Infections by P. aeruginosa can be complicated, life-
threatening and have become an epidemic problem in healthcare settings. Hence, P. aeruginosa 
is a model system for studying many bacterial related problems.85 Very common victims of P. 
aeruginosa infections are the patients with weakened immune systems and patients with wounds 
from surgery or burn.86 But P. aeruginosa is most studied in context of lung infections associated 
with Cystic fibrosis patients. Cystic fibrosis (CF) is a hereditary condition which disrupts the 
normal function of epithelial cells.87 Cystic fibrosis is a genetic disorder and the rate of its 
inheritance among Caucasians is 1 in every 2,000 live births.88 In CF patients, P. aeruginosa 
colonizes the lung and over time mutates to an alginate overproducing mucoid phenotype.89 It 
has been reported that the biofilm formed by mucoid P. aeruginosa is more resistant to the 
antibiotics than wild type P. aeruginosa.35, 90 The overproduction of alginate by mucoid P. 
aeruginosa is ultimately responsible for poor prognosis and high mortality rates among CF 
patients.36  
Overall P. aeruginosa biofilms are difficult to eradicate as compared to other bacterial 
biofilms due to low permeability of antibiotics through outer membranes of P. aeruginosa and 
therefore, it is intrinsically resistant to most antibiotics.91, 92 Outer membrane permeability of P. 
aeruginosa is 12 -100 times lower than that of Escherichia coli (E. coli).93 Low antibiotic 
membrane permeability along with mutation to mucoid phenotype enables secondary adaptive 
resistance mechanisms of P. aeruginosa to work more effectively.41 Therefore, the increase in 
the emergence of the antibiotic-resistant bacteria calls for fundamentally new approaches to treat 
 
 
wide range of infectious diseases.29, 37, 94 The relevance of quorum sensing in bacterial biofilm 
formation,7, 13, 95, 96 and the detrimental effect of the biofilms thus formed has made the 
exploration of nonmicrobicidal anti-quorum sensing or anti-biofilm approaches an important area 
of research.26, 61, 62 
2.1.2 Clinically relevant Mucoid strain of P. aeruginosa 
 
Over time P. aeruginosa residing in the lungs of Cystic fibrosis (CF) patients mutates 
into a mucoid strain.89 The microenvironments within the lungs of the CF patients support 
conversion of wt. P. aeruginosa into mucoid strain.97, 98 Mucoid strain of P. aeruginosa is known 
to overproduce a biopolymer known as alginate and the biofilm formed as a consequence does 
not easily dehydrate and has added impermeability for antibiotics.99, 100 For example, Parsek and 
co-workers showed that the biofilm formed by mucoid strain was a thousand-fold more resistant 
than the non-mucoid strain to the action of antibiotic Tobramycin.101  Hengzhuang and 
coworkers demonstrated that the treatment of biofilms formed by mucoid strains required higher 
doses and longer treatment times with two antibiotics, Colistin and Imipenem, as compared to 
the biofilms of nonmucoid strain.102 While many nonmicrobicidal small molecule based 
treatments of P. aeruginosa biofilms have been reported, most of these studies were done using 
the nonmucoid strain, therefore, potency of these small molecules on the clinically relevant 
mucoid strain remains essentially unknown.103 However, Singh and coworkers did explore the 
use of Esomeprazole molecules to control the biofilms formed by mucoid strain.104   
2.1.3 Different virulence factors secreted by P. aeruginosa 
 
Virulence factors are the gene products or the properties that help bacteria to establish 
themselves on or into the host systems to cause an onset of infectious diseases.41 The prominent 
 
 
virulence factors that ensure bacterial survival and maintain its pathogenicity include secretion of 
toxins, expression of surface proteins to mediate bacterial attachment, secretion of 
polysaccharides and the secretion of hydrolytic enzymes.Virulence factors for P. aeruginosa are 
adhesins (flagella and pili),105 alginate,106 biosurfactant-rhamnolipids,107 iron uptake system,108 
pyocyanin,109 protease,110 elastase,111 quorum sensing112 and type III secretion system.113 
Therefore, a good strategy for controlling bacterial infections can be developed by targeting 
these virulence factors. While, individual virulence factors are easier to control, controlling 
multiple virulence factors at the same time is a more challenging task. The overall goal of this 
chapter is to inhibit the biofilms of P. aeruginosa with the help of a class of synthetic molecules 
that are predicted to mimic a prominent virulence factor of P. aeruginosa, rhamnolipids.  
2.1.4 Quorum sensing circuit of Pseudomonas aeruginosa 
 
As biofilm formation is highly influenced by the quorum sensing (QS) pathways of the 
bacteria, extensive work has been done toward inhibiting the quorum sensing of bacteria to 
reduce the bacterial biofilm formation.61, 114, 115 Quorum sensing system in P. aeruginosa is 
controlled by two regulatory systems which are homologous to lux QS systems of V. fischeri. 
These two regulatory systems in P. aeruginosa are las and rhl QS circuits.116 Each of these 
systems is controlled by a set of two proteins, of which one is the autoinducer synthase and other 
is the autoinducer receptor. In las system, LasI protein (homologous to luxI of V. fischeri) 
catalyzes the synthesis of autoinducer, N-3-oxododecanoyl-homoserine lactone (PAI-1) which 
binds to the receptor protein, LasR (homologous to luxR of V. fischeri). The LasR-PAI-1 
complex further controls the activation of the rhl QS system. In rhl QS system, RhlI protein 
(homologous to luxS of V. fischeri) synthesizes N-butyryl-homoserine lactone (PAI-2) which 
binds to RhlR protein (homologous to luxP of V. fischeri).117, 118 Complexes LasR-PAI-1 and 
 
 
RhlR-PAI-2 together control almost 600 genes of P. aeruginosa and many of these genes are 
responsible for secretion of different virulence factors.119 Therefore, designing mimics of PAI-1 
and PAI-2 (Figure 2.1) that can interfere with bacterial quorum sensing and modulate biofilm 
formation is an important anti-biofilm strategy.62, 120  
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Figure 2.1.  PAI-1 secreted by las system and PAI-2 secreted by rhl system of P. aeruginosa 
2.1.5 Role of naturally occurring disaccharide hydrocarbons in biofilm formation and adhesion 
of P. aeruginosa 
 
2.1.5.1 Biosurfactant production in P. aeruginosa and its significance in biofilm formation  
 
P. aeruginosa produces biosurfactants rhamnolipids, which is one of the many virulence 
factors it secretes. The production of rhamnolipids by P. aeruginosa was first reported by Jarvis 
et al in 1949 and the structure of the rhamnolipids was first discovered in 1965 by Hayashi J. 
A.121, 122 Apart from P. aeruginosa, such glycolipid biosurfactants are also produced by other 
bacterial species.123  
 The rhlAB operon is responsible for rhamnolipids synthesis and this operon is under rhl 
QS system.124 Study by Greenberg and coworkers showed that rhlAB operon is over expressed in 
the stalks of the mushroom-like biofilm structures.124 P. aeruginosa secretes three types of 
 
 
surface active molecules, di-rhamnolipids, mono-rhamnolipids, and 3-(3 hydroxyalkanoyloxy) 
alkanoic acids (HAAs) (Figure 2.2).125 Di-rhamnolipids are synthesized via a three step 
enzymatically catalyzed process. Firstly, HAA acids are synthesized and this step is catalyzed by 
the RhlA protein.126 In the next step, membrane bound rhamnosyl transferase enzyme RhlB, 
transfers and attaches one sugar moiety (dTDP-L-rhamnose) to the precursor HAA to yield 
mono-rhamnolipids.127 In the third step, RhlC protein adds the second sugar moiety to the mono-
rhamnolipid product of step two to give di-rhamnolipids.128 In general, a mixture of HAA, mono-
rhmanolipids and di-rhamnolipids produced in-situ by P. aeruginosa is referred to as 
rhamnolipids. Since the production of rhamnolipids is controlled by quorum sensing, extensive 
research has been done to understand the role of rhamnolipids in multicellular behaviors of P. 
aeruginosa. In 2002, O’Toole and co-workers showed that rhamnolipids are required for 
maintaining water channels and pores in the biofilm of P. aeruginosa .129 A mutant incapable of 
producing rhamnolipids was unable to form three-dimensional biofilms and rather formed 
collapsed layers (pancake-like) of biofilm over each other.130 Rhamnolipids inhibit the adhesion 
of P. aeruginosa and E. coli, suggesting that biosurfactants have the ability to disrupt cell-to-cell 
and cell-to-surface interactions.129 Another role of rhamnolipids is to protect intrusion of other 
bacterial species into the biofilms formed by P. aeruginosa.129 Over production of rhamnolipids 
by P. aeruginosa helps in the dispersion of bacteria from mature biofilms.129 Rhamnolipids have 
also been reported to disperse biofilms formed by other bacteria.131 
 
 
 
Figure 2.2 Biosynthesis of rhamnolipids by P. aeruginosa. [Adapted and modified with 
permission from Citation: E C Pesci, (1997), “Regulation of las and rhl quorum sensing in 
Pseudomonas aeruginosa” Journal of Bacteriology (179), 3127-3132; Copyright: 1997, 
American Society for Microbiology.] 
2.1.5.2 Role of carbohydrates in controlling bacterial adhesion 
 
Adhesion of bacteria on host surface is the first and a critical step in the establishment of 
bacterial infectious diseases.132 In general, carbohydrate-protein interactions are known to 
mediate many biological events but, in bacteria specifically, such interactions mediate most of 
the adhesion processes with host surfaces.133 Therefore, preventing adhesion by creating 
molecular interventions that block bacterial adhesins like pilus, lectins and flagellin is an 
important therapeutic approach to control infections.134, 135 P. aeruginosa adhesin, pili, has been 
shown to be responsible for mediating initial adherence to both biotic and abiotic surfaces.50, 136 
The mediation of adherence by pili protein is through the carbohydrate-protein type of 
interaction. Further studies have shown that a domain in the C-terminal region of pili protein is 
 
 
the minimum binding sequence that recognizes βGalNAc(1-4)βGal disaccharide moieties offered 
by asialo-GM1 and asialo-GM2 present on human buccal epithelial cells (HBECs).137-139 This 
minimum binding sequences was later identified as a seventeen aminoacid residue looped 
sequence that is semi-conserved in many P. aeruginosa strains.140, 141 Structurally identical 
synthetic peptides having similar sequence to naturally occurring C-terminal pili protein were 
shown to inhibit adhesion of bacteria on HBECs.50 Randall and co-workers have reported the use 
of βGalNAc(1-4)βGal based hydrocarbons to interfere with adhesion of  P. aeruginosa.140, 142, 143 
Although, the effects of structural variation of βGalNAc(1-4)βGal based hydrocarbons on P. 
aeruginosa adhesion were reported by Randall and co-workers, the potency of other sugar 
stereochemistries on adhesion and the use of such agents for biofilm inhibition still remains 
unexplored.   
2.1.6 Use of surfactants to inhibit biofilm formation 
 
Surfactants are amphiphilic molecules that can be easily immobilized onto a surface and 
therefore are commonly used to lower the surface tension of a material. Detergency and 
dispersant properties of surfactants make them useful in washing and cleaning purposes in day to 
day life. The hypothesis that surfactants can be used to wash away bacterial biofilms has been 
pursued but it still remains a relatively unsuccessful anti-biofilm strategy as compared to quorum 
sensing inhibitor techniques. The use of cationic surfactants which are toxic to microorganisms, 
anionic surfactants, and nonmicrobicidal non-ionic surfactants to inhibit biofilm formation has 
been reported.144, 145  Surfactin is an example of a biosurfactant that has been used for inhibition 
and dispersion of Bacillus subtilis biofilm.146 Zegans and coworkers demonstrated the use of a 
non-ionic surfactant, polysorbate 80 for P. aeruginosa biofilm inhibition.147 Rhamnolipids which 
are self-secreted by P. aeruginosa have been shown to be effective in dispersion of biofilm 
 
 
formed by PA17 strain of P. aeruginosa.148 Additionally, biosurfactants rhamnolipid and 
surfactin have been shown to inhibit the adhesion and biofilm formation of several food borne 
pathogens.149  
2.1.7 Aim of the project  
The abilities of three types of generic surfactants; non-ionic, anionic and cationic, to inhibit 
the biofilm formation of P. aeruginosa were investigated. The preliminary investigation brought 
forward the non-ionic surfactant, dodecyl-β-maltoside as a potent biofilm inhibitor. Additionally, 
the diverse bioactivities of the biosurfactant rhamnolipids, which include, their role in 
maintaining three-dimensional structures of P. aeruginosa biofilms and their ability to disperse 
bacteria from mature biofilms, along with the fact that many saccharide-hydrocarbons are 
involved in bacterial surface recognition events, further prompted us to explore the effect of 
different maltose derivatives on bacterial adhesion and biofilm formation. 
2.2 Results  
2.2.1. Non-ionic surfactant dodecyl-β-maltoside inhibits biofilm formation where as other 
generic surfactants do not 
Four generic surfactants were tested for anti-biofilm activities against P. aeruginosa. For 
this, an anionic surfactant, sodium dodecyl sulfate (SDS); a cationic surfactant, dodecyl trimethyl 
ammonium chloride (DTAC); and two nonionic surfactants, tetra (ethylene glycol) monododecyl 
ether (C12EG4OH) and dodecyl-β-maltoside (DβM) were used (Figure 2.3A). The toxicity of 
these surfactants at 170 µM was tested on the growth of planktonic bacteria. While all four tested 
surfactants were non toxic to microbial growth, DTAC seemed to retard the growth of 
planktonic P. aeruginosa (Figure 2.3B). The biofilm was grown for 24 h in media within the 
wells of 96-well microtiter plate. The amount of surface attached biofilm formed in presence or 
 
 
in absence of such agents on the surface of the wells was quantified using crystal violet dye-
stain. The percent biofilm inhibition was calculated by comparing the biofilm content in wells 
treated with various surfactants against biofilm formed in wells without any agent. Surprisingly, 
only the surfactant with a sugar head group and a long aliphatic chain, dodecyl-β-maltoside 
(DβM) was active against the biofilm formation of P. aeruginosa. Among the tested surfactants, 
DβM exhibited 64 % biofilm inhibition, whereas other types of surfactants showed no inhibition 
(Figure 2.3C). The biofilm growing in wells treated with 170 µM of DβM appeared to be loosely 
bound to the surface with chunks floating in the culture (Figure 2.3D). These initial results 
suggested that the maltose derived hydrocarbon DβM was effective at inhibiting the biofilm 
formation of P. aeruginosa although the mechanism of such an inhibition seemed unclear. The 
biofilm inhibition by DβM could either be due to the physical washing away of the biofilm or it 
could be a biological effect wherein, DβM targets a particular biological pathway of P. 
aeruginosa. A preliminary observation that, another non-ionic surfactant, C12EG4OH which has 
better surface activity than DβM (Table 1) was incapable of inhibiting biofilm formation 
suggests that, surface activity alone cannot explain the biofilm inhibition ability of DβM.  
 
 
 
 
 
  
 
 
 
Figure 2.3 (A) Structures of generic surfactants, DβM, C12EG4OH, SDS and DTAC. (B) 
Growth curve of P. aeruginosa in presence of 170 μM of generic surfactants. (C) Inhibition of P. 
aeruginosa biofilm by 170 µM of generic surfactants measured by crystal violet dye staining; 
Error bar is standard error of the mean from 6 replicates. (D) Image of P. aeruginosa (PAO1) 
biofilm in presence or in absence of 170 µM DβM taken after 24 h of inoculation. 
Table 2.1 Surface activity of generic surfactants 
Generic Surfactant  Critical micelle 
concentration (CMC) 
Surface tension  
(γ) at CMC 
Tetraethylene glycol dodecyl 
ether (C12EG4OH) 
50 µM 27.6 mN/m 
Dodecyl-β-maltoside (DβM) 170 µM 35.3 mN/m 
 
 
 
 
2.2.2. Design and synthesis of maltose derivatives 
 
In order to understand the importance of structural details for biofilm inhibition activity, 
variants with the same disaccharide stereochemistry as of DβM (Glcα(14)Glcβ) were included 
in the structure activity study (Figure 2.4). The structures synthesized include maltose derivative 
having a 10 (decyl β-matoside; DeβM), 11 (undecyl β-maltoside; UβM) and 12 (dodecyl β-
maltoside; DeβM) carbons aliphatic chain. Maltose derivatives with the hydrocarbon tails having 
terminally bulky aromatic groups such as, benzyl decyl-β-maltoside (BDeβM); benzyl dodecyl-
β-maltoside (BDβM); 4-tertiary butyl benzyl decyl-β-maltoside (4-tBuBDeβM); 4-tertiary butyl 
benzyl dodecyl-β-maltoside (4-tBuBDβM); 3,5-dimethyl benzyl dodecyl-β-maltoside (3,5-
DMBDβM); 4-methyl benzyl dodecyl-β-maltoside (4-MBDβM) and benzophenonyl decyl-β-
maltoside (BPDeβM) were synthesized. Maltose derivative with hydrocarbon tail bearing 
terminal non-aromatic bulky group, adamantane dodecyl-β-maltoside (ADβM) was also 
synthesized. Additionally, the effect of having a polar group attached at the end of the 
hydrocarbon chain was also investigated by synthesizing 12-hydroxyl decyl-β-maltoside (12-
HODeβM).  
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Figure 2.4 Library of maltose derivatives 
Synthesis of all the maltose derivatives was done using a literature reported procedure with a 
few modifications.150 Here the synthesis of one maltose derivative, BDβM (5) is described 
(Scheme 1) and the synthesis of others was done similarly (see materials and methods). Briefly, 
maltose was per-O-acetylated with AcBr/AcOH mixture with simultaneous bromination at the 
anomeric position. This was followed by glycosidation with 12-(benzyloxy) dodecan-1-ol in 
presence of FeCl3. Separation of α and β anomer was done by column chromatography. The 
deprotection of acetyl groups with sodium methoxide followed by neutralization to pH ~ 6.5 
with amberlite H+ resins (Zemplen deacetylation) yielded molecule BDβM (5).  
 
 
 
  
Scheme 2.1 Synthesis of maltose derivative BDβM (5) 
 
2.2.3. Maltose derivatives did not inhibit the growth of P. aeruginosa  
 
All the maltose derivatives were first examined for their effect on the growth of 
planktonic P. aeruginosa. None of the tested maltose derivatives inhibited the growth of P. 
aeruginosa strain at 170 μM (Figure 2.5). In fact at 170 μM, some of the maltose derivatives 
promoted the growth of P. aeruginosa. The concentration (170 μM) tested is higher than the 
effective concentration of these molecules at which all the following biological assays (biofilm 
inhibition, bacterial adhesion, biofilm dispersion and gene reporter assays) were done. The non- 
toxicity of these agents against P. aeruginosa indicates that the associated biological activities of 
such agents are not consequences of growth inhibition. Such a non-microbicidal mode of action 
is important as these agents are less likely to invoke drug resistance over time.26     
AcBr
AcOH
CH3ONa
CH3OH
Benzyl bromide NaH, DMF
HO(CH2)12OH
M e C N
F e C l3
H+ (pH ~6.5)
(5)
 
 
 
Figure 2.5 P. aeruginosa growth response curve in absence and in presence of various maltose 
derivatives at 170 µM. Error bar is the standard error of the mean from 6 replicates. 
2.2.4. Nonmicrobicidal anti-biofilm and anti-adhesion activities of maltose derivatives         
The amount of biofilm inhibited by maltose derivatives was quantified using crystal violet 
(CV) dye based assays. Two generic surfactants, SDS and C12EG4OH and one quorum sensing 
inhibitor, brominated furanone (BF8)151 was used as a control to contrast the anti-biofilm 
activities of the twelve maltose derivatives against P. aeruginosa biofilms. The results indicate 
that biofilm inhibition activity of maltose derivatives was sensitive to their structural details 
(Figure 2.6). Introduction of an aromatic bulky group on the aliphatic chain increased the 
potency of three maltose derivatives, BPDeβM, BDβM and 4-tBuBDeβM as compared to the 
maltose derivative with n-alkyl aliphatic chain, DβM. Five maltose derivatives, BPDeβM, 
BDβM, 4-tBuBDeβM, DβM, and 4-MBDβM inhibited more than 80 % of P. aeruginosa 
biofim. Inhibition in the range of 40 to 60 % was obtained by six maltose derivatives, ADβM, 
3,5-DMBDβM, 4-tBuBDβM, BDeβM, UβM and DeβM. Maltose derivative, 12-HODeβM 
having a hydrophilic terminal group (hydroxyl) on the aliphatic chain was structurally different 
than other maltose derivatives in not having an amphiphilic structure. This non-amphiphilic 
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molecule showed very low anti-biofilm activity (only ~ 30% inhibition). Increasing the aliphatic 
chain length of maltose derivatives from ten carbons (DeβM) which had a biofilm inhibition of ~ 
40% at 110 µM to twelve carbons (DβM) increased the inhibition to ~ 64 % at similar 
concentration. This suggests that the length of the aliphatic chain plays an important role in 
conferring anti-biofilm property to the agents.  
Usually the adhesion of planktonic cells onto the surfaces is the first step of bacterial 
infections and biofilm formation. While many studies have been done on designing carbohydrate 
ligands that behave as molecular interventions against microbial adhesion,143, 152, 153 not many 
studies have focused on using these ligands for inhibition of bacterial biofilm formation. 
Important examples are the GalNacβ(1→4)Galβ  based carbohydrate ligands reported by Randall 
and co-workers, which can bind P. aeruginosa adhesin protein, pili. 140 The anti-biofilm 
activities of such GalNacβ(1→4)Galβ  based molecules remains unknown. Hence all the maltose 
derivatives were further tested for anti-adhesion activities against P. aeruginosa. A P. 
aeruginosa strain (PAO1-EGFP) that constitutively expresses green fluorescent protein (GFP) 
was allowed to adhere on a polystyrene surface for two hours with (85 µM) and without maltose 
derivatives (no agent). After two hours, the bacterial culture was discarded and replaced with 
fresh media. The amount of bacteria attached on the polystyrene surface was determined by 
measuring the fluorescence of the GFP expressed by the adhered bacteria. The amount of 
fluorescence from wells treated with maltose derivatives was compared to the fluorescence from 
the control wells and percent inhibition of adhesion was calculated (Figure 2.6). Most of the 
effective anti-biofilm agents were also potent anti-adhesion agents and in general there was a 
direct correlation between anti-biofilm and anti-adhesion activities Two maltose derivatives, 4-
tBuBDeβM and BDβM inhibited almost 80% of the P. aeruginosa adhesion on polystyrene 
 
 
surface. Five maltose derivatives; BPDeβM, DβM, 4-MBDβM, ADβM and 3, 5-DMBDβM 
inhibited more than 50 % of P. aeruginosa adhesion, while the remaining four maltose 
derivatives; 4-tBuBDβM, BDeβM, UβM and DeβM inhibited the adhesion by 20 to 50%. 
Maltose derivative; 12-HODeβM did not show any anti-adhesion activity.  
Although the known biofilm inhibitor, brominated furanone (BF8) inhibited the biofilm 
formation of P. aeruginosa by 40 %, it did not inhibit the bacterial adhesion. While the biofilm 
inhibition activity by BF8 can be attributed to the disruption of quorum sensing, the interference 
of quorum sensing does not lead to inhibition of adhesion.68 Even though the biofilm inhibition 
by two generic surfactants; SDS and C12EG4OH was very poor (Figure 2.6); these agents were 
able to inhibit the adhesion of P. aeruginosa by ~40 % (Figure 2.6). This set of two contrasting 
results suggests the following. Firstly, inhibition of quorum sensing may not imply inhibition of 
adhesion and that such maltose derivatives may not have a traditional mode of action, i.e through 
disruption of quorum sensing. Secondly, while surface activity or washing property seemed 
important to prevent bacterial adhesion, this physical property alone cannot explain why at 85 
µM, DβM, having lower surface activity than C12EG4OH (Table 2.1), was able to prevent more 
bacterial adhesion. 
 
 
 
Figure 2.6 Inhibition of biofilm and adhesion by maltose derivatives, generic surfactants (SDS, 
C12EG4OH) at 110 µM (anti-biofilm) and 85 µM (anti-adhesion) and known anti-biofilm agent 
BF8 at110 µM (anti-biofilm) and 100 μM (anti-adhesion) measured using CV dye-based and 
fluorescence assays, respectively. Error bar is standard error of the mean from 6 replicates. 
2.2.5. Dose-dependent anti-biofilm activity of maltose derivatives 
Five of the most potent anti-biofilm inhibitors; BPDeβM, BDβM, 4-tBuBDeβM, 4-
MBDβM and DβM were further tested in a dose-dependent manner (between ~20 to 140 μM) to 
determine their half maximal inhibitory concentrations (IC50)s for inhibition. For this, the percent 
biofilm inhibition at each selected concentration was plotted against the concentration (Figure 
2.7). Accordingly, the IC50s were calculated by solving for equation y = mln(x), where y = 50%. 
Maltose derivatives, BPDeβM and 4-tBuBDeβM showed the lowest IC50 of 23 μM (Figure 7). 
For the rest of the three maltose derivatives; BDβM, 4-MBDβM, and DβM, IC50s for biofilm 
inhibition were in the range of 23 to 48 μM (Figure 2.7). The IC50s values of the DSHs reported 
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here are comparable to and in some cases even better than the IC50s of some of the known potent 
biofilm inhibitors reported in literature previously.55, 60, 154, 155 
 
Figure 2.7 Dose response curve for biofilm inhibition and IC50 values for compounds (A) 
BPDeβM (11) and BDβM (5) (B) 4-MBDβM (9), 4-tBuBDeβM (6) and DβM (3). Biofilm was 
quantified by staining with CV dye. Error bar is standard error of the mean from 6 replicates. 
2.2.6 Demonstrating anit-biofilm activities of maltose derivatives by fluorescence microscopy   
        
Anti-biofilm activity of three active maltose derivatives; BPDeβM, BDβM and DβM 
was also verified by fluorescence based static biofilm assay.  P. aeruginosa strain, PAO1-EGFP 
that constitutively expresses green fluorescent protein (GFP) was allowed to grow on sterile steel 
coupons for 24 h. The biofilms formed on the steel coupons grown in presence (85 µM) and in 
absence of maltose derivatives were viewed under confocal laser scanning microscope (CLSM). 
The fluorescence observed indirectly indicates the amount of biofilm formed on the steel 
coupons. The CLSM micrographs shows that the fluorescence signal and hence the biofilm 
formed on steel coupons in presence of BPDeβM, BDβM and DβM was significantly lower than 
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the steel coupons without agents (Figure 2.8). Additionally, the biofilm thickness on steel 
coupons treated with maltose derivatives was significantly lower than the thickness of biofilm on 
steel coupons grown in absence of such agents. Results obtained by fluorescence based static 
biofilm assay were consistent with the results obtained from crystal violet assays.  
 
Figure 2.8 Representative confocal laser scanning microscopy (CLSM) micrographs of biofilm 
formed by PAO1-EGFP on steel coupons; (A) in the absence of agents, and in the presence of 85 
μM (B) BPDeβM (11); (C) BDβM (5); (D) DβM (3). Scale bar = 76 µm.  
2.2.7 Minimal media (M9+) is the optimum medium for higher biofilm inhibition activities by 
maltose derivatives.  
The type of nutrients and the carbon sources present in the culturing media impact both the 
amount of biofilm formed and its structure.156, 157 Hence, maltose derivatives anti-biofilm 
activities were tested in three different culture medias, Luria-Bertani (LB), Luria-Bertani no salt 
(LBNS) and minimum media M9+ (95 % M9 and 5 % LB). Luria-Bertani (LB) medium is very 
rich in nutrients and contains sodium chloride, tryptone and yeast extracts and LB media without 
sodium chloride is known as LBNS medium. Minimal media M9+ contains inorganic salts, 
 
 
carbon source like glucose and casamino acids as nitrogen source. Detailed composition of each 
of these media is discussed in Materials and Methods. The amount of biofilm formed was 
maximum in LB broth followed by M9+ medium and then LBNS medium. Blackwell and co-
workers have reported that despite the higher biofilm formation in LB media, the biofilm 
adhered to the bottom of the well surfaces, known as “surface attached” biofilm, is maximum in 
M9+ medium and not in LB media.114 The anti-biofilm activities of the maltose derivatives 
appeared to be lower in LB media than in M9+ media, and no significant biofilm inhibition was 
observed in a medium without sodium chloride, LBNS (Figure 2.9). This suggests that the 
quantitatively lesser biofilm formed in LBNS medium was more robust and maltose derivatives 
are incapable of inhibiting this biofilm. 
 
Figure 2.9 Inhibition of P. aeruginosa (PAO1) biofilm with selective maltose derivatives in M9+ 
(95 % M9 and 5 % LB), LB and LBNS medium 
2.2.8 Maltose derivatives disperse one-day old P. aeruginosa biofilm  
Dispersing preformed biofilms is not only a more challenging task, but also more relevant 
for applications related to medical devices and industries. Once biofilms mature, they become 
more robust and more immune to treatment techniques than biofilms that are still in the early 
stages of development. To test the versatility of these maltose derivatives as both biofilm 
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inhibitors and dispersers, we screened the ability of all the maltose derivatives at 110 μM to 
disperse 24 h old biofilm of P. aeruginosa (Figure 2.10). P. aeruginosa was first grown in M9+ 
media within wells of 96-well microtiter plates for 24-h and the one day old biofilm thus formed 
was further treated for additional 24-h with the various maltose derivatives. The biofilms 
remaining in the wells after the treatment with agents for 24-h was quantified by staining with 
crystal violet (CV) dye stain. The percent biofilm dispersed was calculated by comparing the 
biofilm remaining in wells treated with maltose derivative to wells that contained no agents. The 
trend in the ability of maltose derivatives to disperse the preformed biofilm was similar to the 
trend for biofilm inhibition activity (Figure 2.10). Two maltose derivatives, BPDeβM and 
BDβM were the most potent biofilm dispersers. Five maltose derivatives BPDeβM, BDβM, 4-
tBuBDβM, DβM and 4-MBDβM exhibited > 50 % biofilm dispersion.  
A dose-dependence study was also done using the biofilm dispersers that exhibited 
maximum dispersion activity at 110 μM, BPDeβM, BDβM, 4-tBuBDβM, DβM and 4-
MBDβM. Dose dependence study for dispersion of 24 h old biofilm gave half-maximal 
dispersion (DC50) values to be 31 μM, 32 μM, 43 µM, 66 µM and 77 µM for BPDeβM, BDβM, 
4-tBuBDβM, DβM and 4-MBDβM, respectively (Figure 2.11). The DC50 values of DSHs 
reported here are comparable to dispersion potencies of some of the best biofilm dispersers 
reported so far.114, 115 However, unlike previously reported biofilm dispersers, we believe that the 
mechanism of the anti-biofilm activities of these maltose derivatives is likely not due to direct 
disruption of bacterial quorum sensing.  
 
 
  
Figure 2.10 Dispersion of PAO1 biofilm by adding 110 µM of maltose derivatives to the 24-h 
old biofilms followed by quantifying the biofilm remaining with CV-dye staining. Error bar is 
standard error of the mean from 6 replicates. 
 
Figure 2.11 Dose response curve and values of half-maximal inhibitory concentrations for 
biofilm dispersion (DC50) for compounds BPDeβM (11), BDβM (5), 4-MBDβM (9), 4-
tBuBDeβM (6) and DβM (3). The biofilm remaining after treatment with various maltose 
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derivatives were quantified by staining with crystal violet dye. Error bar is standard error of the 
mean from 6 replicates. 
2.2.9 Maltose derivatives are effective at inhibiting the biofilm formation of mucoid P. 
aeruginosa 
As discussed previously, inhibition of mucoid biofilm is more difficult than the inhibition 
of wild type P. aeruginosa biofilms. However, the inhibition of the biofilm formed by mucoid P. 
aeruginosa is important because this strain is associated with multiple medical conditions 
including Cystic Fibrosis. Therefore, three maltose derivatives, BDβM, DβM and ADβM were 
tested against the biofilm formation of mucoid P. aeruginosa.  At 160 µM, all the three maltose 
derivatives were effective at inhibiting the biofilm formation of mucoid P. aeruginosa and the 
trend in biofilm inhibition activities was similar to the trend for wild type P. aeruginosa (Figure 
2.12 A). Maltose derivative BDβM inhibited almost ~78% of the mucoid P. aeruginosa biofilm. 
Interestingly, maltose derivatives were capable of reducing the secretion of extra polymeric 
substances by mucoid P. aeruginosa as seen from the pictures of the falcone tube in which 
mucoid P. aeruginosa was allowed to grow (stationary) for 24 h with and without 160 µM of 
DβM (Figure 2.12 B).  
 
 
 
 
 
Figure 2.12 (A) Inhibition of mucoid P. aeruginosa biofilm by maltose derivatives at 160 µM. 
The biofilm contents after inhibition were measured by staining with CV dye-stain. Error bar is 
standard error of the mean from 6 replicates. (B) Inhibition of production of extra polymeric 
substances by maltose derivatives. Mucoid P. aeruginosa incubated in 15 mL falcone tube with 
(160 µM) and without DβM at 37 °C for 24 h.  
2.2.10 Maltose derivatives do not interfere with the quorum sensing of P. aeruginosa 
 
A very common and well studied strategy for biofilm inhibition is the disruption of 
bacterial quorum sensing. Autoinducer mimics introduced into the bacterial cultures interfere 
with the natural quorum sensing process and hence these mimics are able to inhibit multicellular 
phenomena like biofilm formation. Even though the structure of maltose derivatives had no 
resemblance to the structures of natural autoinducers, they did possess some structural 
similarities with another molecule secreted by P. aeruginosa, biosurfactant rhamnolipids. The 
production of rhamnolipids by P. aeruginosa is controlled by the quorum sensing circuits of the 
bacteria. Hence a gene reporter assay was used to investigate if maltose derivatives interfered 
with the quorum sensing circuits of P. aeruginosa. The quorum sensing process in P. aeruginosa 
 
 
is controlled by las and rhl gene systems. In antagonist gene reporter assay externally added 
agents compete with natural autoinducers for the two receptor proteins of las and rhl systems, 
lasR or rhlR, respectively. Depending upon whether external agents are lasR or rhlR protein 
agonists or antagonists, they either activate or repress the expression of lasI or rhlI, synthases 
proteins. Expression of lasI and rhlI proteins is quantified by measuring the expression of green 
fluorescent protein (GFP) fused to lasI and rhlI genes in a plasmid. We tested the effect of 
maltose derivatives on the las or rhl quorum sensing system by quantifying the GFP expressed 
by two reporter strains (PAO1/plasI_LVAgfp or PAO1/prhlI_LVAgfp). For both las and rhl 
quorum sensing systems addition of maltose derivatives had no significant change in the 
fluorescence of the two reporter strains (Figure 2.13), which implies that maltose derivatives do 
not compete with natural autoinducers of  P. aeruginosa and their biological activity is not by 
interfering with the major quorum sensing circuitry. 
For investigating the agonistic activities of the maltose derivatives, we used the double 
knockout strains of PAO1, PAO-JP2 (plasI-LVAgfp) and PAO-JP2 (prhlI-LVAgfP) that lack the 
synthesis of both the natural autoinducers AI-1 and AI-2.61 For the double knock out strains, the 
activation of las and rhl systems, by agonists is reflected by the expression of green fluorescent 
protein (GFP) expressed by the plasmids plasI-LVAgfp and prhlI-LVAgfP respectively.62 The 
addition of maltose derivatives did not increase in the fluorescent signals of the two double 
knock out reporter strains (Figure 2.14), indicating that these agents do not agonize the quorum 
sensing of P. aeruginosa. 
 
 
 
Figure 2.13 Fluorescence (GFP) signal by PAO1 having plasmid (a) plasI_LVAgfp, and (b) 
prhlI_LVAgfp in the absence and in the presence of selective maltose derivatives (85 µM). 
Fluorescence signals were corrected for cell density by dividing by OD600 of cell culture. Error 
bar is standard error of the mean from 4 replicates. 
 
Figure 2.14 Agonist gene reporter assay with two reporter stains PAO-JP2(plasI-LVAgfp) (for 
las system) and PAO-JP2(plasI-LVAgfp) (for rhl system). Fluorescence signal by two reporter 
strains in the presence of natural autoinducers was used as a control.  Concentration of all the 
maltose derivatives used was 85 µM. Fluorescence signals were corrected for cell density by 
dividing by OD600 of the cell culture. Error bar is standard error of the mean from 4 replicates. 
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2.3 Discussion 
The structure activity studies with maltose derivatives revealed that the effects of such 
agents on biofilm formation and adhesion were highly sensitive to the structural details. For 
example, the only difference between the structures of the two maltose derivatives, 4-
tBuBDeβM and 4-tBuBDβM is that the aliphatic chain is longer in 4-tBuBDβM by two 
methylene units, but the anti-biofilm and anti-adhesion activities of 4-tBuBDeβM were 
significantly better than 4-tBuBDβM (Figure 2.6). A contrasting comparison was obtained for 
two other maltose derivatives, BDeβM and BDβM, where the agent with the longer aliphatic 
chain, BDβM was a better anti-biofilm and anti-adhesive agent than the agent possessing the two 
methylene shorter aliphatic chain, BDeβM. These results suggest that there exists a requirement 
for appropriate size of the agent, where agents with extra bulky terminal groups (4-tertiary butyl 
benzyl) exhibit higher potencies when attached to a shorter aliphatic chain (ten carbons) and 
agents with relatively smaller terminal groups (benzyl) had better activities when attached to 
longer aliphatic chains (twelve carbons). Because of this structural sensitivity for various 
bioactivities, we believe that these results support the notion that such maltose derivatives bring 
about different levels of allosteric activations of the putative receptor leading to different 
agonistic or antagonistic effects.  
Another hypothesis is that the physical washing-away effect of such maltose-based 
amphiphilic molecules can explain the anti-adhesion and the anti-biofilm activities of such 
agents. However, at least two observations here could not be explained by the physical 
explanation alone. Firstly, the half-maximal inhibitory constants for inhibition and dispersion 
(IC50 and DC50 respectively), for most of these agents were much lower that the critical micelle 
concentration (CMC) of a typical maltoside (DβM ~170 μM). Secondly, in general other generic 
 
 
surfactants like SDS and C12EG4OH did not exhibit any observable anti-biofilm activities. Also, 
the non-ionic surfactant, C12EG4OH has a higher surface activity than DβM, but C12EG4OH 
was comparably a much poorer anti-biofilm and anti-adhesive agent than DβM.  
Therefore, we believe that, there exists a receptor or multiple receptors for such maltose 
derivatives on the surface of the bacteria. It is widely understood that many protein receptors do 
exist on the bacterial surface that can recognise different saccharide stereochemistries.140, 143, 158  
For P. aeruginosa, there exist at least two receptors systems that are known to be 
involved in adhesion or the biofilm formation processes, pilus protein and putative rhamnolipids 
receptor. Pilus protein is known to be essential for mediating bacterial adhesion onto surfaces. 
The pilus protein has been found to specifically recognize the disaccharide-derivatives 
possessing GalNAcβ(14)Galβ stereochemistry. The maltose derivative presented in this study 
possesses Glcα(14)Glcβ stereochemistry and it remains to be found if such a stereochemistry 
is also recognized by the pili of P. aeruginosa. Another possible target of such maltose 
derivatives could be the putative receptor system of rhamnolipids ligands. Rhamnolipids are 
disaccharide based lipids that are known to control biofilm architecture and biofilm dispersion. 
While the receptor for rhamnolipids remains unclear, rhamnolipids have been suspected to be 
strongly associated with protein SadB (surface attachment-defective gene product).159  
While maltose derivatives could be targeting either of the two mentioned receptor 
systems, they could also possess promiscuous binding abilities to bind both pili and putative 
rhamnolipids receptor, or they could also have entirely different receptor system. 
 
 
 
2.4. Conclusion and perspectives  
In this study, we presented a class of maltose derivatives that are effective towards three 
bioactivities of P. aeruginosa: reducing adhesion, preventing biofilm formation and inducing 
dispersion of the formed biofilms. Structure-activity study brought forward some potent agents 
and revealed that potency is closely related to structural details. The washing effect due to 
surface activity of maltose derivatives could not be used to explain the anti-biofilm activities of 
these agents as a surfactant molecule with better surface activity than a maltose derivative 
showed insignificant effect on biofilm of P. aeruginosa. It is possible that, the maltose 
derivatives interfere with the putative receptor site of rhamnolipids or they are recognized by 
pilus protein of P. aeruginosa. Formation of biofilm is a multicellular behaviour that is 
consistent across most microbes and if such microbes have homologous disaccharide receptors, 
then a nonmicrobicidal anti-biofilm strategy based on the use of maltose derivatives could be 
developed for an array of microbes or for biofilms formed by two or more microbes together.123  
2.5 Materials and Methods 
 
Bacterial strains and growth media    
Wild type P. aeruginosa, PAO1 and mucoid P. aeruginosa strains were obtained from Dr. 
Guirong Wang (Upstate Medical University). Strains PAO-JP2 (plasI-LVAgfp) and PAO-JP2 
(prhlI-LVAgfp) were obtained from Dr. Helen E. Blackwell (Univ. of Wisconsin-Madison). 
Plasmids plasI-LVAgfp and prhlI-LVAgfp were gifted by Dr. Hiroaki Suga (The University of 
Tokyo). All the bacterial strains were grown in Luria-Bertani (LB) medium containing 10 g/L 
tryptone, 5 g/L yeast extract, and 10 g/L NaCl at 37 °C. For biofilm inhibition and dispersion 
assays 95 % M9+ medium with 5% of LB broth was used unless otherwise stated. M9+ medium 
 
 
contained 18.7 mM NH4Cl, 21.7 mM KH2PO4, 47.7 mM Na2HPO4, 8.6 mM NaCl, 0.1 mM 
CaCl2, 1 mM MgSO4, 0.2% anhydrous α-D(+)-glucose, 0.4% L-Arg, 0.2% citric acid 
monohydrate, 0.5% Casamino Acids (CAA), 0.2% sodium succinate dibasic hexahydrate and 
0.2% L-glutamic acid monopotassium salt monohydrate.114 
 
Stock solutions of generic surfactants and synthesized maltose derivatives        
Stock solutions of all the agents (11.5 mM) were prepared in autoclaved water, sterilized by 
filtering through 0.2 µm syringe filter, and stored at -20 °C in sealed vials. Appropriate amount 
of sterile water was added to controls in all assays to eliminate the solvent effect. 
Crystal violet dye-based biofilm inhibition assay   
Inhibitory effect of all the maltose hydrocarbons on P. aeruginosa biofilm formation was 
determined by crystal violet dye based biofilm inhibition assays (Figure 2.S1). Overnight culture 
of wild type P. aeruginosa (PAO1) was sub cultured to an OD600 of 0.01 into the 95:5 M9+/LB 
medium or LB medium. Aliquots (200 µL) of the sub culture were introduced into the wells of 
96-well polystyrene microtiter plate when it reached the OD600 of 0.1. Predetermined 
concentrations of the test compounds were then added to the respective wells containing sub 
culture. Sample plates were wrapped in GLAD Press n’ Seal® followed by incubation under 
stationary conditions for 24 h at 37 °C. After incubation the media was discarded and the plates 
were washed with water and dried for 1 h at 37 °C. The sample plates were stained with 200 μL 
of 0.1% aqueous solution of crystal violet (CV) and followed by incubation at ambient 
temperature for 20 min. The CV stain was then discarded and the plates were washed with water. 
The remaining biofilm adhered stain was re-solubilized with 200 μL of 30 % acetic acid. After 
the stain was dissolved (15 minutes), 100 μL of the solubilized CV was transferred from each 
 
 
well into the corresponding wells of a new polystyrene microtiter dish. Biofilm inhibition was 
quantified by measuring the OD600 of each well in which a negative control lane wherein no 
biofilm was formed served as a background and was subtracted out. The percent inhibition was 
calculated by the comparison of the OD600 for biofilm grown in the absence of compound 
(control) versus biofilm grown in the presence of compound under identical conditions. Biofilm 
inhibition assay with all the maltose derivatives was repeated four times and each data point in 
the graph is the average of values from 6 wells. 
 
 
Figure 2.S1 Schematic representation of crystal violet (CV) dye based biofilm inhibition assay 
Anti-adhesion assay     Overnight culture of PAO1-GFP was subcultured to an OD600 of 
0.01 into the 95/5 M9+/LB medium. Subculture was allowed to reach the OD600 of 0.1 in a rotary 
shaker at 250 rpm and 37 °C. 200 µL of the subculture was then transferred to the wells of black 
microtiter plate with and without (control) maltose derivatives. This black 96-well plate was then 
incubated in a shaker at 37 °C for 2 h. After 2 h, bacterial culture from the plate was discarded 
and each well was washed once with saline water (0.85 w/v% aqueous NaCl solution). Fresh 
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95/5 M9+/ LB medium was added to the black 96 well plate and fluorescence of the surface 
adhered bacteria was measured by Synergy 2 multi-mode microplate reader with Gen5 data 
analysis software at an excitation wavelength of 500 nm and an emission wavelength of 540 nm. 
Background signal from 95/5 M9+/LB medium was eliminated from all the samples.    
Dispersion assay for preformed biofilm Plate for biofilm dispersion assay was set up similar 
to crystal-violet based- biofilm inhibition assay but without adding any maltose derivative at the 
time of inoculation of bacteria in the 96 well plate (Figure 2.S2). PAO1 was allowed to grow for 
24 h at 37 °C. After 24 h, bacterial culture was pipetted out and replaced with 200 µL of 110 µM 
maltose hydrocarbons in fresh medium. After 24 h treatment with maltose hydrocarbons, biofilm 
was fixed and quantified using crystal violet dye as described above. The amount of dispersed 
biofilm was determined by comparing (normalizing) the amount of biofilm at 48 h with and 
without maltose hydrocarbons. 
 
Figure 2.S2 Schematic representation of crystal violet (CV) dye based biofilm dispersion assay 
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Dose dependence assays for biofilm inhibition and dispersion  Five maltose derivatives with 
highest activity for biofilm inhibition and dispersion were selected for plotting dose response 
curve. Predetermined amounts of maltose derivatives stock solution were added to the 200 µL 
bacterial culture in 96 well plate so that the final concentration of the agent reaches the desired 
values of 1, 5, 10, 20, 40, 85, 113, 140 µM.  
Effect of maltose derivatives on the growth of P. aeruginosa Optical density was measured 
using Biotek ELx800 TM absorbance microplate reader (BioTek Instruments, Inc., Winooski, 
VT) using Gen5TM data analysis software. The OD600 values were taken in sterile conditions at 
0, 2, 4, 6, 8, 10, 12, and 24 h after bacterial culture inoculation in 96-well polystyrene plate with 
and without agents in LB broth. 
Gene reporter assays for las and rhl quorum sensing systems of P. aeruginosa 5,6  Plasmids plasI-
LVAgfp and prhlI-LVAgfp were provided by Dr. Hiroaki Suga (The University of Tokyo). 
Strains PAO-JP2 (plasI-LVAgfp) and PAO-JP2 (prhlI-LVAgfp) were obtained from Dr. Helen 
Blackwell. For an antagonist assay, overnight culture of P.aeruginosa PAO1/plasI-LVAgfp (las 
system ) or PAO1/prhlI-LVAgfp (rhl system) in LB broth (supplemented with 300 µg/mL 
carbenicillin) was grown from a single colony on a LB agar plate supplemented with 300 µg/mL 
carbenicillin. The overnight culture was diluted and grown to OD600 of 0.1 in LB broth 
containing 300 µg/mL of carbenicillin. Bacterial culture (200 µL) was added to each well of a 
polystyrene 96-well microtiter plate containing an appropriate amount of maltose derivatives or 
sterile water as a control. The plate was incubated at 37 °C for 24 h in a rotary shaking incubator 
(250 rpm). The culture from each well was then transferred to a flat-bottom, 96-well plate with 
black wall (µClear, Greiner-One 655096). The fluorescence and OD absorbance in each well was 
measured by Synergy 2 multi-mode microplate reader with Gen5 data analysis software. 
 
 
Background signals from LB broth were eliminated from all samples. Fluorescence was 
measured at an excitation wavelength of 500 nm and an emission wavelength of 540 nm. Agonist 
assay was also done in a similar manner except PAO-JP2 (plasI-LVAgfp) and PAO-JP2 (prhlI-
LVAgfP), double knockout strains (do not produce natural autoinducers) were used instead of wt 
PAO1. Agonist activities of the maltose derivatives were compared to the activities exhibited by 
externally added natural autoinducers. 
Electroporation of plasmids to prepare gene reporter strains   Plasmids plasI-LVAgfp and prhlI-
LVAgfp were transferred to wild type P. aeruginosa (PAO1) by electroporation method. Briefly, 
overnight culture of PAO1 was subcultured in 25 mL LB broth and was grown to reach the 
OD600 of 0.5 to 0.8 by shaking the culture at 37 °C. Flask containing subculture was cooled on 
ice for 30 min. Cell pellet was obtained by centrifugation at 4500 rpm for 5 min. Supernatant 
was removed and cell pellet was resuspended in 20 mL ice-cold 300 mM sucrose solution. Cells 
were centrifuged at 4500 rpm for 5 min. Supernatant was discarded and cell pellet was 
resuspended in 1 mL ice-cold 300 mM sucrose solution. Cell suspension was transferred to a 
new 1.5 mL ice-cold microcentrifuge tube and spun down at 13,000 rpm for 30 sec. Supernatant 
was discarded and cell pellet was resuspended in 500 µL ice-cold 300 mM sucrose solution. For 
the last time cells were spun down at 13,000 rpm for 30 sec. After removal of the supernatant, 
cell pellet was resuspended in 100 µL ice-cold 300 mM sucrose solution. 50 µL of the competent 
cell suspension along with 5 µL of plasmid DNA in TE buffer was transferred to the cold 0.1 cm 
electroporation cuvette. Electroporator was set to Ec1 and pulse was passed through the cells. LB 
medium (1 mL) was immediately added to the electroporator cuvette and cell suspension was 
transferred to a sterile microcentrifuge tube and incubated for 1 h at 37 °C with shaking at 180 
rpm. Cells were then spread on the LB agar (1.5 %) plates supplemented with 300 µg/ mL 
 
 
carbenicillin (antibiotic) and incubated over night at 37 °C to get the microcolonies of PAO1 
(plasI-LVAgfp) or PAO1 (prhlI-LVAgfp). 
 
Materials and methods for organic synthesis 
All reagents were bought from commercial sources (Sigma-aldrich, TCI-America, 
Acros). Solvents were obtained from Fisher and Sigma and used without any further purification. 
HRMS was obtained through positive ESI on Bruker 12 Tesla APEX-QE FTICR-MS with an 
Apollo II ion source at Cosmic instrumentation center, Virginia. TLC visualization was done 
under UV light (254 nm) or with ceric ammonium molybdate (CAM) staining. Solvents were 
removed in vacuo using Bűchi rotary evaporator below 40oC. EMD silica gel 60 F254 pre-coated 
plates (0.25-mm thickness) were used for TLC. Column chromatography was performed using 
Silicycle, silia-P flash silica gel with 40-63 μ mesh size. 1H and 13C NMR spectra were recorded 
on 300 MHz or 400 MHz and 75 MHz or100MHz Bruker instruments respectively. 1H chemical 
shifts are reported in ppm relative to CDCl3 δ 7.27 or CD3OD δ 3.31. 13C chemical shifts are 
reported in ppm relative to CDCl3 δ 77.0 or CD3OD δ 49.0.  
Organic Synthesis 
Synthesis of monobenzyl alkyl ether 
R3
R2
R1 Br
HO OH
n
R3
R2
R1
O OHnNaH (0.8 eq), DMF
rt, 12h
4a - 10a, 11a  
1,12-dodecanediol or 1,10-decanediol (5.0 mmol) was dissolved in 20 mL DMF and to 
this was added a heterogeneous dispersion of NaH (60% by weight) in mineral oil (0.22 g, 4 
 
 
mmol). Reaction mixture was stirred at room temperature (rt) for one hour and benzyl bromide-
derivative (5.0 mmol) was added slowly to this heterogeneous solution. Reaction was allowed to 
stir at room temperature for 12 h. The reaction mixture was added into 100 mL water and 
extracted with diethyl ether (30 X 3 mL). The organic layer was washed with brine (100 mL), 
dried over Na2SO4, and concentrated in vacuo. The crude product was purified by column 
chromatography (15% EtOAc/hexanes) to afford the monobenzyl alkyl ether. 160 
O OH
8
4a  
(4a: R1= R2= R3 = H, n = 8) A white solid (0.6 g, 40%) Rf – 0.62 (Hexane : EtOAc, 3:2). 1H 
NMR (300 MHz, CDCl3): δ 7.38-7.26 (m, 5H), 4.51 (s, 2H), 3.64 (t, J = 6.6 Hz, 2H), 3.47 (t, J = 
6.6 Hz, 2H), 2.05 (br s, 1H), 1.64-1.52 (m, 4H), 1.37-1.27 (m, 12H). 
 
O OH
10
5a  
(5a: R1= R2= R3 = H, n = 10) A white solid (1.3 g, 43%) Rf – 0.70 (Hexane : EtOAc, 3:2). 1H 
NMR (300 MHz,CDCl3): δ 7.45-7.21 (m, 5H), 4.50 (s, 2H), 3.63 (t, J = 6.8 Hz, 2H), 3.47 (t, J = 
6.8 Hz, 2H), 2.10 (br s, 1H), 1.66-1.52 (m, 4H), 1.31-1.27 (m, 16H); 13C NMR (100.6 MHz, 
CDCl3): δ 138.6, 128.3, 127.6, 127.4, 126.9, 72.8, 70.5, 63.0, 32.7, 29.7, 29.5, 29.4 (br), 29.3 
26.1, 25.7.161  
 
 
 
 
O OH
8
6a  
(6a: R1= R3 = H, R2= t-Butyl, n = 8) Colorless liquid (0.83g, 40%) Rf – 0.72 (Hexane: EtOAc, 
1:1). 1H NMR (300 MHz,CDCl3): δ 7.38 (dt, J = 8.4Hz, J = 1.7Hz, 2H), 7.29 (m, 2H), 4.48 (s, 
2H), 3.65 (dd, J = 9.7Hz, J = 6Hz, 2H), 3.46 (t, J = 6.6Hz, 2H), 1.55-1.64 (m, 4H), 1.27-1.33 (br 
s, 12H), 1.32 (s, 9H). 13C NMR (75 MHz, CDCl3): δ 150.7, 150.4, 138.0, 135.7, 127.5, 126.9, 
125.5, 125.3, 77.4, 77.2, 77.0, 76.7, 72.7, 70.5, 65.2, 63.1, 34.6, 34.5, 32.8, 31.4, 29.8, 29.6, 29.5, 
29.4, 26.2, 25.7. HRMS (ESI) m/z: Calcd. (C21H36O2)Na+: 343.2607; Found: 343.2608. 
 
O OH
10
7a  
(7a: R1= R3 = H, R2= t-Butyl, n = 10) White solid (1.23g, 36%), Rf – 0.74 (Hexane: EtOAc, 1:1). 
1H NMR (400 MHz,CDCl3): δ 7.41 (dt, J = 8.6Hz, J = 2.2Hz, 2H), 7.29-7.34 (m, 2H), 4.51 (s, 
2H), 3.67 (t, J = 6.6Hz, 2H), 3.50 (t, J = 6.6Hz, 2H), 1.55-1.67 (m, 4H), 1.35 (s, 9H), 1.27-1.45 
(br s, 16H). 13C NMR (75 MHz, CDCl3): δ 150.7, 150.4, 138.0, 135.7, 127.5, 126.9, 125.5, 
125.3, 77.4, 77.2, 77.0, 76.7, 72.7, 70.5, 65.2, 63.1, 34.6, 34.5, 32.8, 31.4, 29.8, 29.6, 29.5, 29.4, 
26.2, 25.7. HRMS (ESI) m/z: Calcd. (C23H40O2)Na+: 371.2920; Found: 371.2921. 
 
 
 
 
 
 
O OH
10
8a
 
(8a: R1 = R3 = -CH3, R2 = H, n= 10) White solid, yield (0.57 g, 36 %) Rf – 0.60(Hexane: EtOAc, 
3:2). 1H NMR (300 MHz, CDCl3): δ 6.99-6.91 (m, 3H), 4.42 (s, 2H), 3.68 -3.61 (m, 2H), 3.45 (t, 
J = 6.6 Hz, 2H), 2.61-2.27 (m, 6H), 1.66 -1.52 (m, 4H), 1.44 -1.27 (m, 16H). 
O OH
10
9a  
(9a: R1= R3 = H, R2= -CH3, n = 10) White solid, yield (0.45 g, 41%) Rf – 0.60 (Hexane : EtOAc, 
3:2). 1H NMR (300 MHz, CDCl3): δ 7.28-7.14 (m, 4H), 4.64 (s, 2H), 3.64 (t, J = 6.6 Hz, 2H), 
3.55 (t, J = 6.6 Hz, 2H), 2.55 (s, 3H), 2.05 (br s, 1H), 1.68-1.52 (m, 4H), 1.37-1.27 (m, 16H).  
O
O
8
OH
11a  
(11a: R1= -(C=O)Ph, R2= R3 = H, n = 8) White solid, yield (0.30 g, 22 %) Rf – 0.50 (Hexane : 
EtOAc, 3:2). 1H NMR (300 MHz, CDCl3): δ 7.81-7.78 (m, 4H), 7.62-7.55 (m, 1H), 7.48-7.41 
(m, 4H), 4.59 (s, 2H), 3.68 -3.61(m, 2H), 3.50 (t, J = 6.6 Hz, 2H), 2.61-2.27(m, 6H), 1.69-1.58 
(m, 2H), 1.44 -1.29 (m, 14H)  
 
 
 
 
 
 
Synthesis of adamantyl dodecyl ether 
O
OH
10
Br
HO OH
10
TEA
110 °C, 12 h 10a
 
Mixture of 1-bromoadamantane (2 g, 4.648 mmol), triethylamine (1.6 mL, 28.2 mmol) and 1,12-
dodecanediol (20 g, 46.48 mmol) was heated at 110 °C for 12 h. After 12 h, reaction mixture was 
cooled down to rt and diluted with 50 mL of CH2Cl2. The solution was washed with 1 M HCl (3 
× 10 mL) and water (2 × 10 mL). The organic layer was dried over Na2SO4 and concentrated in 
vacuo. The crude product was purified by column chromatography (15% EtOAc/hexanes) to 
afford 10a as a colorless solid (0.438 g, 14 %), Rf – 0.65 (Hexanes: EtOAC, 3:2).162  1H NMR 
(300 MHz, CDCl3): δ 3.64 (t, J = 6.6 Hz, 2H), 3.38 (t,  J = 6.9 Hz, 2H), 2.13 (s br, 3H), 1.74 (d, J 
= 3 Hz, 5H), 6.78 - 1.45 (m, 10 H), 1.27 (s, 17 H). 
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i. AcBr, AcOH, rt, 50 min
ii. 4a-11a, or 1,10-decanediol 
(12a), MeCN (for β anomer ), 
         FeCl3, rt. 1 h 4b - 12b  
The synthesis of aceto-bromo maltose was done under anhydrous conditions. D-(+)-
Maltose monohydrate (1.0 g, 2.8 mmol), AcBr (~7.2 mL, 88.8 mmol), and AcOH (19 mL) were 
mixed in oven dried round bottom flask and stirred at rt for ~ 50 min. Reaction mixture was 
concentrated in vacuo at 35 ⁰C followed with co-evaporation three times with PhMe (2×10 mL, 
anhydrous). The flask was further heated in vacuo at 50 ⁰C for 15 min to obtain a crude aceto-
bromo maltose as foamy solid.  
 
 
The crude aceto-bromo maltose was dissolved in MeCN (10mL) and various alcohols (2 
equivalents as compared to maltose monohydrate) were added. Under vigorous stirring, FeCl3 (2 
equivalents as compared to maltose monohydrate) was added to this mixture and the reaction 
mixture was allowed to stir at rt for 1 h. To the reaction mixture was added aq KBr (10%, 25 
mL) and PhMe (60 mL) under stirring. The organic phase was washed twice with aq KBr (10%, 
2×25 mL), once with aq NaHCO3 (5%, 25 mL) and twice with H2O (2×25 mL). Using a gradient 
elution (100 % hexane to 35 % ethyl acetate in hexane) the crude product was then purified 
through a silica column. 150 
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Foamy solid, Yield: (0.25 g, 9 %, 2 steps), Rf – 0.47 (Hexane : EtOAc, 1:1). 1H-NMR (300 MHz, 
CD3OD): δ 7.35-7.26 (m, 5H), 5.42 – 5.25 (m, 2H), 5.23 (t, J = 7.2 Hz, 1H), 5.03 (t, J = 11.4 Hz, 
1H), 4.94 – 4.67 (m, 2H), 4.50 – 4.43 (m, 4H), 4.27 (m, 2H), 4.18 – 3.92 (m, 4H), 3.82 (m, 1H), 
3.68 – 3.60 (m, 1H), 3.43 (t, J = 6.6 Hz, 3H), 2.17 – 1.98 (s, 7 × 3 H), 1.61 -1.45 (m, 4H), 1.23 (s, 
12 H). 13C NMR (75 MHz, CDCl3): δ 170.2, 170.1, 170.0, 169.8, 169.5, 169.1, 169.0, 138.2, 
127.9, 127.1, 127.0, 99.8, 95.0, 75.0, 72.4, 72.3, 71.8, 71.6, 71.5, 70.1, 69.8, 69.5, 68.9, 68.0,  
67.6, 67.4, 62.4, 62.3, 61.0, 29.3, 29.1, 29.0, 29.0, 28.9, 28.8, 28.7, 25.7, 25.5, 25.3, 20.5, 20.5, 
20.4, 20.2, 20.2, 20.2,20.1. HRMS (ESI) m/z: Calcd. (C43H62O19)Na+: 905.3777; Found: 
905.3781. 
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White solid, Yield: (0.45 g, 17 %, 2 steps), Rf – 0.47 (Hexane : EtOAc, 1:1). 1H-NMR (300 
MHz, CD3OD): δ 7.33-7.21 (m, 4H), 5.42 – 5.30 (m, 2H), 5.23 (t, J = 7.2 Hz, 1H), 5.03 (t, J = 
11.4 Hz, 1H), 4.94 – 4.67 (m, 2H), 4.50 – 4.43 (m, 4H), 4.27 (m, 2H), 4.18 – 3.92 (m, 4H), 3.82 
(q, J1-3 = 16.8 Hz, J1-2 = 7.2 Hz, 1H), 3.68 – 3.60 (m, 1H), 3.43 (t, J = 6.3 Hz, 3H), 2.16 – 1.98 (s, 
7 × 3 H), 1.65 -1.45 (m, 4H), 1.23 (s, 16 H). 13C NMR (75 MHz, CDCl3): δ 170.1, 170.1, 169.9, 
169.9, 169.6, 169.2, 169.0, 138.3, 127.9, 127.2, 127.0, 99.9, 95.1, 95.1, 75.1, 72.4, 72.3, 71.8, 
71.6, 71.1, 70.1, 69.8, 69.6, 68.9, 68.4, 68.0, 67.6, 67.0, 62.5, 62.4, 61.1, 61.0, 60.0, 29.4, 29.2, 
29.1, 29.0, 28.9, 28.8, 25.8, 25.6, 25.4, 20.7, 20.6, 20.5, 20.5, 20.3, 20.2. HRMS (ESI) 
m/z: Calcd. (C45H66O19)Na+: 933.4090; Found: 933.4080. 
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White solid, Yield: (0.275g, 17%, 2 steps), Rf – 0.53 (Hexane: EtOAc, 1:1). 1H-NMR (300 MHz 
CDCl3): δ 7.35-7.39 (m, 2H), 7.26-7.29 (m, 2H), 5.42 (d, J = 4.1Hz, 1H), 5.37 (t, J = 11.8Hz, 
1H), 5.26 (t, J = 9.3Hz, 1H), 5.06 (t, J = 10Hz, 1H), 4.79-4.89 (m, 2H), 4.52 (d, J = 8Hz, 1H), 
4.45-4.49 (m, 3H), 4.25 (h, J = 12.4Hz, J = 6.8Hz, J = 4.2Hz, 2H), 3.95-4.07 (m, 3H), 3.85 (dt, J 
= 9.6Hz, J = 6.1Hz, 1H),3.65-3.70 (m, 1H), 3.45-3.50 (m, 3H), 2.01-2.18 (s, 7*3H), 1.55-1.60 
(m, 4H), 1.32 (s, 9H), 1.25-1.40 (br s, 12H). 13C NMR (400 MHz, CD3OD): δ 20.6, 20.7, 20.8, 
 
 
20.9, 25.8, 26.0, 26.2, 29.3, 29.4, 29.5, 29.8, 31.4, 32.8, 34.5, 61.5, 62.9, 67.5, 68.0, 68.5, 68.8, 
69.4, 70.0, 70.2, 70.5, 71.5, 72.0, 72.2, 72.7, 72.8, 75.5, 76.7, 77.1, 77.3, 77.4, 95.5, 100.3, 125.2, 
127.5, 135.7, 150.4, 169.4, 169.6, 169.8, 169.9, 170.3, 170.5, 170.7. HRMS (ESI) m/z: Calcd. 
(C47H70O19)Na+: 961.4403; Found: 961.4386. 
O
AcO
OAc
AcO
O
AcO
AcO
OAc
O
OAc O O
10
7b  
Colorless solid, Yield: (0.261g, 11.3%, 2 steps), Rf – 0.55 (Hexane: EtOAc, 1:1). 1H-NMR (400 
MHz CDCl3): δ 7.37 (dt, J = 8.4Hz, J = 2Hz, 2H), 7.27 (m, 2H, overlapping with CDCl3), 5.42 
(d, J = 4Hz, 1H), 5.36 (t, J = 10.3Hz, 1H), 5.25 (t, J = 9.3Hz, 1H), 5.06 (t, J = 10Hz, 1H), 4.79-
4.88 (m, 2H), 4.51 (d, J = 7.9Hz, 1H), 4.47 (m, 3H), 4.25 (h, J = 12.4Hz, J = 7.9Hz, J = 4Hz, 
2H), 3.94-4.06 (m, 3H), 3.84 (dt, J = 9.6Hz, J = 6.3Hz, 1H), 3.67 (ddd, J = 9.6Hz, J = 4Hz, J = 
2.8Hz, 1H), 3.44-3.49 (m, 3H), 2.00-2.14 (s, 7*3H), 1.57-1.62 (m, 4H), 1.32 (s, 9H), 1.25-1.40 
(br s, 16H). 13C NMR (400 MHz, CD3OD): δ 20.6, 20.7, 20.8, 20.9, 22.7, 25.8, 26.0, 26.1, 26.2, 
28.6, 29.2, 29.3, 29.4, 29.5, 29.6, 29.7, 29.8, 31.4, 32.8, 34.5, 60.9, 61.5, 62.9, 64.7, 67.2, 68.0, 
68.5, 69.4, 70.0, 70.2, 70.5, 70.6, 72.1, 72.1, 72.2, 72.7, 72.8, 75.5, 76.7, 77.0, 77.2, 77.4, 86.6, 
95.5, 100.3, 125.2, 126.4, 127.1, 127.5, 128.3, 130.0, 130.3, 130.4, 132.4, 135.7, 150.4, 169.4, 
169.5, 169.6, 169, 170.0, 170.3, 170.5. HRMS (ESI) m/z: Calcd. (C49H74O19)Na+: 989.4716; 
Found: 989.4699. 
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White solid.Yield: (0.18 g, 11%, 2 steps), Rf – 0.43 (Hexane : EtOAc, 1:1). 1H-NMR (300 MHz, 
CD3OD): δ 6.93-6.84 (m, 3H), 5.41 – 5.30 (m, 2H), 5.24 (t, J = 9.0Hz, 1H), 5.03 (t, J = 9.9 Hz, 
1H), 4.87 – 4.77 (m, 2H), 4.51 – 4.39 (m, 4H), 4.26-4.21 (m, 2H), 4.05 – 3.85 (m, 4H), 3.81-3.74 
(m, 1H), 3.68 – 3.60 (m, 1H), 3.43 (t,  J = 6.6Hz ,3H), 2.29 (s, 6H), 2.21 – 1.99 (s, 7 × 3 H), 1.71 
-1.45 (m, 4H), 1.23 (s, 16 H). 13C NMR (75 MHz, CDCl3): δ 170.1, 170.0, 169.8, 169.5, 169.1, 
169.0, 138.1, 137.4, 128.6, 125.1, 99.8, 95.0, 75.0, 72.5, 72.3, 71.8, 71.6, 70.1, 69.8, 69.5, 68.9, 
68.0, 67.5, 67.0, 62.4, 61.0, 29.3, 29.1, 29.0, 28.9, 28.8, 25.7, 25.4, 20.8, 20.5, 20.4, 20.2, 20.2, 
20.2, 20.1  HRMS (ESI) m/z: Calcd. (C47H70O19)Na+: 961.4403; Found: 961.4391. 
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Colorless liquid, Yield: (0.21 g, 11 %, 2 steps), Rf – 0.43 (Hexane : EtOAc, 1:1). 1H-NMR (300 
MHz, CD3OD): δ 7.26-7.12 (m, 4H), 5.41 – 5.32 (m, 2H), 5.24 (t, J  = 9.0Hz, 1H), 5.03(t, J = 9.9 
Hz, 1H), 4.87 – 4.75 (m, 2H), 4.51 – 4.34 (m, 5H), 4.26-4.21 (m, 2H), 4.05 – 4.00 (m, 3H), 3.85-
3.81 (m, 1H), 3.68 – 3.60 (m, 1H), 3.46 - 3.40 (m, 3H), 2.32(s, 3H), 2.13 – 1.98 (s, 7 × 3 H), 1.71 
-1.45 (m, 4H), 1.23 (s, 16 H). HRMS (ESI) m/z: Calcd. (C46H68O19)Na+: 947.4247; Found: 
947.4233. 
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Colorless liquid, yield: (0.05 g, 13 %, 2 steps), Rf – 0.51 (Hexane : EtOAc, 1:1). 1H-NMR (300 
MHz CDCl3): δ 5.38-5.29 (m, 1H), 5.21 (t, J = 8.7 Hz, 1H), 5.00 (t, J = 9.9 Hz, 1H), 4.84-4.74 
(m, 2H), 4.49-4.40 (m, 2H), 4.24-4.17 (m, 2H), 4.03-3.89 (m, 3H), 3.84-3.76 (m, 1H), 3.67-3.60 
(m, 1H), 3.47-3.38 (m, 1H), 3.37 (t, J = 6.6 Hz, 2H), 2.25-1.96 (s, 7 ×3H), 1.70 (d, J = 3.04 Hz, 
5H), 1.64-1.40 (m, 10 H), 1.21 (br s, 18 H). 13C NMR (75 MHz, CDCl3): δ 170.1, 170.1, 169.9, 
169.7, 169.6, 169.2, 169.0, 99.9, 95.1, 75.1, 72.4, 71.8, 71.6, 71.2, 69.8, 69.6, 69.0, 68.1, 67.6, 
62.5, 61.1, 59.4, 41.2, 36.2, 30.4, 30.1, 29.2, 29.2, 29.1, 29.0, 28.9, 25.9, 25.4, 20.5, 20.5, 20.3, 
20.2, 20.2. HRMS (ESI) m/z: Calcd. (C48H74O19)Na+: 977.4716; Found: 977.4705. 
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White solid.Yield: (0.11 g, 7 %, 2 steps), Rf – 0.46 (Hexane : EtOAc, 1:1). 1H-NMR (300 MHz, 
CD3OD): δ 7.85-7.77 (m, 4H), 7.65-7.41(m, 5H), 5.55 – 5.48 (m, 1H), 5.46-5.30 (m,2H), 5.06 (t, 
J = 9.9Hz, 1H), 4.95-4.94 (m, 1H), 4.89 – 4.84 (m, 1H), 4.74 – 4.70 (m, 1H), 4.58 (s, 2H), 4.48-
4.40 (m, 1H), 4.30 – 4.14 (m, 2H), 4.09-3.90 (m, 4H), 3.71 – 3.60 (m, 1H), 3.51-3.40 (m, 3H), 
2.17 – 1.99 (s, 7 × 3 H), 1.71 -1.55 (m, 4H), 1.25 (s, 12 H). 13C NMR (75 MHz, CDCl3): δ 
197.0,170.2, 170.1, 169.9, 169.5, 169.4, 169.0, 143.2, 137.2, 136.2, 131.9, 129.8, 129.6, 127.8, 
126.6, 95.1, 95.0, 72.3, 72.2, 71.8, 71.0, 70.5, 69.8, 69.5, 68.9, 68.4, 68.0, 67.5, 67.0, 29.3, 29.1, 
 
 
29.1, 29.0, 28.9, 28.8, 25.7, 25.5, 20.5, 20.4, 20.2, 20.2, 20.2, 20.1. HRMS (ESI) 
m/z: Calcd. (C50H66O20)Na+: 1009.4039; Found: 1009.4043. 
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White solid.Yield: (0.24 g, 15 %, 2 steps), Rf – 0.40 (Hexane : EtOAc, 1:1). 1H-NMR (300 MHz, 
CD3OD): δ 5.43-5.33 (m, 2H), 5.29-5.26 (m, 1H), 5.09-5.02(m, 1H), 4.89-4.79 (m, 2H), 4.52 – 
4.45 (m, 2H), 4.29 – 4.21 (m, 2H), 4.06-3.93 (m, 3H), 3.88 – 3.78 (m, 1H), 3.70-3.61 (m, 3H), 
3.51 – 3.43 (m, 1H), 2.15 – 2.01 (s, 7 × 3 H), 1.51 -1.46 (m, 4H), 1.41-1.26 (br s, 12 H). 13C 
NMR (75 MHz, CDCl3): δ 170.2, 170.1, 170.0, 169.8, 169.5, 169.1, 169.0, 99.8, 95.0, 77.0, 76.6, 
76.2, 75.0, 72.3, 71.8, 71.6, 69.8, 69.5, 68.9, 68.0, 67.5, 62.5, 29.0, 29.0, 28.9, 28.9, 28.8, 25.3, 
25.2, 20.5, 20.4, 20.2, 20.2, 20.2, 20.1, 20.1.  
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MeONa, MeOH, rt.
overnight, H+ (amberlite 
resin), neutralize 
(~ pH 7.0)
4b-12b 4-12  
Zemplen deacetylation was used to deprotect the acetylated glycosides.150 Briefly, 
acetylated glycosides were treated with methanolic solution of MeONa (10 mM) followed by 
neutralization (pH ~ 7) over H+ amberlite resins. The product was filtered and dried under 
vacuum overnight.  
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White solid.Yield: (0.15 g, 80 %), 1H-NMR (300 MHz, CD3OD): δ 7.34-7.26 (m, 5H), 5.15 (t, J 
= 4.2 Hz, 1H), 4.46 (br S, 2H), 4.23 (d, J = 7.5 Hz, 1H), 3.93-3.79 (m, 4H), 3.70-3.53 (m, 4H), 
3.52-3.42 (m, 5H), 3.35-3.18 (m, 3H), 1.59 (m, 4H), 1.28 (br s, 12 H). 13C NMR (75 MHz, 
MeOD): δ 137.9, 127.5, 127.0, 126.8, 102.5, 101.1, 79.5, 76.0, 74.7, 73.2, 72.9, 72.8, 72.2, 72.0, 
70.4, 69.7, 69.6, 69.2, 60.8, 60.3, 29.0, 28.9, 28.8, 28.8, 28.7, 25.4, 25.2. HRMS (ESI) 
m/z: Calcd. (C29H48O12)Na+: 611.3037; Found: 611.3041. 
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Yield: (0.11 g, 85 %), 1H-NMR (300 MHz, CD3OD): δ 7.36-7.29 (m, 5H), 5.15 (t, J = 4.2 Hz, 
1H), 4.48 (br S, 2H), 4.27 (d, J = 7.5 Hz, 1H), 3.93-3.79 (m, 4H), 3.70-3.57 (m, 4H), 3.54-3.42 
(m, 5H), 3.35-3.21 (m, 4H), 1.60 (m, 4H), 1.29 (br s, 16 H). 13C NMR (75 MHz, CD3OD): δ 
128.6, 127.6, 127.1, 126.9, 126.5, 125.9, 102.5, 101.1, 79.5, 76.0, 74.7, 73.9, 73.3, 73.0, 72.8, 
72.4, 72.0, 69.7, 69.6, 69.2, 60.9, 60.4, 30.6, 29.0, 29.0, 28.9, 28.9, 28.7, 27.3, 27.1, 25.5, 25.3. 
HRMS (ESI) m/z: Calcd. (C31H52O12)Na+: 639.3350; Found: 639.3345. 
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Colorless solid, Yield: (0.163g, 85%), 1H-NMR (400 MHz, CD3OD): δ 7.37 (dt, J = 8.4Hz, J = 
2Hz, 2H), 7.24 (dt, J = 8.4Hz, J = 2Hz, 2H), 5.14 (d, J = 4Hz, 1H), 4.44 (s, 2H), 4.25 (d, J = 8Hz, 
1H), 3.84-3.90 (m, 2H), 3.77-3.82 (m, 2H), 3.57-3.69 (m, 4H), 3.52 (p, J = 9.6Hz, J = 4.8Hz, 
2H), 3.45 (t, J = 6.4Hz, 2H), 3.43 (dd, J = 10Hz, J = 3.6Hz, 1H), 3.34 (ddd, J = 9.6Hz, J = 4.8Hz, 
J = 2.4Hz, 1H), 3.23 (p, J = 17.6Hz, J = 9.2Hz, 2H, overlapping with CD3OD), 1.59 (m, 4H), 
1.30 (s, 9H), 1.25-1.40 (br s, 12H). 13C NMR (100 MHz, CD3OD): δ 150.4, 135.3, 127.4, 127.1, 
124.8, 124.5, 102.9, 101.5, 79.9, 76.5, 75.2, 73.7, 73.5, 73.4, 73.3, 72.8, 72.3, 70.1, 69.9, 69.6, 
61.4, 60.8, 33.9, 30.4, 30.2, 29.4, 29.3, 29.2, 29.1, 25.8, 25.7, 25.5. HRMS (ESI) m/z :  
Calcd. (C34H60O12)Na+: 611.3037; Found: 611.3041. 
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Light brown solid, Yield: (0.056g, 29 %), 1H-NMR (400 MHz, CD3OD): δ 7.38 (dt, J = 8.6Hz, J 
= 2.1Hz, 2H), 7.25 (d, J = 8.4Hz, 2H), 5.17 (d, J = 3.8Hz, 1H), 4.46 (s, 2H), 4.27 (d, J = 7.8Hz, 
1H), 3.80-3.93 (m, 4H), 3.60-3.72 (m, 4H), 3.51-3.57 (m, 1H), 3.44-3.49 (m, 3H), 3.35-3.39 (m, 
1H), 3.25 (p, J = 17.4Hz, J = 9.3Hz, 2H, overlapping with CD3OD), 1.61 (m, 4H), 1.32 (s, 9H), 
1.25-1.45 (br s, 16H). 13C NMR (100 MHz, CD3OD): δ 150.3, 135.3, 127.4, 124.8, 102.9, 101.5, 
 
 
79.9, 76.4, 75.2, 73.7, 73.4, 73.3, 72.8, 72.3, 70.1, 69.9, 69.6, 61.4, 60.8, 33.9, 30.4, 29.4, 29.3, 
29.2, 29.1, 25.8, 25.7. HRMS (ESI) m/z: Calcd. (C34H60O12)Na+: 667.3663; Found: 667.3667. 
O
HO
OH
HO
O
HO
HO
OH
O
OH O O
10
8  
White solid.Yield: (0.10 g, 80 %), 1H-NMR ( 300 MHz, CD3OD): δ 6.89-6.85 (m, 3H), 5.12 (d, J 
= 3.9 Hz, 1H), 4.37 (s, 2H), 4.24-4.21 (m, 1H), 3.87-3.70 (m, 4H), 3.70-3.35 (m, 6H), 3.35-3.19 
(m, 6H),  2.30 (s, 6H),1.63-1.57 (m, 4H), 1.39-1.31 (m, 16 H). 13C NMR (75 MHz, CD3OD): δ 
136.6, 134.9, 128.1, 127.2, 102.5, 101.1, 79.5, 76.0, 74.7, 73.2, 72.9, 72.8, 72.3, 71.9, 69.7, 69.4, 
69.1, 60.9, 60.3, 29.0, 28.9, 28.9, 28.8, 28.7, 25.4, 25.3, 19.4. HRMS (ESI) m/z : Calcd. 
 (C33H56O12) Na+ : 667.3663; Found: 667.3660. 
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White solid.Yield: (0.10 g, 89 %), 1H-NMR ( 400 MHz, CD3OD): δ 7.23-7.15 (m, 4H), 5.17 (d, J 
= 4.4 Hz, 1H), 4.45 (s, 2H), 4.28 (d, J = 7.6 Hz, 1H), 3.91-3.84 (m, 4H), 3.70-3.45 (m, 6H), 3.36-
3.33 (m, 3H), 3.33-3.24 (m, 3H), 2.34(s, 3H), 1.63-1.57 (m, 4H), 1.39-1.31 (m, 16 H). 13C NMR 
(100 MHz, CD3OD): δ 137.9, 135.3,128.5, 128.2, 127.6, 102.9, 101.5, 98.6, 80.4, 79.9, 76.4, 
75.1, 73.6, 73.5, 73.3, 73.2, 72.8, 72.7, 72.3, 71.8, 70.8, 70.0, 69.8, 69.5, 67.9, 62.9, 61.6, 61.3, 
 
 
60.7, 60.6, 32.2, 29.4, 29.3, 29.3, 29.2, 29.1, 25.8, 25.7, 25.5, 22.8.  HRMS (ESI) m/z: Calcd. 
(C32H54O12)Na+: 653.3507; Found: 653.3504. 
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White solid, Yield: (0.02 g, 88 %), 1H-NMR (300 MHz, CD3OD): δ 5.17 (d, J = 3.6 Hz, 1H), 
4.28 (d, J = 7.8 Hz, 1H), 3.92-3.78 (m, 4 H), 3.72 – 3.51 (m, 6H), 3.47 – 3.34 (m, 4H, 
overlapping with CD3OD), 3.29 – 3.19 (m, 2H), 2.13 (S, 3H), 1.77 – 1.73 (m, 13H), 1.46 (m, 
2H), 1.32 (br s, 17 H). 13C NMR (75 MHz, CD3OD): δ 102.5, 101.1, 79.5, 76.0, 74.7, 73.2, 72.9, 
72.8, 72.3, 71.6, 69.6, 69.1, 66.4, 61.1, 59.0, 40.8, 35.7, 30.1, 29.8, 29.0, 28.9, 28.8, 28.7, 25.4, 
25.2. HRMS (ESI) m/z: Calcd. (C34H60O12)Na+: 683.3976; Found: 683.3971. 
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White solid.Yield: (0.064 g, 83 %), 1H-NMR (300 MHz, CD3OD): δ 7.89-7.80 (m, 4H), 7.68-
7.43 (m, 5H), 5.15 – 5.14 (m, 1H), 4.88-4.87 (m, 1H), 4.76 (s, 2H), 3.91 – 3.81 (m, 4H), 3.70 – 
3.53 (m, 5H),  3.51 – 3.35 (m, 6H), 3.34-3.27 (m, 3H), 1.71 -1.55 (m, 4H), 1.25 (s, 12 H).  13C 
NMR (75 MHz, CD3OD): δ 196.4, 143.6, 137.0, 136.0, 131.9, 129.3, 129.1, 127.7, 126.5, 101.1 , 
98.1, 79.9, 73.2, 73.0, 72.9, 72.4, 71.3, 71.2, 70.4, 70.0, 69.6, 67.4, 60.8, 60.2, 29.3, 28.9,  28.8, 
28.8, 28.7, 28.7, 25.4. HRMS (ESI) m/z: Calcd. (C36H52O13)Na+: 715.3300; Found: 715.3304. 
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White solid.Yield: (0.061 g, 85 %), 1H-NMR (300 MHz,CD3OD): δ 5.13-5.10 (m, 1H), 4.26-
4.21 (m, 1H), 3.91-3.71 (m, 4H), 3.69-3.45 (m, 8H), 3.44-3.17(m, 4H),1.64-1.45 (m, 4H), 1.30 
(br s, 12 H). 13C NMR (75 MHz, CD3OD): δ  102.4, 101.0, 79.4, 76.0, 74.7, 73.2, 72.9, 72.8, 
72.2, 69.6, 69.1, 62.4, 61.1, 60.8, 60.3, 31.8, 28.9, 28.8, 28.8, 28.7, 25.2, 25.1. HRMS (ESI) 
m/z: Calcd. (C22H42O12)Na+: 521.2568; Found: 521.2567.  
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Chapter 3 
Swarming Activation and Phenotypic Bifurcation of Nonswarming 
P. aeruginosa Mutant by Maltose Derivatives 
Overview: 
Like biofilm formation, swarming is a multicellular behavior adopted by many bacterial 
species for colonizing surfaces during infections. Rhamnolipids are biosurfactants secreted by 
Pseudomonas aeruginosa and these amphiphilic molecules are known to be critical for at least 
three bacterial bioactivities; making channels in the biofilm, dispersing bacteria from mature 
biofilms and assisting in swarming motility. The maltose derivatives are amphiphilic molecules 
with structural similarities to rhamnolipids and results in the previous chapter showed that such 
agents are able to interfere with two bioactivities of P. aeruginosa that are associated with 
presence of rhamnolipids; biofilm formation and dispersion. It was thus logical to test the effect 
of these maltose derivatives on swarming motility of P. aeruginosa, the third activity controlled 
by secretion of rhamnolipids. Results presented here show that maltose derivatives activated the 
swarming of a P. aeruginosa mutant, rhlA that cannot produce rhamnolipids and is therefore 
nonswarming in nature. The swarming activation of wild type P. aeruginosa and its 
nonswarming mutant (rhlA) by maltose derivatives at lower concentration is peculiarly reversed 
at relatively higher concentration, signifying an apparent “activity reversal” with increase in 
concentration of maltose derivatives. Similar “activity reversal” phenomenon was also observed 
during the early discovery of a bacterial cell signaling molecule. Several results presented here 
indicate that maltose derivatives are mimicking the natural ligand in controlling swarming 
motility of P. aeruginosa. In the argument of whether secreted rhamnolipids play a biological or 
 
 
a physical role during swarming, the results are more inclined to the rhamnolipids having a 
biological role. While maltose derivatives seem to mimic natural rhamnolipids, some maltose 
derivatives dominate others at activating the swarming of rhlA mutant. These maltose derivatives 
were also able to induce a concentration dependent phenotypic bifurcation of swarming PAO1 
and rhlA cells. Maltose derivatives presented here are potential mimics of rhamnolipids, and 
these agents posses the versatility of controlling three bioactivities of P. aeruginosa, biofilm 
formation, dispersion and swarming motility. Results brought to the forefront the biofunctions of 
rhamnolipids as new therapeutic target for controlling bacterial behaviors.  
3.1 Background and significance 
 
3.1.1 Swarming: A bacterial multicellular motility behavior 
 
When bacteria comes in contact with a surface, they either decide to stay and form sessile 
colonies known as biofilms or they decide to move rapidly (several µm s-1) on the surface with a 
motility behavior known as swarming.72 Swarming is an important translocation movement that 
is used by the bacteria to colonize surfaces in the natural environment and this kind of movement 
is common to many flagellated bacteria.163 The decision to either form biofilm or swarm on the 
surface is an important one for the bacteria and is made after receiving and evaluating the 
information about nutrients availability, antagonistic conditions and other bacterial species 
around in the environment.72 For many bacterial species the first step where bacteria sense the 
surface is a very poorly understood phenomenon, but in the case of V. parahaemolyticus flagella 
has been implicated as a sensor for surface contact.164  
 
 
Swarming motility in bacteria was first discovered by Henrichsen and coworkers in 1972, 
where hundreds of bacterial strains were tested for different types of translocation movements 
and based on these results bacterial translocations were classified into six categories; swarming, 
swimming, twitching, gliding, sliding and darting.165 Unlike the other five motilities, swarming 
is a multicellular behavior and like biofilm formation swarming motility is also controlled by 
quorum sensing.166, 167 Although, swarming has been observed in different gram negative and 
gram positive flagellated bacteria, this kind of motility has been extensively studied only in a few 
bacterial species like Escherichia coli (E. coli), Pseudomonas aeruginosa (P. aeruginosa), 
Bacillus subtilis (B. subtilis) and salmonella.166  
Since swarming motility is a multicellular phenomenon like biofilm formation, swarming 
cells of P. aeruginosa isolated from Cystic fibrosis patients have also shown the ability to 
produce high levels of virulence factors.168 Recently Butler and co-workers also showed that 
swarming colonies are resistant to otherwise lethal doses of antibiotics.76 This resistance to 
antibiotics during swarming was attributed to the high cell densities and high rate of mobility at 
the swarm edge.76 It has been reported that during infections in Cystic fibrosis, a switch to either 
sessile (biofilm) or motile (swarming) lifestyle by P. aeruginosa is usually accompanied by an 
increase in resistance to a range of antibiotics.41 
3.1.2 Two multicellular behaviors, biofilm formation and swarming motility are inversely 
regulated 
 
Switching between sessile and motile multicellular behavior is an important decision for the 
bacteria to ensure its survival.72 Clinically it is critical to understand under exactly which 
conditions bacteria prefer one social behavior over other. However, external environmental 
stimuli that causes transition from sessile to motile mode still remains unclear.72, 167, 169 As both 
 
 
swarming and biofilm formation are surface associated multicellular behaviors that are 
controlled by bacterial quorum sensing, it is important to understand the relation between the two 
behaviors. Recently, O’Toole and co-workers have proposed that sadB gene of P. aeruginosa is 
responsible for inversely regulating the swarming and biofilm formation through the chemotaxis 
cluster IV (Figure 3.1).73, 170  It has been observed that, during biofilm formation bacterial cells 
differentiate and likewise in transitioning from one lifestyle to another, cells differentiate to 
adapt to the new lifestyle.171 For example, during biofilm formation the cells of P. aeruginosa 
usually synthesize single polar flagella to assist in surface adherence, but during swarming 
motility, P. aeruginosa seems to develop two polar flagella.167, 172  
 
Figure 3.1 Biofilm formation and swarming motility are inversely regulated. Both SadB gene 
and type IV cluster together are responsible for deciding whether the bacteria will swarm or form 
biofilm on the surface. The variation in the greyness of the surface indicated that the properties 
of the surface like viscosity and wetness also play an important role in choosing between the two 
multicellular behaviours. [Reprinted and modified with permission from Citation: Nicky C. 
Caiazza, (2007), “Inverse Regulation of Biofilm Formation and Swarming Motility by 
Pseudomonas aeruginosa PA14” J. Bacteriol. (189), 3603-3612; Copyright: 2007, American 
Society for Microbiology.] 
 
 
3.1.3 Swarming modulation by small molecules 
 
Swarming motility is dependent on the quorum sensing process; a process which 
proceeds through the recognition of small-molecule based chemical signals. Therefore, small 
molecules like brominated furanones that interfere with bacterial quorum sensing are reported to 
be effective swarming inhibitors for two different bacteria, B. subtilis and E. coli.56, 173 In another 
report, a synthetic cationic peptide consisting of nine amino acids inhibited both the biofilm 
formation and swarming motility of P. aeruginosa.174 Salicylic acids, which are known to 
interfere with the flagella related motilities, inhibited the swarming motility of P. aeruginosa and 
also inhibited the biofilm formation.175    
 
3.1.4 Swarming motility of Pseudomonas aeruginosa 
 
Swarming is a complex mode of translocation that is fundamentally different from other 
bacterial motilities like swimming and twitching. While swarming is a surface associated 
adaptive multicellular social behavior, swimming and twitching motilities are associated with the 
planktonic mode of living that may be unrelated to surface propagation.166 It has been reported 
that, P. aeruginosa requires all of the following features to successfully swarm on a semisolid 
surface; quorum sensing , flagella, pili and production of biosurfactant rhamnolipids.167 In the 
laboratory set up, swarming motility of bacteria is observed on the semisolid surface (0.5% agar) 
and swimming motility can be studied on the soft surfaces (0.3%).159 What is unique and still a 
poorly understood swarming phenomenon is the formation of complex patterns on the swarm 
gels. While, some strains of P. aeruginosa when inoculated at the center of a semisolid surface, 
grow outward from the point of inoculation to form complex branched tendrils,176  others simply 
 
 
grow outward from the point of inoculation without forming any pattern. Deziel and coworkers 
compared swarming motility of various strains of P. aeruginosa obtained from different sources 
and studied their swarming motility under identical swarming conditions.176 Based on this study, 
some strains were capable of forming tendrils but some were not under similar swarming 
conditions (Figure 3.2).176 PAO1 strain used in this study does not form tendrils while swarming 
and rather swarms like PAO1-Lory and PG201 strains from Figure 3.2.  
 
Figure 3. 2 Swarm patterns of different P. aeruginosa strains on semisolid surface (0.5% agar). 
[Reprinted with permission from Citation: Eric Déziel, (2008), “Improving the reproducibility of 
Pseudomonas aeruginosa swarming motility assays” Journal of Basic Microbiology (48), 509-
515; Copyright: 2008, WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.] 
3.1.5 Importance of flagella in swarming    
                                                                                                                       
Flagella have been demonstrated to be critical for carrying out swimming motility 
associated with planktonic bacteria. Apart from their role in swimming motility, flagella also 
play an important role in swarming process associated with bacterial swarm colonies.166 
 
 
Generally, it is reported that, for swarming on a surface, bacteria modify their phenotype and go 
from vegetative swimming cells having only one flagellum to hyper-flagellated swarmer cells 
having a peritrichous arrangement of flagella along the surface.167 Swarming entails that a group 
of cells move side-by-side to each other and such an association is called a raft. The existence of 
raft formation has been demonstrated in Proteus mirabilis with the aid of scanning electron 
microscopy and an integrity of rafts is attributed to the bundling of flagella.177  
There are phenotypic differences between the swarming cells at the edge of the swarm 
colony and the cells at the center of the swarm colony.167 Hyperflagellated swarming cells found 
on the swarm edge are more elongated (3-4 µm) than the cells in the center of the swarm colony 
(2 µm).167 Kohler and coworkers demonstrated that the deletion of the gene responsible for 
flagellar biosynthesis in P. aeruginosa resulted in generation of a nonswarming mutant strain.167 
P. aeruginosa is known to use a single polar flagellum to enable the swimming process. But 
during swarming, P. aeruginosa produces a second polar flagellum and also synthesizes an 
alternative motor system to rotate the flagellum and enable movement through viscous 
environments.166, 172 
3.1.6 Requirement of pili in swarming of P. aeruginosa 
 
Pilus is one of the appendages present on the bacterial surface and are known to facilitate 
initial adherence to the surfaces.142 Particularly, the type IV pili of P. aeruginosa recognize 
carbohydrate epitopes present on human epithelial cells and enable adhesion.50, 140 Kohler and 
coworkers reported that the existence of type IV pili in PAO1 strain is necessary for swarming 
on semisolid surface.167 They reported that, while PAO1 could swarm on a semisolid surface its 
pili mutant, pilA that lack type IV pili was unable to swarm. However, in two different studies, 
 
 
O’Toole et al and Kornberg et al showed that the requirement of type IV pili for swarming in 
another P. aeruginosa strain, PA14 was not important.172, 178 These contradictory reports that IV 
pili may or may not be important could manifest from different experimental conditions or 
different bacterial strains.  
3.1.7 Quorum sensing controls swarming 
 
Many studies have brought forward the role of bacterial quorum sensing (QS) in 
swarming motility.179  These include the acyl homoserine lactone (AHL, AI-1) based expression 
of genes that control the synthesis of biosurfactants that are required for swarming. For example, 
the LuxI and LuxR system of genus Serratia control the production of biosurfactant 
serrawettin.180 Another example is the secretion of biosurfactant rhmanolipids by P. aeruginosa 
which is under the control of las and rhl quorum sensing systems of the bacteria.124 It has also 
been demonstrated that, AHL mimics can modulate the swarming of S. liquefaciens, E. coli, B. 
subtilis and Acinetobacterium  baumanni.181 Relation between AI-2 mediated QS and swarming 
was found in Proteus mirabilis and Vibrio parahaemolyticus. It is also known that QS regulates 
the differentiation of swarmer cells that are required for the swarming process.  
Study by Kohler et al. in 2000, showed that the swarming of P. aeruginosa is dependent 
on quorum sensing circuits, las and rhl.167 In their study they used lasI, lasR, rhlI and rhlR 
mutants of wild type P. aeruginosa. As per the hierarchy of P. aeruginosa QS circuits, the las 
system controls the rhl system which further controls the rhlAB operon that eventually controls 
the biosynthesis of rhamnolipids. Among the four mutants, swarming of lasI and lasR mutants 
was reduced but the swarming of rhlI and rhlR mutants was completely abolished. The complete 
inability of rhlI and rhlR mutants to swarm could either be attributed to lack of flagellar 
 
 
functioning or to the lack of biosurfactant synthesis. However, Kohler and coworkers showed 
that rhlI and rhlR mutants are capable of flagella dependent motility movement, swimming in 
soft gels. Therefore, the inability of rhlI and rhlR mutants to swarm on semisolid surface could 
be due to the lack of production of biosurfactant rhamnolipids.  
3.1.8 Production of biosurfactants is critical for P. aeruginosa swarming 
 
Many bacteria produce biosurfactants to reduce surface tension and facilitate their 
movement through viscous environments.182  During swarming, B. subtilis and S. liquefaciens 
secrete the lipopeptide surfactants surfactin and serrawettin, respectively, whereas P. aeruginosa 
secretes di-rhamnolipids, mono-rhamnolipids and rhamnolipid precursor fatty acid β-
hydroxydecanoyl-β-hydroxydecanoate (HAA) (Figure 3.3).  
Apart from reducing the surface tension to enable swarming, rhamnolipids have been 
implicated to play a role in bacterial cell signaling.130 O’Toole et al showed that in P. aeruginosa 
swarming process, rhamnolipids prevent colonization between two tendrils. O’Toole et al 
showed that when rhamnolipids extracted from P. aeruginosa culture were externally added into 
the semisolid gel (0.5 % agar), the swarming cells detected the presence of rhamnolipids and 
changed courses to move away from the region that contained rhamnolipids. In another work, 
O’Toole et al inoculated wild type P. aeruginosa or its SadB mutant along with P. aeruginosa 
nonswarming mutant flgK.  Although flgK mutant is nonswarming, it still retains the ability to 
produce rhamnolipids. Results showed that, swarming tendrils of wild type P. aeruginosa moved 
away from the region inoculated with the nonswarming mutant, flgK.159 Therefore, they conclude 
that rhamnolipids act as repellants and that wild type P. aeruginosa was able to detect the 
presence of such a repellant. Swarming tendrils of sadB mutant did not deviate from the region 
 
 
where flgK mutant was inoculated and hence O’Toole et al strongly suggested that protein SadB 
could be the receptor for rhamnolipids. 
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Figure 3.3 Chemical structures of HAA, mono-rhamnolipids, di-rhamnolipids 
3.1.9 Existence of different phenotypes during swarming 
 
P. aeruginosa biofilms are known to contain many phenotypes that are responsible for 
performing various functions in the biofilm.170, 171 Swarming is another bacterial multicellular 
behavior and therefore the existence of multiple phenotypes within the swarming colonies is 
highly anticipated. The swarming of P. aeruginosa is associated with three types of phenotypic 
changes: lag phase, cell elongation and colony pattern formation.166  
The first phenotypic change occurs after the inoculation of bacteria from a liquid medium 
onto the semisolid surface (0.5 % agar). During this lag phase, the bacteria are characterized by a 
non-motile behavior. While this non-motile phase is poorly understood, it is believed that during 
this time the swimming bacteria undergo multiple phenotypic transformations to prepare for 
swarming motilities. In B. subtilis, the lag-phase constitutes at least three important activities; 
increase in cell-density, biosurfactant production and hyperflagellation.164, 183  
The second phase of swarming is characterized by phenotypic changes that cause reduced 
cell divisions and hence cell elongation.166 It has been shown that in the liquid cultures, Proteus 
mirabilis grows as short rod-shaped cells, but during swarming it becomes multinucleated, 
 
 
elongated and multiflagellated.183, 184 In the case of P. aeruginosa, it has been reported that the 
cells at the edge of the swarm colony are elongated with two polar flagella.178  
The third phenotypic change occurs during the formation of complex macroscopic 
colonies by swarming bacteria on semisolid surfaces remains the most poorly understood 
phenotypic change. 
For example P. mirabilis forms bullseye shaped colonies that result from the periodic 
synchronized movement and halting of the bacteria.185 P. aeruginosa (PA14) when inoculated on 
a semisolid surface is known to form tendrils that grow outwards from the point of inoculation. 
Another gram negative bacteria B. subtilis swarms with the formation of tendrils that arise when 
the local rates of motility exceed the rate of bulk population growth.186, 187  
3.1.10 Different theories to explain the tendril formation during swarming by P. aeruginosa  
 
(A) Physical explanation- Marangoni effect 
As many bacteria secrete surfactants to perform swarming motility, according to some 
reports, the likelihood of gradients in surface tension driving flow and creating tendrils is highly 
probable.188, 189 As bacteria continuously secrete biosurfactants at the interface of the swarm 
colony and the semisolid surface, there is expected to be a gradient of surface tension caused by 
either the change in composition of surfactant, change in viscosity; or change in temperature.190 
This surface tension gradient gives rise to Marangoni forces that in turn generate flow forming 
tendrils.191 190 There seems to be biomass accumulation at the tendril tips and this gives rise to 
swarm patterns. Although, the involvement of signaling molecules, transport of oxygen or 
transport of nutrients was taken into account while using Marangoni effect to explain tendril 
formation; further understanding of the complex pattern forming process is desirable.192   
 
 
(B) Chemotaxis 
Bacteria sense and respond to their environment through a physicochemical process called as 
chemotaxis. The response of the bacteria to chemicals that can either be attractants or repellants 
has often been used to articulate complex pattern formation.  Modeling studies have shown that 
bacteria can change their swarming patterns depending upon the nutrient levels in the 
surroundings.193 Based on these modeling studies, at high nutrient concentrations bacteria first 
swarm in a circular pattern up to a certain distance and then start forming tendrils; when the 
concentration of the nutrients is decreased, the simulation model predicted a swarm pattern with 
branched tendrils; with very low nutrient concentrations the model predicted a spread out 
colonial pattern (Figure 3.4).193 Using general modeling studies and experimental evidences, 
Vicsek and coworkers showed that the pattern formation by bacteria changed with the 
concentration of peptones in the agar.194 A concentration dependent study with peptone by 
Vicsek and coworkers showed pattern formation similar to Figure 3.4.  
 
Figure 3.4 Different patterns formed by bacteria depending on the level of concentration of food. 
(A) tendrils formed at higher level of food; (B) pattern formed at intermediate food levels; (C) 
colonial patterns formed at low food level. [Reprinted with permission from Citation: Ben‐Jacob, 
E., (2009) Learning from bacteria about natural information processing. Annals of the New York 
Academy of Sciences, 1178, (1), 78-90; Copyright: 2009, New York academy of sciences]  
 
 
(c) Deziel’s coworker’s attractant/repellant theory  
Deziel and co-workers extracted and purified the components of the rhamnolipids extract 
to obtain three amphiphilic molecules, di-rhamnolipid, mono-rhamnolipid and HAA.195 In this 
work, Deziel and coworkers showed that di-rhamnolipid acts as an attractant and promotes 
tendril formation whereas mono-rhamnolipids only serve as wetting agents and third the 
component HAA acids, act as repellants that inhibit tendril formation during swarming.195 They 
also showed that in the semisolid gel the rate of diffusion of attractant is faster than that of the 
repellant (Figure 3.5). Deziel and coworkers proposed that the ratio of attractant to repellant 
propels the outward movement of swarmer cells from the point of inoculation to initiate the 
formation of tendrils (Figure 3.5). Also, externally added di-rhamnolipids activated swarming of 
a non-swarming P. aeruginosa mutant that lacks the production of rhmanolipids, rhlA.195  
 
Figure 3.5 Deziel and coworkers attractant repellant model for explaining tendril formation. (A) 
rate of diffusion from the point of inoculation of the attractant (di-rhamnolipids) on the semisolid 
surface is faster than that of the repellent (HAA). (B) At the edge of the swarming colony, the 
cells are attracted towards di-rhamnolipids and repelled by the mono-rhamnolipids and therefore 
cells move outward up the attractant/repellent concentration gradient. [Reprinted with permission 
from Citation: Eric Déziel, (2007) Self-produced extracellular stimuli modulate the 
 
 
Pseudomonas aeruginosa swarming motility behavior, Environmental Microbiology, 9, 2622-
2630; Copyright © 2007, John Wiley and Sons]  
3.1.11. Concenpt of “Activity Reversal”                                                                                               
            Eberhard and coworkers in their pioneering work reported that the production of light in 
Photobacterium fischeri was increased by both synthetic and natural AHLs, between 0.3 and 3 
µg /mL and then decreased upon further increase of the ligand concentration.10 LuxI enzyme of 
V. fischeri synthesizes autoinducer which is AHL. Autoinducers can freely diffuse across the cell 
and their concentration is dependent on the density of the bacterial culture. As cell density 
increases concentration of AHL also increases and when concentration reaches threshold, AHL 
molecules binds to the receptor protein LuxR regulated by gene luxI. Binding of AHL with LuxR 
protein regulates different set of genes. Genes which come under positive feedback system are 
upregulated, whereas genes which come under negative feedback system are downregulated. 
Since autoinducer synthase gene luxI comes under positive feedback loop, synthesis of 
autoinducer is accelerated which leads to an exponential increase in the light production by V. 
fischeri. But at the same time autoinducer receptor gene luxR comes under negative feedback 
loop. Therefore, binding of AI with luxR, reduces the expression of luxR protein, and hence the 
intracellular concentration of receptor protein decreses. Hence this negative regulatory system is 
responsible for the decrease in the light production of V. fischeri.   
 
 
 
 
3.1.11 Aim of the chapter 
In this chapter the correlation between reduction of surface tension and activation of 
swarming was investigated and the importance of structural details of the surface active agent 
was examined. Also the effect of various maltose derivatives on swarming motilities of P. 
aeruginosa and its nonswarming mutant, rhlA were examined. Swarming experiments were 
analyzed to understand the correlation between the anti-biofilm activities of the maltose 
derivatives and the effect of such agents on swarming motilities. 
3.2 Results and Discussion 
 
3.2.1 Surface activity of molecules does not correlate with swarming activation ability 
 
In order to reduce the surface tension between the bacterial cell and the surface on which 
bacteria swarm, certain gram negative bacteria secrete biosurfactants.123, 166 Gram negative 
bacteria, P. aeruginosa secrete a class of glycolipid based biosurfactant known as rhamnolipids. 
If reduction in surface activity is the sole factor responsible to activate swarming in bacteria like 
P. aeruginosa, then any generic surfactant should induce a similar effect on swarming. Here we 
test the hypothesis that any surface tension reducing agent can modulate swarming of P. 
aeruginosa. To test this hypothesis we investigated the ability of generic surfactants to reactivate 
swarming of a non-swarming P. aeruginosa mutant, rhlA. Since rhlA mutant lacks the 
production of natural biosurfactant rhamnolipids, introduction of generic surfactants into the 
swarm agar plates constitutes an agonist type swarming assay. 
 
 
Different types of generic surfactants used here to investigate the activation of rhlA 
swarming include, anionic, sodium dodecyl sulfate (SDS, CMC ~ 8000 µM); cationic, dodecyl 
trimethyl ammonium chloride (DTAC, CMC ~ 20300 µM); and two non-ionic, tetraethylene 
glycol monododecyl ether (C12EG4OH, CMC ~ 69 µM) and dodecyl-β-maltoside (DβM, CMC 
~ 170 µM). These generic surfactants were homogeneously mixed in the swarm agar (0.5%) 
plates to a final concentration of 170 µM. Nonswarming mutant, rhlA was inoculated on such 
swarm agar (0.5%) plates containing various generic surfactants and the swarming modulation 
was compared to the rhlA inoculated on agar plates lacking any surfactant. Among all the tested 
generic surfactants, only DβM activated the swarming in nonswarming mutant, rhlA while other 
generic surfactants (SDS, DTAC, C12EG4OH) were incapable of restoring swarming (Figure 
3.6). This result indicated that, while DβM; having amphiphilic structure similar to that of 
biosurfactant rhamnolipids; restored swarming in nonswarming mutant rhlA; other generic 
surfactants also having amphiphilic structures were incapable of inducing a similar effect. 
Although surface tension (Table 3.1) of C12EG4OH (27.6 mN/m at CMC ~ 50 µM) at 170 µM 
was lower than that of DβM (35.3 mN/m at CMC ~ 170 µM), only DβM was able to activate the 
swarming of rhlA mutant. Therefore, results indicate that surface activity alone cannot explain 
the activation of swarming in rhlA mutant by DβM and that a ligand-receptor approach would be 
more applicable to explain this phenomenon. Results also show that, DβM induced tendril 
formation in the swarm pattern of rhlA mutant (Figure 3.6). Deziel and coworkers have 
previously shown that externally added rhamnolipids extracts not only restore the swarming in 
nonswarming mutant, rhlA but also induce tendril formation in the swarm patterns.195 
Additionally, the formation of tendrils in rhlA swarm patterns by presence of DβM was similar 
 
 
to the swarm pattern of a wild type P. aeruginosa strain, PA14. Therefore, these results suggest 
that DβM could be mimicking rhamnolipids.  
 
Figure 3.6 Swarming activation of non-swarming mutant rhlA by dodecyl β-maltoside, dodecyl 
(DβM), dodecyl trimethyl ammonium chloride (DTAC), sodium dodecyl sulfate (SDS), tetra 
ethyleneglycol monododecyl ether (C12EG4OH). Concentration of all the surfactants in the 
swarm agar (0.5%) plate was 170 µM. 
Table 3.1. Surface activity of generic surfactants  
Generic Surfactant  Critical micelle 
concentration (CMC) 
Surface tension  
(γ) at CMC 
Tetraethylene glycol dodecyl 
ether (C12EG4OH) 
50 µM196 27.6 mN/m196 
Dodecyl-β-maltoside (DβM) 170 µM197 35.3 mN/m197 
Sodium dodecyl sulfate (SDS) 8000 µM197 39 mN/m197 
Dodecyl trimethyl ammonium 
chloride (DTAC) 
20300 µM198 39.25 mN/m198 
 
 
 
3.2.2 Synthetic library of maltose derivatives used for swarming studies 
 
In order to investigate the ligand-receptor approach for explaining the swarming 
activation by maltose based derivatives we did a structure-activity study. The same library of 
maltose derivatives which was previously tested (Chapter 2) for its effect on biofilm inhibition 
was used to study the effect on swarming of both rhlA and PAO1 (Figure 3.7). The structures 
used for the swarming assays include amphiphilic molecules; with varying number of carbon 
atom in aliphatic chains, decyl-β-maltoside (DeβM), undecyl-β-maltoside (UβM), dodecyl-β-
maltoside (DβM), with terminal bulky group, adamantane dodecyl-β-maltoside (ADβM), with 
aromatic bulky groups, benzyl decyl-β-maltoside (BDeβM), benzyl dodecyl-β-maltoside, 
(BDβM), 4-tertiary butyl benzyl decyl-β-maltoside (4-tBuBDeβM), 4-tertiary butyl benzyl 
dodecyl-β-maltoside (4-tBuBDβM), 3,5-dimethyl benzyl dodecyl-β-maltoside (3,5-DMBDβM), 
4-methyl benzyl dodecyl-β-maltoside (4-MBDβM), benzophenonyl decyl-β-maltoside 
(BPDeβM) and a nonamphiphilic molecule having maltose on one side and hydroxyl group on 
the other side of the ten carbon aliphatic chain, 1,2-hydroxy decyl-β-maltose (12-HODeβM). 
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Figure 3.7 Library of maltose derived hydrocarbons 
3.2.3 Three types of swarming behaviors by rhlA mutant in presence of maltose derivatives 
suggest different level of agonism to the putative receptor 
  
All the maltose derivatives (Figure 3.7) were tested for their ability to activate the 
swarming of nonswarming mutant, rhlA at 85 µM concentration. Based on the swarming 
activation abilities, the twelve maltose derivatives were classified into three groups. Group I, 
four maltose derivatives (UβM, BDeβM, BDβM and BPDeβM) activated swarming of rhlA 
mutant but did not induce tendril formation (Figure 3.8). Group II, four maltose derivatives 
(DβM, 3,5-DMBDβM, 4-MBDβM and ADβM) activated the swarming of rhlA mutant with 
 
 
tendril formation (Figure 3.8). Group III, four maltose derivatives (DeβM, 4-tBuBDeβM, 4-
tBuBDβM, HODeβM) did not activate the swarming of rhlA mutant (Figure 3.8). 
It is evident from the images of group I swarm agar plates that the diameters of rhlA 
mutant swarm with 85 µM of three maltose derivatives, UβM (83 %), BDβM (77 %) and 
BPDeβM (87 %) were comparable to the swarm diameter of the wild type PAO1 (100 %) 
without any added agents. However the fourth group I maltose derivative, BDeβM had a 
significantly reduced swarm diameter (51 %) as compared to wild type PAO1 (100 %). 
However, with the four group II maltose derivatives, the rhlA swarm diameter was comparable to 
the diameter of wild type P. aeruginosa, the overall swarm area of rhlA mutant in presence of the 
four maltose derivatives was less than the swarm area of wild type P. aeruginosa due to tendril 
formation. Maltose derivative in group II, ADβM promoted tendrils that were thinner than the 
tendrils formed in presence of other group II maltose derivatives. Also, tendrils formed in 
presence of ADβM showed irregular turns and the pattern thus formed was more fractal-like. 
The swarming diameter of rhlA mutant in presence of a four group III maltose derivatives, 
(DeβM, 4-tBuBDeβM, 4-tBuBDβM, HODeβM) were approximately the same (1-2 cm), and 
comparable to swarm diameter of rhlA mutant without any added agents (~1.2 cm) and about 95 
% less than the swarming diameter of wild type PAO1. Generic non-ionic surfactant C12EG4OH 
was also included in the swarming study at 85 µM and the results indicate that this molecule 
behaved like maltose derivatives in Group III.  
The swarming results of rhlA mutant show that the modulation of swarming by maltose 
derivatives is dependent upon the structural details and with no direct correlation to both 
aliphatic chain bulkiness or the biofilm inhibition ability of these agents (See Figure 2.6 for % 
 
 
biofilm inhibition). If these agents are mimicking rhamnolipid, then the difference in swarming 
activation abilities suggest different levels of agonism to the putative rhamnolipid receptor.    
 
 
 
 
 
 
 
 
Figure 3.8 Nonswarming P. aeruginosa mutant rhlA inoculated on the M8 swarm agar (0.5 % 
agar) plates with and without 85 µM of maltose hydrocarbons and generic surfactant 
C12EG4OH. Pictures were taken 24 h after the inoculation of bacteria on the plates. 
3.2.4 Maltose derivatives modulate swarming motility of wt. P. aeruginosa 
 
We also tested the twelve maltose derivatives (Scheme 1) at 85 µM for their ability to 
modulate PAO1 swarming. Although the presence of maltose derivatives did not alter the swarm 
diameter of PAO1, the ability to induce tendril formation gives two classes of maltose 
derivatives. Group I, six maltose derivatives did promote tendril formation (4-tBuBDeβM, 
DβM, 4-MBDβM, 3,5-DMBDβM, ADβM and 4-tBuBDβM) and Group II, six maltose 
 
 
derivatives did not promote tendril formation (BPDeβM, BDβM, UβM, BDeβM, DeβM and 
HODeβM). There is no correlation between PAO1 biofilm inhibition ability (See Figure 2.6 for 
% biofilm inhibition) of these agents and the ability to form tendrils in swarming of wild type 
PAO1. For example, agent BDβM which inhibited ~ 89 % of PAO1 biofilm did not promote 
tendril formation but 4-tBuBDeβM with ~ 88% promoted tendril formation (Figure 3.9).   
 
Figure 3.9 Wild type P. aeruginosa inoculated on the M8 swarm agar (0.5 % agar) plates with 
and without 85 µM of maltose hydrocarbons. Pictures were taken 24 h after the inoculation of 
bacteria on the plates.  
3.2.5 Concept of concentration dependent “activity reversal” during swarming motility, 
activated by different maltose derivatives  
 
(A) Increasing the concentration of DβM exhibits a transition from swarm activating at low 
concentrations to swarm inhibiting at relatively higher concentrations for the rhlA mutant  
Preliminary results suggested a role of ligand-receptor interaction and traditionally protein 
carbohydrate binding is regarded as weak interactions that can be countered by either increasing 
 
 
the valency of the ligand or by increasing the concentration of the ligand.133, 199 Therefore, we 
were curious to know the effect of concentration of such carbohydrate ligands on swarming. 
Therefore, we initially tested DβM in a concentration and time dependent manner for its ability 
to modulate swarming of both wild type P. aeruginosa and its nonswarming mutant, rhlA. 
Firstly, we tested the effect of DβM on swarming of rhlA mutant in the concentration range 
between 10 to 250 µM (Figure 3.10). The time-elapse images of this swarming assays show that, 
at 10 µM; DβM rhlA mutant did not swarm (~ 8.80 cm2 at 12 h), but  as concentration was 
increased to 20 µM the swarm area increased significantly (~ 36.6 cm2 at 12 h), when the 
concentration was increased further to 85 µM, although there was an overall swarming activation 
(~ 24.51 cm2 at 12 h) as compared to control (no added agents, 8.8 cm2 at 12 h), there was a 
reduction (33%) in swarming area as compared to swarming at 20 µM. On further increasing the 
concentration beyond 85 µM to 250 µM, there is an apparent increase in swarming area. This 
“activity reversal” of swarming area (Figure 3.13) on increasing the concentration of DβM is 
indicative of a phenomenon reported in the early discovery of the quorum sensing molecule N-
(3-oxohexanoyl)-3-aminodihydro-2(3H)- furanone by Eberhard and coworkers.10 Eberhard and 
coworkers in their pioneering work reported that the production of light in Photobacterium 
fischeri was increased by both synthetic and natural AHLs, between 0.3 and 3 µg /mL and then 
decreased upon further increase of the ligand concentration.10 Intrigued by this we were further 
curious to know the exact concentration at which this transition from swarming activating to 
swarming inhibiting occurred for DβM. Therefore, we tested additional concentrations between 
10 and 80 µM (Figure 3.11). With rhlA mutant, the “transition concentration” for DβM from 
swarm activating to swarm inhibiting was ~ 45-50 µM. Figure 3.11 shows that at 45 µM of DβM 
swarming of rhlA was more like wild type PAO1, i.e without tendril formation and a swarming 
 
 
area of 45.8 cm2, but, as the concentration of DβM increased from 45 to 50 µM, rhlA mutant 
swarmed with distinct tendril formation and reduced overall swarming area to 21.72 cm2, 47.4% 
reduction as compared to swarm area at 45 µM (Figure 3.11).  
    
Figure 3.10 Effect of DβM on swarming of rhlA 
 
 
 
 
Figure 3.11 Effect of DβM on swarming of rhlA mutant 
(B) Antagonistic swarming assay with PAO1 in presence of increasing concentration of DβM 
traces an “activity reversal” for swarming area 
Performing the swarming assay with rhlA mutant that lacked the production of 
rhamnolipids served as a platform for testing the agonistic effect of DβM. On the contrary, 
because wild type PAO1 produces the natural rhamnolipids, the swarming assay with this wild 
type strain constitutes an antagonistic assay. Therefore, we tested DβM in a concentration 
dependent manner for its ability to modulate PAO1 swarming. Similar to the swarming results of 
rhlA mutant in presence of DβM, PAO1 also exhibited no observable tendril formation in the 
concentration range between 20 and 40 µM, however at 85 µM there was distinct tendril 
formation (Figure 3.12). After 12 h, swarm area of PAO1 on 40 µM DβM plate was 85.31 cm2 
and at 85 µM was 41.75 cm2 (Figure 3.13), which indicated that DβM can induce concentration 
dependant “activity reversal” of PAO1 too.  
If surface activity was the only important factor for promotion of swarming then, 
swarming areas would increase with increasing concentration of surface active agent. It is 
 
 
predicted that, as the concentration of DβM is increased the surface tension would 
simultaneously decrease.200 Results of swarming area for both PAO1 and rhlA mutant with 
increasing concentration of DβM shows an “activity reversal.” For example maximum swarming 
activation by DβM for PAO1 was observed at 20 µM beyond which the swarm area decreased 
(Figure 3.13). These “activity reversal” results indicate that, surface activity of the agent is not 
the most important factor for predicting the size of the swarm pattern. Maltose derivative, DβM 
modulated PAO1 swarming at all tested concentrations, suggesting that DβM probably is a better 
antagonist than natural rhamnolipids for the putative rhamnolipids receptor.  
 
Figure 3.12 Time dependent (h) effect of increasing concentration of DβM on swarming of 
PAO1. Concentrations (µM) are indicated above and times (h) are shown to the left of the 
pictures. PAO1 was inoculated on the semisolid gel (0.5 % agar).  
 
 
 
Figure 3.13 Plot of swarming areas of either (A) rhlA mutant or (B) PAO1 versus the 
concentrations of DβM. The bacteria were inoculated on semi-solid (0.5 % agar) for 24 h in 
presence of various concentrations of DβM.  
(C) Concentration-dependant swarming study with different maltose derivatives for both the rhlA 
mutant and PAO1  
Since DβM exhibited a concentration dependent “activity reversal” of swarm area for 
both PAO1 and rhlA mutant, a swarming concentration study with selective maltose derivatives 
from each group mentioned in Figure 3.8 and 3.9 was also done for the rhlA mutant and PAO1.      
From group I, two maltose derivatives, BPDeβM and BDeβM showed a gradual increase 
in the swarm area with neither any distinct tendril formation nor any swarming area “activity 
reversal” (Figure 3.14). But another group I maltose derivative, BDβM, showed distinct tendril 
formation at concentrations higher than 85 µM with an overall “activity reversal” for swarming 
area (Figure 3.14). Among group II participants, 4-MBDβM and 3,5-DMBDβM showed 
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“activity reversal” with tendril formation at higher concentrations similar to the activity exhibited 
by DβM which also belongs to the same group (Figure 3.14).  
From group III, four maltose derivatives, DeβM, 4-tBuBDeβM, 4-tBuBDβM, and 
HODeβM were tested. Maltose derivative HODeβM did not show any effect on the swarming 
of rhlA mutant at any of the tested concentrations (i.e, between 5 to170 µM, result not shown). 
The rest of the group III maltose derivatives, DeβM, 4-tBuBDeβM, 4-tBuBDβM exhibited 
swarming activation of rhlA mutant at different concentration ranges. While DeβM at 85 µM did 
not show much promotion of swarming area, it completely activated the swarming of the rhlA 
mutant at 170 µM with fine tendril formation (Figure 3.14). The other two group III maltose 
derivatives, 4-tBuBDeβM and 4-tBuBDβM activated the swarming motility of rhlA mutant at 
low concentrations (5-10 μM), but at higher concentration (40-170 uM) they were not active 
(Figure 9). In the low concentration (5-10 μM) range of 4-tBuBDeβM and 4-tBuBDβM, the 
activated swarming area of the rhlA mutant varied significantly. A graph of swarming area 
versus the concentration of the two group III maltose derivatives, 4-tBuBDeβM and 4-
tBuBDβM was plotted (Figure 3.15). Both the plots exhibited “activity reversal” around 5-10 
μM. But maltose derivative 4-tBuBDeβM gave a maximum swarming area of ~39.6 cm2 at ~ 10 
μM while 4-tBuBDβM had a maximum swarming area of ~ 5.5 cm2 at ~ 5 μM (Figure 3.15). 
The control, rhlA mutant, without agents had a swarming area of 1.4 cm2. 
 
  
 
 
                                                                        
Figure 3.14 Effect of different concentrations of various maltose derivatives on swarming of the 
rhlA mutant. Concentrations (µM) are indicated above the pictures and identities of the maltose 
 
 
derivatives are indicated to the left. Pictures were taken 24 h after inoculation of the bacteria on 
semi-soft gel (0.5 % agar).    
                                                  
Figure 3.15 Plot of swarming areas of the rhlA mutant versus the concentrations of 4-
tBuBDeβM (6) or 4-tBuBDβM (7). The rhlA mutant was inoculated on semi-solid (0.5 % agar) 
for 24 h in presence of various concentrations of 4-tBuBDeβM (6) or 4-tBuBDβM (7). 
At 85 µM, four group I maltose derivatives, 4-tBuBDeβM, 4-tBuBDβM, 4-MBDβM, 
3,5-DMBDβM had induced tendril formation in PAO1 swarms (Figure 3.9). Concentration 
dependent study with these four group I maltose derivatives revealed that induction of tendril 
formation in PAO1 swarms becomes apparent at 20 µM concentrations of these agents in the 
semi-solid gel (0.5 % agar). Tendril formation in presence of 4-tBuBDeβM was unique as the 
swarm patterns formed petal shaped protrusions unlike the usual thin tendrils induced by the 
other three group I maltose derivatives (Figure 3.16).    
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Of the three group II agents, two maltose derivatives BDeβM and DeβM did not induce tendril 
formation in PAO1 at any of the tested concentrations (5 to 170 µM). However, for the third 
group II maltose derivative, BDβM, when the concentration of was increased from low to high, 
PAO1 showed wide petal-like tendril formation at 5 µM which transitioned into no tendrils 
between 10-20 µM followed by thin tendril formation around 40-60 µM and then transitioning 
again into wide tendrils followed by a final transition to form thin tendrils at 170 µM. This 
oscillation in swarming pattern activity due to difference in chemical concentration is symbolic 
of an oscillatory response by the bacteria to the chemical stimuli.201  
 
 
 
Figure 3.16 Effect of different concentrations of various maltose derivatives on swarming of the 
PAO1. Concentrations (µM) are indicated above the pictures and identities of the maltose 
derivatives are indicated to the left. Pictures were taken 24 h after inoculation of the bacteria on 
semisolid gel (0.5 % agar).  
 
 
3.2.6 Swarming competition assay shows that 4-tBuBDeβM and 4-tBuBDβM inhibits DβM 
promoted rhlA swarming 
 
The wild type PAO1 is known to produce rhamnolipids and hence a swarming study 
using such a strain would imply that these maltose derivatives have to compete with naturally 
secreted rhamnolipids for the putative rhamnolipids receptor. Such a swarming assay serves as a 
competitive antagonistic swarming assay. On the contrary, the rhlA mutant lacks the production 
of rhamnolipids and serves as a platform for an agonist swarming assay. The rhlA mutant was 
used in order to examine the effect of group III maltose derivatives on swarming.  
Maltose derivatives in group III, 4-tBuBDeβM, 4-tBuBDβM and HODeβM at 85 µM, 
showed no apparent swarming activation of the rhlA mutant. This swarming activation inability 
of the group III maltose derivatives could imply the following: either these group III maltose 
derivatives are not recognized or are non-binding to the putative receptor site and hence the 
subsequent signaling cascade is not triggered leading to no swarming activation, or these maltose 
derivatives are capable of binding to the putative receptor but unlike the group I and group II 
derivatives which can agonize, group III agents antagonize the receptor site and hence no 
swarming activation is observed.  
The concentration dependent study using the two group III maltose derivatives, 4-
tBuBDeβM and 4-tBuBDβM, indicated that these agents were swarming agonists at a relatively 
low concentration range of 5-10 µM and the third group III maltose derivative, HODeβM 
showed no apparent effect on the rhlA mutant swarming at all tested concentrations (5-170 µM). 
To investigate further if 4-tBuBDeβM, 4-tBuBDβM and HODeβM interact with the putative 
receptor, a competition swarming assay was designed. Maltose derivative DβM fully activated 
the swarming of the rhlA mutant (in comparison to swarming of wild type PAO1) with no 
 
 
distinct tendril formation at 20 µM (figure 3.10). For the competition assays, semisolid gels (0.5 
% agar) supplemented with 20 µM of DβM and incremental concentrations of either 4-
tBuBDeβM, 4-tBuBDβM or HODeβM were created and the rhlA mutant was inoculated. The 
competition assays reveal that 40 µM of 4-tBuBDeβM completely inhibited the swarming 
promoted by DβM (20 µM) of the rhlA mutant (Figure 3.17), while only 20 µM of 4-tBuBDβM 
was required to completely inhibit the swarming. Also, both 4-tBuBDeβM and 4-tBuBDβM at 
concentrations as low as 10 µM, started to induce tendril formation of 20 µM DβM-activated 
rhlA mutant’s swarming (Figure 3.17). Maltose derivative HODeβM is incapable of inhibiting 
the DβM-activated swarming of rhlA mutant. Also, the plot of resultant rhlA swarming area 
versus increasing concentration of three maltose derivatives, 4-tBuBDeβM, 4-tBuBDβM and 
HODeβM shows that effective concentrations of 4-tBuBDeβM and 4-tBuBDβM for inhibiting 
DβM activated swarming were 40 and 20 µM respectively, whereas HODeβM did not inhibit 
swarming at any tested concentration (Figure 3.18). These results indicate that two of the group 
III maltose derivatives, 4-tBuBDeβM, 4-tBuBDβM may be stronger binding ligands than DβM 
and that HODeβM may be a weaker binding ligand than DβM or may have no binding with the 
putative receptor.  
 
 
                                
Figure 3.17 Nonswarming P. aeruginosa mutant, rhlA, inoculated on the M8 swarm semisolid 
agar (0.5 %) plates containing mixture of 20 μM DβM with different concentrations of 4-
tBuBDeβM (6), or 4-tBuBDβM (7), or HODeβM (12) 
 
 
 
                                 
Figure 3.18 Swarm area of rhlA mutant inoculated for 24 h on semisolid agar (0.5%) gel 
containing a mixture of 20 µM DβM and increasing concentrations of or HODeβM (12), 4-
tBuBDeβM (6), or 4-tBuBDβM (7).  
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3.2.7 Swarming competition assay shows that C12EG4OH inhibits DβM promoted swarming of 
rhlA mutant and SDS has no apparent effect  
 
At 170 µM, two generic surfactants C12EG4OH and SDS showed no apparent effect on the 
swarming of the rhlA mutant (Figure 3.6). A swarming competition assay with rhlA mutant 
inoculated on semisolid gels (0.5% agar) containing DβM (at 20 µM) and increasing 
concentrations of either C12EG4OH or SDS were set up to investigate whether these generic 
surfactants are inhibiting or have no effect on swarming (Figure 3.19). While DβM at 20 µM 
activates the swarming of the rhlA mutant, adding 20 µM of C12EG4OH in the semisolid gel 
completely inhibited the DβM promoted swarming. On the contrary, SDS as high as 40 µM was 
incapable of completely inhibiting the swarming of the rhlA mutant promoted by DβM. These 
results indicate that while one generic surfactant, C12EG4OH could be having an interaction with 
the putative swarming receptor another generic surfactant SDS exhibits no such interaction.  
 
Figure 3.19 Nonswarming P. aeruginosa mutant, rhlA inoculated on the M8 semisolid (0.5 % 
agar) swarm gels containing a mixture of 20 μM of DβM with different concentrations of 
C12EG4OH, or SDS.  
 
 
3.2.8  Maltose derivatives mimic rhamnolipids : DβM (85 µM) activated tendrils in non-
swarming mutant rhlA repel each other  
Tendril formation by P. aeruginosa swarms is an intriguing and a challenging 
phenomenon. The primary understanding of why P. aeruginosa forms tendril is that it is an 
adaptive mode of living in order to adjust to the environmental conditions. The tendril formation 
phenomenon has been explained by many physico-chemical theories which include marangoni 
effect, chemotaxis, and attractant-repellent theory.190, 193-195 While several models have been 
proposed to explain tendril formation in P. aeruginosa, the mechanism of pattern formation still 
remains unclear.   
While it is clear that under the tested swarming conditions the PAO1 strain used in this 
study does not form tendrils, the introduction of 85µM of DβM in the semisolid gel (0.5 % agar) 
induced tendril formation (Figure 3.12). Also, inoculating the nonswarming mutant rhlA on 
semisolid gel (0.5 % agar) with 20µM of DβM caused swarming activation with the swarm 
covering the entire gel surface with no clear tendril formation (Figure 3.10). However, when the 
concentration of DβM was increased to 85 µM, rhlA mutant swarms with fine tendril formation 
(Figure 3.10). Additionally, at 85 µM, six maltose derivatives; 4-tBuBDeβM, DβM, 4-MBDβM, 
3,5-DMBDβM, ADβM and 4-tBuBDβM induced tendril formation in PAO1 (Figure 3.9) and 
four maltose derivatives; DβM, 3,5-DMBDβM, 4-MBDβM and ADβM reactivated rhlA mutant 
with tendril formation (Figure 3.8). Deziel and co-workers had demonstrated that externally 
added rhamnolipids can reactivate rhlA swarming with tendril formation similar to that of wild 
type P. aeruginosa.195  The ability some maltose derivatives to activate the swarming of rhlA 
mutant and induce tendril formation in both rhlA mutant and PAO1 indicates that these agents 
could be mimicking rhamnolipids.  
 
 
O’Toole and co-workers have also reported that when two colonies of wild type of P. 
aeruginosa strain PA14 are inoculated on the same semisolid surface (0.5 % agar), the tendrils of 
the two colonies seem to repel each other.202 The possible explanation given by O’Toole and co-
workers is that the wild type strain secretes extracellular factors (possibly rhamnolipids) that 
prevent colonization between two tendrils and also the merger of two swarm colonies. 
Encouraged by the rhamnolipid mimicking ability of the maltose derivatives, semisolid gel (0.5 
% agar) containing either zero or 85µM of DβM was inoculated with two colonies PAO1 
separated on the surface. The two colonies of PAO1 on the semisolid agar that lacked DβM did 
not merge. However, the distance between the tendrils of the two PAO1 colonies inoculated on 
the semisolid agar containing 85µM of DβM was larger than between the two colonies on the gel 
that lacked DβM (Figure 3.20). On increasing the concentration of DβM in the semisolid gel (0.5 
% agar) inoculated with two colonies of rhlA mutant brought forward two kinds of colony 
behaviours. At 20 µM of DβM the two rhlA colonies seem to merge to form one 
indistinguishable swarm colony (Figure 3.20). However, when the concentration of DβM was 
increased to 40 µM the two rhlA swarm colonies did not merge and the tendrils formed seemed 
to repel each other (Figure 3.20). The separation and repulsion of tendrils seem to increase when 
the concentration of DβM was increased to 85 µM (Figure 3.20). Such behaviour suggests the 
generation of different rhlA phenotypes at different concentrations of DβM. Therefore we 
hypothesize that at 20 µM DβM induces rhlA mutant to go from nonswarming to hyperswarming 
phenotype whereas, at 85 µM DβM causes coexistence of hyperswarming and hyposwarming or 
hyperswarming and nonswarming phenotype of rhlA (Figure 3.21). 
 
 
 
 
 
 
 
Figure 3.20 PAO1 or rhlA mutant inoculated on two different locations on the same semisolid 
agar (0.5 %) plate containing DβM (0 or 20 or 40 or 85 μM). Pictures are taken 24 h after 
inoculation of bacteria on the agar plate.  
                                                   
Figure 3.21 Different phenotypes of rhlA on semisolid gel (0.5 % agar) depending on the 
concentration of DβM       
3.2.9 The swarming phenotype of rhlA mutant generated depends on the concentration of DβM  
In order to test our hypothesis, whether DβM can induce formation of two different 
phenotypes at different concentrations, the following swarming assay with rhlA mutant was 
designed. A semisolid gel (0.5 % agar) was created such that two different concentrations of 
DβM were present in the same swarm agar gel and rhlA mutant was inoculated.           
 
 
Swarm gels containing one concentration of DβM were initially poured and solidified to 
occupy half the volume of a petri dish and the other half was then filled with gel containing a 
different or same concentration of DβM. In this way swarm plates were created having a 
boundary at the center with two different concentration of DβM on either side (Figure 3.22). The 
rhlA mutant was then inoculated on the swarm gel having a particular concentration of DβM and 
the spread of the swarm colony across the concentration boundary was observed. We note that, 
across the boundary the change the concentration may not be sharp and may actually be a 
gradient from one concentration to another.   
  
Figure 3.22 Schematic representations for creating semisolid swarm agar plate containing two 
concentrations of DβM  
When the rhlA mutant was inoculated on the side of the semisolid gel that contained 
85µM of DβM the reactivated swarm pattern had tendril formation but this swarm colony could 
not spread across the boundary into a region that contained either lower or same concentrations 
of DβM (20µM, 25µM, 35µM, 45µM, 85µM). On the contrary, when the rhlA mutant was 
inoculated on the side that contained lower concentrations of DβM (20µM) the swarm colonies 
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spread with no distinct tendril formation and also crossed the concentration boundary into the 
region of higher DβM concentrations (45µM, 65µM, 85µM). Interestingly, the swarming pattern 
on entering the region of higher DβM concentration changed from no tendrils in the lower 
concentrations to formation of distinct tendrils in the region of higher concentrations (Figure 
3.23). This result suggests that, the phenotype formed on gels with 85 µM and 20 µM 
concentrations of DβM are different. Also, the phenotype formed on 85 µM did not readily 
change to form the phenotype associated with 20 µM concentration, but the phenotype formed 
on 20 µM can change to form phenotype associated with 85 µM of DβM. 
 
Figure 3.23 Images of swarm colonies of the rhlA mutant on semisolid gel (0.5 % agar) 
containing two different concentrations of DβM. The rhlA mutant was inoculated on (A) 85 μM 
DβM side of the agar plate. (B) 20 μM side of the agar plate. (C) both sides of the agar plate.  
 
 
3.3 Conclusion         
                                                                                                                                  
It has been reported that a P. aeruginosa mutant, rhlA that lacks the gene to produce 
rhamnolipids is nonswarming but when rhamnolipids are externally added, the mutant swarms 
with patterns similar to the wild type strain.202 This study brought forward a class of maltose 
derivatives that are structurally related to rhamnolipids and that can activate the swarming of the 
rhlA mutant. Other generic surfactants with poor structural resemblance to the natural 
biosurfactant were incapable of exhibiting such swarming activation. Therefore, while swarming 
is linked to the secretion of surface-active agents, not all surface active agents could accomplish 
this bioactivity. The activation of swarming in rhlA mutant with patterns similar to that of wild 
type strain by many maltose-derivatives suggested that these agents mimic the natural 
biosurfactant, rhamnolipids. In the swarming agonist assays with the rhlA mutant, maltose 
derivatives had variable ability to activate swarming and to induce tendril formation, suggesting 
different levels of agonism to the putative receptor. The ability of maltose derivatives to 
modulate swarming of wt. P. aeruginosa in the swarming antagonist assay also showed 
variations.  
Both the agonist and the antagonist assays showed that many maltose derivatives exhibited 
an “activity reversal” phenomenon of transitioning from swarm-activating to swarm-inhibiting as 
the concentration of the agents was increased. A similar “activity reversal” phenomenon had 
been observed for the discovery of the prominent cell signaling molecule N-(β-ketocaproyl) 
homoserine lactone.10 In addition, certain maltose derivatives appeared to cause a second 
activation of swarming at relatively higher concentrations after first “activity reversal” cycle.  
 
 
The physico-chemical theory of chemical attractant and repellant by Deziel and coworker 
could not be applied to explain the activation of rhlA mutant’s swarming by maltose derivatives. 
A representative maltose derivative, dodecyl-β-maltoside, caused phenotypic bifurcations of the 
rhlA mutant and generated hyperswarming and hyposwarming cells. While, in the presence of 
maltose derivative, the hyposwarming phenotype could transform into the hyperswarming 
phenotype, the reverse transformation was not observed. 
Multiple evidences presented here suggest an overall biological response by the bacteria to the 
presence of maltose derivatives with many biological traits suggesting that these agents are 
mimicking the natural ligand rhamnolipids. While the involvement of rhamnolipids in P. 
aeruginosa bioactivities has been reported in a number of reports, the identification of its protein 
receptor still remains elusive. Surface attachment deficient (SadB) protein being the target 
receptor for rhamnolipids has been suggested by one such report. On the other hand, many 
biological recognition events are mediated by carbohydrate-protein interaction and adhesins 
proteins such as pilin and flagellin present on the bacterial surface mediate such interactions. 
Therefore, whether maltose derivatives target the same receptor as that of rhamnolipids or 
whether there exists a separate receptor for such ligands is an intriguing question for the future 
work. Also, it is to be noted that there exists no correlation between the biofilm inhibition 
abilities and the swarming activating abilities of the maltose derivatives, suggesting that either 
the receptor for these two bioactivities is different or the receptor is the same, but the subsequent 
cascading signaling effects are different. 
This chapter highlighted the versatility of maltose derivatives to control swarming of P. 
aeruginosa, in addition to their role in controlling biofilm development reported in earlier 
chapters. The secretion of rhamnolipids and other biosurfactants have been reported in many 
 
 
other bacteria. The effect of maltose derivatives on such species will be a good test of the 
versatility of these agents to control multicellular behaviors of other species. 
3.4 Materials and methods 
 
Bacterial strains    Wild type P. aeruginosa PAO1 and PAO1-EGFP strains were obtained from 
Dr. Guirong Wang (Upstate Medical University, Syracuse). Non-swarming mutant of P. 
aeruginosa, rhlA (PW6886, rhlA-E08::ISphoA/hah) was obtained from PA two-allele library 
(PAO1transposon mutant library).203 
Stock solutions of generic surfactants and maltose derivatives       Stock solution of all the agents 
(11.5 mM) were prepared in autoclaved water, sterilized by filtering through 0.2 µm syringe 
filter, and stored at -20 °C in sealed vials. Appropriate amount (same amount as of the stock 
solution of maltose derivatives) of sterile water was added to controls in all assays to eliminate 
solvent effect. 
Swarming assay    Swarm agar plates were made using M8 medium (50mM Na2HPO4, 25 mM 
KH2PO4, 4 mM NaCl), supplemented with 0.2% glucose, 0.5% casamino acid (Difco), 1 mM 
MgSO4 and solidified with 0.5 % Bacto-agar (Difco).202 Appropriate amount of maltose 
derivative’s stock solution was added in the agar gel and thoroughly mixed before pouring in to 
the petri dishes. For each set of experiment all the swarm plates were poured from same batch of 
agar and allowed to dry for 1 h before inoculation of bacteria. Bacterial culture with OD600 
between 0.4 to 0.6 was inoculated as 3 µl aliquots. Swarm agar plates were incubated at 37 °C 
for 12 h and then incubated for additional 12 h at room temperature. Each swarming experiment 
was repeated at least three times.  
 
 
Swarm area measurement   To measure swarming area, images of “swarm plates” were adjusted 
to keep the diameters of all the petri dishes containing the semisolid gel to a constant 4.4 inches. 
The adjusted images were printed and the swarming patterns were cut and weighed. With 1 cm2 
square of the copy paper weighing 8.0 mg, the swarming areas were calculated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 
Maltose Derivatives Inhibit the Biofilm Formation of 
Escherichia coli and Staphylococcus aureus 
Overview 
The active maltose derivatives exhibited versatile abilities to control three multicellular 
activities of P. aeruginosa including biofilm formation, dispersion of preformed biofilm and 
modulation of swarming motility (Chapter 2 and 3). All of the three multicellular activities of P. 
aeruginosa that are affected by maltose derivatives are known to be either directly or indirectly 
controlled by rhamnolipids, a class of naturally secreted glycolipid biosurfactants.  
Apart from P. aeruginosa, only a few other bacterial species are known to produce 
biosurfactants that are similar to rhamnolipids. Therefore it was necessary to identify the effect 
of these maltose derivatives on other bacterial species, primarily to evaluate the universality of 
such agents and to distinguish whether the action on P. aeruginosa is by mimicking 
rhamnolipids or by a physical washing effect.  
Two bacterial species that do not produce rhamnolipids, Escherichia coli, a gram negative 
bacterium, and Staphylococcus aureus, a gram positive bacterium, were chosen for this study.  
Tested maltose derivatives effectively inhibited the biofilms of both E. coli and S. aureus. 
However, these maltose derivatives were sluggish dispersers of E. coli biofilm, and exhibited no 
ability to disperse the biofilm of S. aureus. Additionally, contrary to the effect on P. aeruginosa, 
the tested maltose derivatives lacked the ability to prevent the initial adhesion of E. coli on 
polystyrene surface. The stark contrast between the activities of maltose derivative on P. 
 
 
aeruginosa and two other bacteria, E. coli and S. aureus, suggests a biological response by P. 
aeruginosa to these agents. Poor activities of such maltose derivatives against other bacterial 
species also suggest that the antibiofilm action of such agents is not through physical washing 
effects.  
4.1 Background and significance 
 
4.1.1 Difference between Gram positive and Gram negative bacteria 
 
Since maltose derivatives effectively modulated the multiple multicellular activities of P. 
aeruginosa, including initial adhesion on polystyrene surfaces, biofilm formation, dispersion and 
swarming motility, it was important to understand the effect of these maltose agents on the 
activities of other bacterial species. For comparative study of the effects of maltose derivatives  
on the two other bacterial species we selected a Gram negative and a Gram positive strain of 
bacteria, Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), respectively.  
Hans Christian Gram in 1884 discovered and first characterized bacteria into two 
different classes, Gram positive and Gram negative based on their cell wall structure.204 Gram 
negative bacteria have single layer of peptidoglycans in their cell wall and hence do not retain 
the crystal violet (CV) dye, whereas Gram positive bacteria have a thick multilayer of 
peptidoglycans and hence retain the CV dye.204 Apart from their role in being stained by organic 
dyes, the bacterial cell wall and its thickness protects the bacteria from the action of antibiotics 
and host immune system. Gram negative bacteria are usually more resistant to the action of 
antibiotics than the gram positive bacteria.205  Apart from cell wall architecture, bacteria are 
further classified based on their virulence and pathogenicity.  
 
 
4.1.2 Staphylococcus aureus related infections 
 
S. aureus is the most commonly encountered bacterium in nosocomial infections.206 
Gram positive bacterium S. aureus is responsible for skin infections,207 abscesses,208 bloodstream 
infections,209 pneumonia210 and toxic shock syndrome (TSS).211 Presently, some strains of S. 
aureus are resistant to many existing antibiotics due to their intrinsic ability to quickly develop 
resistance against antibiotics.212 During World War II, cell wall targeting antibiotic Penicillin 
was primarily used for treating S. aureus related infections.213 But by the 1960s, Penicillin was 
ineffective on almost eighty percent of the S. aureus related infections. Therefore Penicillin 
structure was further modified to give second generation antibiotic, methicillin. But by the year 
2002, methicillin resistant S. aureus (MRSA) strain emerged which showed resistance against 
the commonly used antibiotic Methicillin.214, 215  S. aureus is therefore classified as multi drug 
resistant (MDR) bacteria and is often referred as “super bug.” Further defense against antibiotics 
can be achieved by the ability of S. aureus to form surface attached communities called biofilms.   
 
4.2.3 E. coli and S. aureus do not produce biosurfactants 
 
Although E. coli is known to swarm on semi-solid agar surfaces, the wetting agent 
required to reduce the surface tension between swarming E. coli cells and the agar surface is still 
unknown.216  It has been reported that, the lipopolysaccharides found on the outer membrane of 
E. coli, are an important class of wetting agents which helps E. coli  during swarming.78 Harshey 
and coworker reported that an E. coli mutant strain that does not produce such 
lipopolysaccharides was unable to swarm. On the other hand, the Gram positive bacterium, S. 
aureus is a non-swarming species because it lacks two important factors that are critical for 
 
 
swarming, the existence of flagella and the production of wetting agents or biosurfactants. But S. 
aureus do retain the ability to colonize surfaces in search of nutrients  by performing slow sliding 
motilities with a rate of ~100 µm/min.217 
4.2.4 Small molecules for inhibition of S. aureus biofilm formation  
 
Gram positive bacteria carry out quorum sensing by secretion of peptide based signaling 
molecules.218, 219 Therefore the acyl homoserine lactone (AHL) based synthetic mimics that can 
interfere with the quorum sensing of many Gram negative bacteria are understandably ineffective 
against Gram positive bacteria like S. aureus. Alternatively, the quorum sensing of Gram 
positive bacteria can be inhibited by synthetic mimics of the signaling peptides. One of the 
significant antagonists used against the biofilm and virulence of S. aureus is RNA-III inhibiting 
peptide (RIP).220, 221 RIP peptide mimics RNA-III activating protein (RAP), and therefore can 
compete with RAP for the phosphorylation of its target protein that ultimately controls S. aureus 
virulence and adhesion. The competitive interference of RIP is through a nonmicrobicidal 
mechanism.222 Other examples of Gram positive QS antagonist include peptides which inhibit 
AgrC, a transmembrane sensor kinase. Protein AgrC is a part of a two-component signal 
transduction system which detects the autoinducer peptides.223   
 
 
4.2.5 Aim of the chapter 
 
Results in chapter 2 suggested that the maltose derivatives do not interfere with the 
quorum sensing of the P. aeruginosa. Results were also indicative of the role of maltose 
derivatives as mimics of the natural biosurfactants that are secreted by P. aeruginosa, 
rhamnolipids. The aim of this chapter was to study the effect of maltose derivatives on other 
 
 
bacterial species such as E. coli and S. aureus that may or may not secrete similar biosurfactants 
as P. aeruginosa.   
4.2 Results and Discussion 
 
4.2.1 Maltose derivatives did not inhibit the growth of E. coli and S. aureus 
 
Selective maltose derivatives which inhibited more than 50 % of P. aeruginosa biofilm 
were selected to further test their effect on the growth of E. coli and S. aureus at 170 µM (Figure 
4.1). Out of five, four maltose derivatives BPDeβM, BDβM, 4-tBuBDeβM and DβM did not 
inhibit the growth of E. coli; in fact, they promoted the growth. The fifth maltose derivative, 4-
tBuBDβM did not inhibit the growth for 12 h but after 12 h this agent retarded the growth of 
planktonic E. coli (Figure 4.2). Four maltose derivatives, BPDeβM, BDβM, 4-tBuBDeβM and 
4-tBuBDβM did not inhibit the growth of S. aureus, but DβM inhibited the growth slightly, 
though it was not completely toxic (Figure 4.2).  
 
Figure 4.1 Structures of the five maltose derivatives tested 
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Figure 4.2 E. coli and S. aureus growth response curve in absence and in presence of various 
maltose derivatives at 170 µM. Error bar is the standard error of the mean from 6 replicates. 
4.2.2 Inhibition of E. coli and S. aureus biofilms by maltose derivatives 
 
After testing the effect of five maltose derivatives on the growth of the E. coli and S. 
aureus these agents were further tested for their effect on biofilm formation.  
For E. coli, the five maltose derivatives exhibited different biofilm inhibition efficacies. 
The maximum E. coli biofilm inhibition was obtained by BPDeβM (58 %) followed by BDβM 
(53 %), and DβM, 4-tBuBDβM and 4-tBuBDeβM showed 42, 28 and 24 % inhibition, 
respectively at 110 µM concentration. Maltose derivative BPDeβM had previously exhibited 
maximum biofilm potency against P. aeruginosa. Interestingly, even though 4-tBuBDβM was 
slightly toxic to the growth of E. coli, its biofilm activity was not comparable to that of BPDeβM 
(Figure 4.3).  
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Figure 4.3 Inhibition of E. coli biofilm formation by maltose derivatives at 110 µM measured 
using CV dye-based assay. Error bar is standard error of the mean from 6 replicates. 
Apart from the action on Gram negative bacteria E. coli, the maltose derivatives were 
also very effective at inhibiting the biofilm formation by S. aureus. The biofilm inhibition 
percentages of maltose derivatives against S. aureus were higher than those against E. coli. The 
most effective maltose derivative against S. aureus biofilm formation was BDβM (~ 89% 
inhibition) followed by BPDeβM (~ 86 % inhibition) and DβM, 4-tBuBDeβM and 4-tBuBDβM 
showed 85, 76 and 59 % inhibition, respectively at 110 µM concentration. The slight toxicity of 
DβM to the growth of S. aureus did not enhance its activity beyond the biofilm inhibition 
activity exhibited by BDβM (Figure 4.4). 
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Figure 4.4 Inhibition of E. coli biofilm formation by maltose derivatives at 110 µM measured 
using CV dye-based assay. Error bar is standard error of the mean from 6 replicates. 
4.2.3 Effectiveness of maltose derivatives to prevent initial bacterial surface adhesion and 
disperse preformed biofilm  
 
Using an E. coli strain that constitutively expresses red fluorescent protein (E. 
coli_pRSH103) the initial adhesion (after 2 hours) of bacteria on polystyrene surfaces in 
presence and in absence of the five maltose derivatives was investigated. The content of adhered 
bacteria on the surface was quantified by the measuring the amount of fluorescence expressed by 
the bacteria. Results indicated that, maltose derivatives did not exhibit good ability to inhibit the 
initial adhesion of E. coli_pRSH103 (Figure 4.5).  
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Figure 4.5 Inhibition of adhesion by maltose derivatives at 110 µM (anti-adhesion) measured by 
fluorescence assay. Error bar is standard error of the mean from 6 replicates. 
The five maltose derivatives (BPDeβM, BDβM, 4-tBuBDeβM, DβM and 4-tBuBDβM) 
were also tested for their abilities to disperse preformed biofilms of both E. coli and S. aureus. 
Although maltose derivatives exhibited the ability to inhibit biofilm formation by E. coli, they 
showed sluggish activity towards the dispersion of preformed E. coli biofilms (Figure 4.6). 
Similarly, the maltose derivatives were also ineffective at dispersing the 24 h old biofilms 
formed by S. aureus (results not shown).  
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Figure 4.6 Dispersion of E. coli biofilm by adding 110 µM of maltose derivatives to the 24-h old 
biofilms followed by quantification of remaining biofilm by staining with CV-dye. Error bar is 
standard error of the mean from 6 replicates. 
4. 3 Conclusion 
 
While the tested maltose derivatives exhibited good ability to inhibit the biofilm 
formation of both E. coli and S. aureus, they were not capable of dispersing the preformed 
biofilms of both the bacteria. Additionally, the tested agents were also incapable of reducing 
initial adhesion of E. coli onto polystyrene surfaces. Contrary to these observations, the maltose 
derivatives had previously demonstrated strong abilities to interfere with multiple multicellular 
behaviors of P. aeruginosa. These observations suggest that the maltose derivatives had poor 
efficacies against bacterial strains that were incapable of producing biosurfactant, rhamnolipids. 
Importantly, since maltose derivatives that were potent against P. aeruginosa had low efficacies 
against E. coli and S. aureus supports the argument that the antibiofilm activities associated with 
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these agents is not a consequence of a physical washing effect but involves an intricate biological 
process.  
4.4 Materials and Methods 
 
Bacterial strains and growth media    
Wild type S. aureus strain was obtained from Dr. Guirong Wang (Upstate Medical University). 
Wild type E. coli and E. coli_pRSH103 strains were obtained from Dr. Dacheng Ren (Syracuse 
University). All the bacterial strains were grown in Luria-Bertani (LB) medium containing 10 
g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl at 37 °C.  
 
Stock solutions of synthetic maltose derivatives        
Stock solutions of all the agents (11.5 mM) were prepared in autoclaved water, sterilized by 
filtering through 0.2 µm syringe filter, and stored at -20 °C in sealed vials. Appropriate amount 
of sterile water was added to controls in all assays to eliminate the solvent effect. 
Crystal violet dye-based biofilm inhibition assay   
Inhibitory effect of all the maltose hydrocarbons on E. coli or S. aureus biofilm formation was 
determined by crystal violet dye based biofilm inhibition assays. Overnight culture of E. coli or 
S. aureus was sub cultured to an OD600 of 0.01 into the LB medium. 200 µL of the sub culture 
was aliquoted into the wells of 96-well polystyrene microtiter plate when it reached the OD600 of 
0.1. Predetermined concentrations of the test compounds were then added to the respective wells 
containing sub culture. Sample plates were wrapped in GLAD Press n’ Seal® followed by 
incubation under stationary conditions for 24 h at 37 °C. After incubation the media was 
 
 
discarded and the plates were washed with water and dried for 1 h at 37 °C. The sample plates 
were stained with 200 μL of 0.1% aqueous solution of crystal violet (CV) and followed by 
incubation at ambient temperature for 20 min. The CV stain was then discarded and the plates 
were washed with water. The remaining biofilm adhered stain was re-solubilized with 200 μL of 
30 % acetic acid. After the stain was dissolved (15 minutes), 100 μL of the solubilized CV was 
transferred from each well into the corresponding wells of a new polystyrene microtiter dish. 
Biofilm inhibition was quantified by measuring the OD600 of each well in which a negative 
control lane wherein no biofilm was formed served as a background and was subtracted out. The 
percent inhibition was calculated by the comparison of the OD600 for biofilm grown in the 
absence of compound (control) versus biofilm grown in the presence of compound under 
identical conditions. Biofilm inhibition assay with all the maltose derivatives was repeated four 
times and each data point in the graph is the average of values from 6 wells. 
 
Anti-adhesion assay     Overnight culture of E. coli_pRSH103 was subcultured to an 
OD600 of 0.01 into the LB medium. Subculture was allowed to reach the OD600 of 0.1 in a rotary 
shaker at 250 rpm and 37 °C. 200 µL of the subculture was then transferred to the wells of black 
microtiter plate with and without (control) maltose derivatives. This black 96-well plate was then 
incubated in a shaker at 37 °C for 2 h. After 2 h, bacterial culture from the plate was discarded 
and each well was washed once with saline water (0.85 w/v% aqueous NaCl solution). Fresh LB 
medium was added to the black 96 well plate and fluorescence of the surface adhered bacteria 
was measured by Synergy 2 multi-mode microplate reader with Gen5 data analysis software at 
an excitation wavelength of 500 nm and an emission wavelength of 540 nm. Background signal 
from LB medium was eliminated from all the samples.    
 
 
 
Dispersion assay for preformed biofilm The plate for biofilm dispersion assay was set up 
similar to crystal-violet based- biofilm inhibition assay but without adding any maltose 
derivatives at the time of inoculation of bacteria in the 96 well plate. E. coli or S. aureus was 
allowed to grow for 24 h at 37 °C. After 24 h, bacterial culture was pipetted out and replaced 
with 200 µL of 110 µM maltose derivatives in fresh LB medium. After 24 h treatment with 
maltose derivatives, biofilm was fixed and quantified using crystal violet dye as described above. 
The amount of dispersed biofilm was determined by comparing (normalizing) the amounts of 
biofilm at 48 h with and without maltose derivatives. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5 
Biofilm Inhibition Activities and Mechanism of Action of Brominated Furanones against 
Escherichia coli and Pseudomonas aeruginosa 
Overview 
Among the different classes of biofilm inhibitors, halogenated furanones form a 
prominent class which disrupts the formation of biofilm by interfering with the quorum sensing 
of the bacterial species. This study is a mechanistic investigation of the action of brominated 
furanones (BFs) on the formation of biofilms by Escherichia coli and Pseudomonas aeruginosa. 
Here, four structurally related brominated furanones were synthesized and followed by study of 
their inhibitory effects on biofilm formed by E. coli and P. aeruginosa. Structure activity studies 
suggested that methyl substituent on the furanone ring and on the exocyclic vinyl double bond 
were important for nonmicrobicidal inhibition of both E. coli and P. aeruginosa biofilms. Also, a 
structure with a methyl substituent on the furanone ring was a more effective anti-biofilm agent 
than the structure with methyl substituent on the exocyclic vinyl double bond. The biofilm 
inhibition activity of brominated furanones on sdiA gene deleted E. coli strain was lower than on 
wild type E. coli. Reduction in biofilm inhibition activity of brominated furanone suggested 
importance of SdiA protein for activity of brominated furanones. Also, results with P. 
aeruginosa shows that these brominated furanones were antagonist to las quorum sensing system 
but agonist to rhl quorum sensing system. The SdiA protein of E. coli and the LasR protein of P. 
aeruginosa are homologous to the acylated homoserine lactone (AHL) binding LuxR protein in 
V. fischeri. Hence, BFs could be recognizing the pocket of the receptor protein that binds AHLs.  
 
 
5.1 Background and significance 
 
5.1.1 Controlling quorum sensing is a very well explored strategy for biofilm inhibition 
 
Biofilms are highly hydrated and organized surface attached bacterial communities, 
composed of bacterial cells embedded in a secreted polymeric matrix. It is estimated that the 
formation of biofilm renders the bacteria thousand fold more resistant to the effect of antibiotics. 
Another problem exacerbated by bacteria occupying a biofilm state is hypermutation. This 
occurs when bacteria, in response to environmental pressures (such as antibiotics), mutate at 
higher rates to evolve the genetic makeup to become resistant against toxic substances. What is 
direr is the spreading of these resistant genes amongst diverse pathogens leading to the 
generation of multi-drug resistant strains. Antibiotic resistance is one of the most acute public 
health problems. From a medical perspective, most of the microbial infections in humans are 
associated with biofilm mode of bacterial living. Billions of dollars are lost every year in 
agriculture, engineering, medical and industrial sectors due to biofilm related problems.  
The biological process that controls the biofilm formation is quorum sensing. Quorum 
sensing is the cell density-dependent regulation of gene expression in bacteria, based on the 
secretion of small molecules also called autoinducers. Among different strategies explored, 
inhibition of quorum sensing is a highly explored antibiofilm strategy. Due to their importance in 
controlling many bacterial multicellular behaviors, autoinducers have served as scaffolds for 
designing small molecules to inhibit biofilm formation. These synthesized mimics possess the 
ability to interfere with the quorum sensing by having either agonistic or antagonistic effects on 
the receptor proteins of autoinducers.   
 
 
Since, the structure of autoinducers and their respective receptor protein sites vary with 
different bacteria, structural tuning is required to attain maximum inhibition. Hence it is 
important to understand the signaling events during QS and the structural details of various 
autoinducers. 
5.1.2 E. coli is a model organism for studying biological processes 
 
Escherichia coli (E. coli) is a gram-negative rod shaped bacterium, and is often the 
“model organism” chosen by researchers for studying many biological processes. E. coli is a 
common gastrointestinal bacterium found within the human gut and is essential for breaking 
down food and releasing nutrients.224 The production of Vitamin K2 and B12 by E. coli is 
beneficial to the host.225 Also, E. coli residing in the intestine have been shown to prevent 
colonization of pathogenic microbes in the gastrointestinal tract.226 Usually, the E. coli strains 
found in human guts are not harmful, but colonization of some E. coli strains can cause serious 
infections to its host like diarrhea and food poisoning.227 The causative symptoms of diarrhea 
arise when E. coli strains within the intestine reduce the ability of epithelial cells to absorb water. 
Other E. coli related infections include gastroenteritis and septicemia. Importantly, many 
diseases arising due to the formation of biofilms on medical devices such as prostatitis and 
catheter infections have been associated with E. coli infestation.228 Since E. coli is one of the 
most well studied bacteria, there exists a vast knowledge of its various biological systems that 
can be used to interpret studies done on elucidating its biofilm formation pathways. 
 
 
 
 
 
 
5.1.3 Quorum sensing in E. coli 
 
E. coli deploys many chemical signals to carry out both intra-species and inter-species 
cell-to-cell communication (Table 5.1). The quorum sensing circuit of E. coli has not yet been 
completely plotted; many of the receptor proteins for putative signals are yet to be identified.18 
Following are the three quorum sensing circuits of E. coli. 
 
SdiA mediated QS system in E. coli 
Signaling molecules, N-acyl-L-homoserine lactones (AHLs) are commonly deployed by 
many gram negative bacteria to carry out quorum sensing, but E. coli lack the syntheses (LuxI 
homolog protein) required for synthesizing AHLs.18, 229 Therefore, E. coli does not perform 
intraspecies QS with the help of AHLs, however E. coli are fully capable of responding to such 
chemical signals produced by other bacterial species.18, 229 This is because E. coli possess AHL 
receptor protein, suppressor of cell division inhibitor, SdiA (homologous to V. fischeri LuxR and 
P. aeruginosa LasR).230 It is known that essential amino acids which are necessary for binding 
with AHLs, are conserved in SdiA and other such homologous proteins found on other bacteria 
such as LuxR of V. fischeri and LasR of P. aeruginosa.231 Studies reveal that SdiA can bind 
AHLs produced by other bacterial species and thereby allow E. coli to regulate gene 
transcription and interspecies communication.232 Amino acids, 1 to 171 out of total 240 amino 
acid of SdiA protein are involved in binding with AHL.233, 234 It has also been illustrated that 
SdiA protein can detect chemical signals other than AHLs, like indoles secreted by E. coli 
itself.235 SdiA protein has been reported to be involved in different bacterial activities including 
biofilm formation, motility, virulence, acid resistance and transportation of autoinducer-II.236 Lee 
 
 
and coworkers have demonstrated that indole, which is another quorum sensing regulator in E. 
coli, controls the acid resistance through SdiA protein.237   
 
AI-II regulated quorum sensing system in E. coli 
AI-I produced by bacteria are used to perform intra-species communication during 
quorum sensing. In addition, bacteria respond to the chemical signals secreted by other bacteria 
through a universal inter-species communication mechanism, and for this, bacteria secrete 
autoinducer-II (AI-II). Although, E. coli do not secrete AI-I, they do secrete AI-II known as 
furanosyl borate diester which is synthesized by the LsrK syntheses and detected by LsrR 
protein.238 It has been reported that when E. coli and S. typhimurium enter the stationary growth 
phase, their AI-II signal gets degraded.239 The domestic laboratory strain of E. coli, DH5α lacks 
the production of AI-II.239 
 
Indole regulated quorum sensing system in E. coli 
Another signaling molecule secreted by E. coli is Indoles. The early discovery of indole 
production by E. coli was in 1897 by Theobald Smith and since then the production of such 
agents has been reported in about 85 Gram-positive and Gram-negative species.240 The synthesis 
of indoles in bacteria is catalyzed by enzyme tryptophanase which synthesizes the three 
components, indole, pyruvate and ammonia on hydrolyzing tryptophan (Table 5.1).240 The 
tryptophan catalyst found in E. coli is the TnaA protein.241, 242 Lee and coworkers also reported 
that the regulation of indole signaling is mediated through the SdiA protein.237, 243 Many bacterial 
bioactivities including biofilm formation,244 swarming motility,244 inducing resistance,245 
 
 
forming persister cells246 and secretion of virulence factors247 is regulated through the indole 
signaling process.  
 
 
5.1.4 Quorum sensing and QS gene reporter assay for P. aeruginosa 
 
As discussed in Chapter 2 and 3 (Sections 2.1.4 and 3.1.7) the two important quorum 
sensing systems of P. aeruginosa are las and rhl circuits (Figure 5.1).248, 249 The synthetic 
analogs of autoinducers are designed such that they can interfere with the QS by binding with the 
receptor “R” proteins of both las and rhl quorum sensing circuits. Two types of assays have been 
developed to investigate the agonistic or antagonistic activities of synthetic agents against the 
two quorum sensing circuits of P. aeruginosa. 
For reporting the agonistic activity of the agents towards either las or rhl quorum sensing 
systems of P. aeruginosa, researchers have used two double knockout strains of PAO1, PAO-JP2 
(plasI-LVAgfp) and PAO-JP2 (prhlI-LVAgfP). These double knockout strains lack the 
autoinducer synthesis proteins, LasI and RhlI of the las and rhl systems, respectively and 
therefore these strains are devoid of the production of natural autoinducers AI-1 and AI-2, 
respectively. When externally added unnatural agents agonize either the LasR or the RhlR 
Protein Function Cognate signal
SdiA Receptor
Indoles (secreted     AI-1 (AHL secreted
by E. coli),                by other bacteria) 
LsrK Regulator
LsrR Receptor Secreted by E. coli
Table 1. Different quorum sensing regulating proteins in E.coli
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proteins, this agonization induces the expression of green fluorescent protein by the two reporter 
plasmids plasI-LVAgfp and prhlI-LVAgfp, respectively. Increase in fluorescence would imply 
agonistic activities of the agents (Figure 5.2). 
For reporting antagonistic effect of a synthetic agent on the las and rhl quorum sensing 
circuits of Pseudomonas aeruginosa, a gene reporter assay has been created by using two 
reporter strains, PAO1/ plasI-LVAgfp and PAO1/ prhlI-LVAgfp. 61, 114 The two reporter strains 
secrete natural autoinducers that bind receptor proteins, lasR and rhlR activating either lasI or 
rhlI genes respectively. The activation of either lasI or rhlI genes in turn expresses green 
fluorescent protein that is encoded by the plasmid.250 If externally added agents are able to 
significantly reduce the fluorescence of the two reporter strains, PAO1/ plasI-LVAgfp and 
PAO1/ prhlI-LVAgfp then it would imply an antagonistic activity wherein the agent competes 
with and dominates the natural autoinducers for the receptor sites (Figure 5.1, 5.2). 61, 114 
 
 
 
Figure 5.1 The las and rhl QS circuits of P. aeruginosa. Competition between the unnatural 
small molecule and natural autoinducers to bind to the receptor protein LasR is shown.251 Also, 
shown in a box is a plasmid used to quantify the activation of LasR protein upon binding with 
natural autoinducer or unnatural small molecule by expression of green fluorescent protein 
(GFP). [Modified and reprinted with permission from Citation: B H Iglewski, (1997) Roles of 
Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and 
rhamnolipid biosynthesis genes. J. Bacteriol. (179), 5756-5767; Copyright : 1997, American 
Society for Microbiology]  
 
Figure 5.2 Cartoon that depicts how expression of green fluorescent protein varies depending on 
the agonistic or antagonistic activity of the small molecules. 
 
 
  
 
 
5.1.5 Inhibition of quorum sensing by small molecules 
 
Different classes of compounds such as pyrroloindoline triazole amides, 2-
aminobenzimidazole, non-native AHL, ketone analogues of AHL’s and brominated furanones, 
have been used as antagonist against quorum sensing circuits of both E. coli and P. aeruginosa 
(Figure 5.3). Melander and coworkers showed that pyrroloindoline triazole amides are effective 
against the E. coli biofilm. Additionally, Melander and coworkers have demonstrated the use of 
synthetic 2-aminoimidazole oroidin analogues for inhibition and dispersion of P. aeruginosa 
biofilm.60 Further, Blackwell and coworkers synthesized more optimum 2-aminobenzimidazole 
derivatives with high potencies for inhibiting and dispersing the biofilm of P. aeruginosa by 
interfering with both las and rhl quorum sensing circuits.59  Blackwell and Suga groups in two 
different works have reported the use of synthetic non-native AHL molecules for interfering with 
the las and rhl quorum sensing circuits of P. aeruginosa.62, 63 Spring and coworkers made further 
improvements to the design of non native AHLs by creating structures in which the lactone 
functionality was replaced by a ketone group to decrease the hydrolysis of the molecule.252 
 
 
Figure 5.3 Examples of small molecules that interfere with bacterial quorum sensing and hence 
attenuate the multicellular behaviors of the bacteria  
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5.1.6 Brominated furanones are an important class of quorum sensing inhibitors 
 
Dichloromethane extract of red algae, Delisea pulchra (Bonnemaisoniaceae) was found 
to have significant antifungal and antibacterial activity.253, 254 Further investigation of the 
dichloromethane extracts obtained from red algae lead to the discovery of brominated furanones 
as the active components for exhibiting anti-bacterial and anti-fungal activities.255 Brominated 
furanones have been extensively studied since then for their role in different biological functions, 
but the exact mechanism of the action of such agents still remains elusive.254 Brominated 
furanones strongly inhibit multicellular behaviors like biofilm formation and swarming of gram-
negative bacteria without inhibiting the growth of the bacteria (Table 5.2).56, 256-258 Structural 
details of brominated furanones can be altered to either inhibit the biofilm without inhibiting the 
growth or to inhibit the growth of certain gram positive bacteria.259-261 Brominated furanones 
have also been used to inhibit the growth of certain fungi like Candida albicans.262  
Persisters are the set of cells in the biofilm which are in a dormant phase with low 
metabolic activities and hence such cells are immune to the action of antibiotics. As a 
consequence persister cells prevent the antibiotics from exhibiting total control over the bacteria. 
Ren and co-workers recently demonstrated that brominated furanones increased the susceptibility 
of P. aeruginosa persister cells towards the action of antibiotic, Ciprofloxacin.263 
Luk and co-workers had synthesized a small library of ten brominated furanones and 
identified the important structural elements necessary for nonmicrobicidal inhibition of E. coli 
biofilm formation.55 Out of the ten synthesized brominated furanones, three structures were 
potent nonmicrobicidal biofilm inhibitors, two structures inhibited the growth of E. coli and the 
rest had no effect on either the growth or biofilm of E. coli.55 The important structural element 
 
 
identified by Luk and coworkers was that the conjugated exocyclic vinyl bromide on the 
furanone ring was important for nonmicrobicidal action.55 
Manefield and co-workers reported that brominated furanones can displace the natural 
AHL ligands of Delisea pulchra from their LuxR homologous receptor protein.264 Further, 
Givskov and co-workers showed that the action of BFs on D. pulchra is through both the 
destabilization and the reduction in cellular concentration of  LuxR homologous receptor 
protein.265 Results by Zhou and co-workers have shown that naturally occurring brominated 
furanones target AI-2 producing enzyme, LuxS (S-ribosylhomocysteine lyase) protein. For this 
Zhou and coworkers first synthesized recombinant LuxS enzyme and then measured its activity 
with increasing BFs concentration.57 They reported that the activity of the LuxS enzyme 
decreased with increasing concentration of BFs. Therefore, even though BFs are structurally 
dissimilar to naturally occurring AHLs, they can still interfere with AHL mediated functions and 
the mechanism of how this interference occurs remains unclear (Figure 5.4). 
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Figure 5.4 (A) General structure of natural acyl homoserine lactone (AHL). (B) Structure of 
natural brominated furanone extracted from Delisea pulchra. 
 
 
 
 
 
Table 5.2 Structures of brominated furanones and their activity against different bacterial species  
Structure  Name of the compound  Active against  References 
Extract from   
Delisea pulchra  
4-bromo-5-(bromomethylene)- 
3(1’-hydroxybutyl )-2(5H)-
furanone  
Swarming of P. Mirabilis and 
virulence factor production of 
Erwinia carotovora 
266, 267 
            
OO
Br
H
Br  
(5Z)-4-bromo-5-
(bromomethylene)-3 - 
butyl-2(5H)-furanone  
Biofilm of E. coli, 
bioluminescence and virulence of 
V. harveyi  
56, 268 
             
OO
Br
Br
Br  
4-brom)-2-(5H)-furanone Swarming of S. liquefaciens  269 
                
OO
H
Br  
5- (Bromomethylene)- 
2-(5H)-furanone 
Biofilm of P. aeruginosa 257 
 
 
4-bromo-5-(bromomethylene)-
2(5H)-furanone 
 
Quorum sensing of P. aeruginosa 270 
 
5.1.7 Aim of the chapter 
 
The aim of the chapter is to identify the important structural elements of brominated 
furanones for nonmicrobicidal inhibition of E. coli and P. aeruginosa biofilm formation and also 
to investigate the mode of action of such agents on the two bacteria. Brominated furanones have 
been shown to displace AHLs from their LuxR type protein.264 E. coli lacks the production of 
AHLs but its biofilm is still inhibited by BFs and therefore it is not clear as to how BFs inhibit E. 
coli biofilms. SdiA protein found in E. coli is homologous to LuxR type proteins and studies 
aimed at exploring the effects of BFs on sdiA mediated quorum sensing of E. coli have never 
been done before. This study examined the effect of BFs on the biofilm formation of both E. coli 
and its sdiA mutant, AY1297. Also, the effect of BFs on both las and rhl quorum sensing 
systems of P. aeruginosa was investigated. 
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5.2 Results and discussion 
 
5.2.1 Synthesis of structurally closely related brominated furanones 
 
Synthesis of three brominated furanones, BF8,55 BF4271 and BF10272, 273 (Figure 5.5) has 
been previously reported. New structure reported, BF15 was synthesized using a literature 
reported procedure with slight modification (Scheme 5.1), where in 4-oxohexanoic acid was first 
brominated followed by dehydration with P4O10 and the double bond was introduced using NEt3 
to eliminate HBr.274 The structures of the four brominated furanones BF8, BF4, BF10 and BF15 
vary in three different ways (Figure 5.5). First, brominated furanones BF8 and BF4 differ only in 
the methyl substitution at position C2 on the furanone ring. Second, BF4 and BF10 differ in a 
bromide substitution at position C3. Third, BF10 and BF15 differ by a methyl substitution on the 
exocyclic vinyl carbon, C5. 
 
Figure 5.5 Brominated furanones with systematic changes in structures. Variation of methyl 
substituent on the furanone ring, carbon C2 (BF8 and BF4) and variation of bromide substituent 
on the furanone ring, carbon C3 (BF4 and BF10), and variation of methyl substituent on the 
exocyclic vinyl carbon C5 (BF10 and BF15).  
[Figures in the result section of this chapter are adapted with permission from Citation: Shetye G. S., 
(2013), “Structures and biofilm inhibition activities of brominated furanones for Escherichia coli and 
Pseudomonas aeruginosa” MedChemComm 4, 1079-1084; Copyright: 2013, Royal Society of 
Chemistry.] 
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Scheme 5.1 Synthetic scheme for brominated furanone, BF15  
 
5.2.2 Methyl substitution either at C2 or C5 position is important for nonmicrobicidal activity of 
brominated furanones 
 
Toxicity assay with four brominated furanones was carried out to investigate their effect 
on the growth of parent E. coli strain, RP437, its isogenic sdiA knockout mutant, AY1297 and P. 
aeruginosa, strain PAO1. For getting the growth curve, optical density at 600 nm (OD600) of 
bacterial culture with and without brominated furanones was plotted against time. Three 
brominated furanones, BF8, BF4 and BF10 and one brominated furanone, BF15 were tested for 
bacterial growth inhibition at the highest concentrations used for biofilm inhibition assays, i.e 
200 µM and 300 µM, respectively (Figure 5.6). At these concentrations, two brominated 
furanones, BF8 and BF15 did not show any observable inhibition of bacterial growth for any of 
the three bacterial strains. However, BF4 and BF10 inhibited the growth of all three bacterial 
strains. These results indicate that the presence of methyl substitution either at C2 (BF8) or C5 
(BF15) position is very important for reducing the toxicity of brominated furanones towards the 
bacterial growth. Brominated furanone BF4, was more toxic to the growth of both the wild type 
E. coli and its sdiA mutant than BF10. This result is consistent with the fact that BF4 has two 
reactive sites with two bromine substitution whereas BF10 has only one. Growth inhibition activity 
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of BF10 reduced in sdiA mutant than in wild type E. coli. Both BF4 and BF10 completely 
inhibited the growth of PAO1. 
 
Figure 5.6 Effect of brominated furanones on the growth of (A) wt. E. coli (RP437), (B) ∆sdiA 
E. coli (AY1297), and (C) wt. P. aeruginosa (PAO1) in LB-media monitored over 24-h at either 
200 µM (BF8, BF4 and BF10) or 300 µM (BF15). Error bar is the standard error of the mean 
from 6 replicates. 
Since BF4 and BF10 inhibited the growth of E. coli and P. aeruginosa at 200 µM, lower 
concentrations of these agents were tested to determine the concentration at which they do not 
inhibit the growth. Both BF4 and BF10 did not inhibit the growth of both wild type E. coli and 
P. aeruginosa at and below 100 µM (Figure 5.7 and Figure 5.8).  
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Figure 5.7 Dose-response growth curve in LB-media of wt E. coli (RP437) and wt P. aeruginosa 
(PAO1) in presence and absence of BF4. Error bar is standard error of the mean from 6 
replicates.  
 
Figure 5.8 Dose-response growth curve in LB-media of wt E. coli (RP437) and wt P. aeruginosa 
(PAO1) in presence and absence of BF10. Error bar is standard error of the mean from 6 
replicates.  
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5.2.3 Biofilm inhibition by brominated furanones was higher for wild type E. coli than its ∆sdiA 
mutant 
 
After determining the effect of all the brominated furanones on bacterial growth, the 
effects of these agents on the biofilm formation ability of E. coli and its ∆sdiA mutant were 
tested. At 200 µM, BF8 inhibited ~ 50 % of the wild type E. coli biofilm (Figure 5.9), but at this 
concentration BF15 did not show any anti-biofilm activity (result not shown).  Hence BF15 was 
tested at 300 µM, but even at this higher concentration, BF15 was not as effective as BF8 at 200 
µM (Figure 5.9 A). This result indicated that the presence of methyl substitution at C2 (BF8) 
position is important for biofilm inhibition activity and the structure with methyl substitution on 
the exocyclic double bond at C5 (BF15) position was not as effective. Both BF8 and BF15 were 
more effective at inhibiting the biofilm of wt. E. coli (~ 50 % and 34 % inhibition respectively) 
than inhibiting the biofilm of ∆sdiA mutant of E. coli (~26 % and 18 % inhibition respectively). 
As discussed previously, SdiA protein is the receptor for AHLs and brominated furanones are 
known mimics of AHLs. The mutant, ∆sdiA lacks the receptor for AHLs, and tested brominated 
furanone had lower anti-biofilm efficacies against the mutant than wt E.coli, suggesting that 
SidA could be a receptor for brominated furanones.  
Brominated furanones, BF4 and BF10 inhibited the growth of wt. E. coli at 200 µM and 
therefore, a lower concentration of 100 µM was used for biofilm inhibition studies. But at this 
nonmicrobicidal concentration, both BF4 and BF10 were ineffective at inhibiting the biofilm of 
E. coli (Figure 5.9 B). 
 
 
  
Figure 5.9 (A) Biofilm inhibition of wt. E. coli strain (RP437) and ∆sdiA E. coli (AY1297) by 
BF8 (200 µM) and BF15 (300 µM) (B) Biofilm inhibition of wt. E. coli strain (RP437) by BF4 
(100 µM) and BF10 (100 µM). As quantified by crystal violet dye-based assay. Media used for 
biofilm assay was LB-media. Error bar is the standard error of the mean from 6 replicates 
5.2.4 Confocal laser scanning microscopy-based assay for quantifying biofilm inhibition 
 
Biofilms formed by wild type E.coli and ∆sdiA mutant with and without BF8, were also 
quantified by confocal laser scanning microscopy (CLSM) based assay. For CLSM assay both 
the E.coli strains RP437 and AY1297 were introduced with plasmid pRSH103 which 
constitutively expresses red fluorescence protein. Biofilms of the parent E. coli strain and its 
mutant ∆sdiA were then grown on sterile stainless steel (316L) coupons for 24-h in presence and 
in absence of brominated furanone, BF8. After 24 h the surface-adhered biofilms on the steel 
coupons were quantified by measuring the fluorescence. Biofilm inhibition results from CLSM 
assay were consistent with those obtained from crystal violet dye-based assay. The representative 
confocal images are presented in Figure 5.10. For both wild type E. coli and its mutant ∆sdiA, 
BF8 treated steel coupons (Figure 5.10 B and 5.10 D) showed less fluorescent signal than steel 
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coupon with no agent (Figure 5.10 A and 5.10 C), indicating biofilm inhibition in the presence of 
agents. However, the reduction in biofilm between steel coupons with and without BF8 for wild 
type E. coli was quantitatively more than its sdiA mutant. To quantify the amount of biomass, 
surface coverage and mean thickness of the biofilm on the steel coupon, software COMSTAT 
was used. Four to five different locations on the steel coupons were randomly selected for this 
quantification and Z-stacked images were taken. The biofilms quantified by measuring the 
fluorescence for each strain without any added agents were normalized as 100% and the percent 
biofilm reductions caused by the addition of BF8 were accordingly calculated. 
The plot of average biomass, surface coverage and mean thickness of the biofilm formed 
with or without 200 μM BF8 as calculated by COMSTAT are shown in Figure 5.11. The 
COMSTAT-based quantification of biomass, average thickness and surface coverage of E. coli 
(RP437) biofilm in presence of BF8 was significantly reduced as compared to its control (no 
added agent). On the contrary, BF8 was less effective at reducing the biomass, average thickness 
and surface coverage of the biofilm formed by the SdiA knockout mutant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10 Representative confocal images of biofilms formed on steel coupon for 24 hr by 
parent strain E. coli RP437 (A) without BF and (B) with 200 µM BF8; and by sdiA knockout 
mutant E. coli AY1297 (C) without BF and (D) with 200 µM BF8. Scale bar = 76 µm. 
 
Figure 5.11 Statistical quantification of the average biomass, average thickness, and surface 
coverage on steel coupons by biofilms formed by wild type E. coli (RP437) and its sdiA mutant 
E. coli (AY1297) in presence and in absence of 200 µM of BF8. Error bar is the standard error of 
the mean from 4 replicates. 
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5.2.5 Characterizing the biofilm inhibition by scanning electron microscopy  
 
Scanning electron microscopy provides a direct characterization of the morphology of 
dried biofilm and embedded microorganisms on a surface. Using microcontact printing, circular 
patches of pentadecanethiol self-assembled monolayers (SAM) surrounded by bioinert tri 
(ethylene glycol)-terminated alkanethiols, HS(CH2)11(OCH2CH2)3OH were created (schematic 
representation is shown in Figure 5.12 E). The patterned gold surfaces were then placed in a 24-
well plate and inoculums of either E.coli RP437 or its ∆sdiA mutant, AY1297 (OD600 =0.05) 
with or without (Controls) 200 μM BF8 were added and the biofilms were allowed to form for 
24 h. Because tri(ethylene glycol)-terminated alkanethiols are bioinert, after 24 h no bacterial 
attachment or biofilms were observed on this region. The formation of biofilms with embedded 
bacteria on the circular regions of pentadecanethiol SAMs created a microarray pattern (Inset in 
Figure 5.12 A). Figure 5.12 A and 5.12 C represents the circular patterned biofilm formed by 
cultures of E.coli RP437 or E.coli AY1297 where as Figure 5.12 B and 5.12 D represents the 
circular patterned biofilm formed by cultures of E.coli RP437 or E.coli AY1297 with added 200 
µM of BF8. In the SEM micrographs, better contrast between circular regions of 
pentadecanethiol and bioinert SAMs represented more amount of biofilm. The amount of E.coli 
biofilm on patterned gold surfaces grown with no added BF8 (control; Figure 5.12 A) appeared 
to be more than that formed with inoculums containing 200 µM of BF8 (Figure 5.12 B). On the 
contrary, the difference in the amount of biofilm on gold surface with AY1297 mutant biofilms 
grown in absence (control; Figure 5.12 C) and in presence of BF8 (Figure 5.12 D) was not very 
conspicuous, suggesting lesser effect of BF8 on AY1297 biofilms.  
 
 
 
 
Figure 5.12 Scanning electron micrographs of biofilm formed on patterned gold surfaces after 
24-h inoculation with E. coli RP437 (A) in absence of BF8 and (B) with 200 µM BF8; and 
biofilm formed by sdiA knockout E. coli AY1297 (C) in absence of BF8 and (D) with 200 µM 
BF8. Scale bar = 200 µm. The insert in (A) shows the details of the E. coli in the pattern. (E) The 
schematic representation of patterned SAMs of pentadecanethiol, HS(CH2)14CH3, surrounded by 
tri(ethylene glycol)-terminated alkanethiols, HS(CH2)11(OCH2CH2)3OH, is shown to the right. 
5.2.6 Inhibition of Pseudomonas aeruginosa biofilm was higher by BF8 than BF15 
 
Unlike E.coli, P. aeruginosa produces quorum sensing signaling molecules, AHLs. 
Previous reports have suggested that brominated furanones displace AHLs from their receptor 
protein LuxR.264, 265 Also, results with E. coli strains in this study indicated that the efficacy of 
brominated furanones to inhibit biofilm decreased for a strain which lacked LuxR type protein 
SdiA (AHL receptor protein). Hence after the E. coli testing, brominated furanones were tested 
for their action on P. aeruginosa biofilms. For P. aeruginosa biofilms, BF15 did not show 
significant biofilm inhibition at 300 µM whereas 200 µM of BF8 showed ~ 43 % inhibition of 
 
 
biofilm (Figure 5.13 A). The structure activity studies for P. aeruginosa biofilms inhibition with 
brominated furanones correlated with inhibition results from E. coli study where the presence of 
methyl unit at C2 position rather than C5 position was important for the activity of brominated 
furanones. Brominated furanones, BF4 and BF10, inhibited the growth of P. aeruginosa at 200 
µM. But BF4 was non-toxic below 100 µM, whereas BF10 was non-toxic at below 50 µM to the 
growth of P. aeruginosa. Hence, BF4 was tested at 100 µM and BF10 was tested at 50 µM for 
inhibition of P. aeruginosa biofilm. At the tested concentrations, both BF4 and BF10 did not 
inhibit the biofilm formation of P. aeruginosa (Figure 5.13 B).  
 
 Figure 5.13 Inhibition of P. aeruginosa PAO1 biofilm by; (A) BF8 (200 µM) and BF15 (300 
µM) (B) BF4 (100 µM) and BF10 (50 µM). As quantified by crystal violet assay. Error bar is the 
standard error of the mean from 6 replicates. 
Crystal violet dye-based inhibition assay results were further confirmed by confocal laser 
scanning microscopy assay (CLSM). Biofilm of fluorescently labeled P. aeruginosa (PAO1-
EGFP) was allowed to form on sterile steel coupons (316L) with or without BF8 for 24 h at 37 
°C. After 24 h steel coupons were washed and viewed under confocal microscope to determine 
the amount of biofilm formed based on the intensity of fluorescent signals from the steel 
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coupons. Steel coupon treated with 200 µM BF8 was less fluorescent and also the average 
thickness of the biofilm was lower than the control which had no BF8 (Figure 5.14 A and B). 
Further the biomass, average thickness and surface area were quantified using COMSTAT 
software. Biomass on steel coupon treated with BF8 was 41 % lesser than its control (No agent) 
(Figure 5.14 C). This percent reduction in biomass (Figure 5.14 C) caused by BF8 is consistent 
with the biofilm inhibition value obtained from crystal violet dye-based assay (Figure 5.13). The 
CLSM micrographs showed that there was no biofilm inhibition on steel coupons treated with 
300 µM of BF15 (results not shown). 
  
Figure 5.14 Representative confocal images of P. aeruginosa biofilms on stainless steel 
coupons; (A) without and (B) with 200 µM BF8. Scale bar = 76 µm; (C) The biomass, average 
thickness and surface area of biofilm was quantified using COMSTAT software. The parameters 
of P. aeruginosa biofilms formed without BF8 (no agent) were normalized as 100%. Error bar is 
the standard error of the mean from 4 replicates. 
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5.2.7 Brominated furanones antagonize the las system but agonize the rhl system of P. 
aeruginosa 
 
 Earlier results (section 5.2.3) from this study indicated that biofilm inhibition by 
brominated furanones for E. coli was through sdiA dependent quorum sensing pathway. The 
SdiA protein is homologous to the LuxR type protein which is also found in P. aeruginosa. P. 
aeruginosa has two LuxR type proteins, LasR in las system and RhlR in rhl system. In order to 
find out the effect of brominated furanones on these two LuxR type proteins we carried out 
quorum sensing gene reporter assays. Two quorum sensing reporter strains were used for the las 
and rhl quorum sensing systems, PAO1/plasI-LVAgfp and PAO1/prhlI-LVAgfp, respectively. 
Both these strains constitutively express green fluorescent protein (GFP) upon activation of lasI 
or rhlI gene, which gets activated upon binding of lasR with autoinducers. If brominated 
furanones are antagonist to las or rhl system then they will displace natural autoinducers from 
the receptor proteins and hence there will be a decrease in fluorescence due to lower levels of 
expression of plasmids plasI-LVAgfp or prhlI-LVAgfp. But if the brominated furanones are 
agonist then upon binding with lasR or rhlR proteins they will activate lasI or rhlI genes, 
respectively and there will be an increase in fluorescence.  
 Decrease in fluorescent signal for PAO1/plasI-LVAgfp strain in presence of BF8 and 
BF15 indicated that these agents are antagonists for las system (Figure 5.15). But increase in 
fluorescent signal for strain PAO1/prhlI-LVAgfp indicated that brominated furanones are 
agonists for rhl system at all the tested concentrations (Figure 10). Being antagonist to one 
quorum sensing system (las) and agonist to another (rhl) could be the reason why brominated 
furanones are not that effective at inhibiting the biofilms of P. aeruginosa. Even though BF15 
was a better antagonist than BF8 to las system, at the same time, BF15 was a better agonist than 
 
 
BF8 for rhl system. Hence, overall, BF15 was not as effective as BF8 at inhibiting biofilm 
formation by P. aeruginosa. 
  
Figure 5.15 Fluorescence signal of GFP expressed by P. aeruginosa having plasmid (A) plasI-
LVAgfp), and (B) prhlI-LVAgfp in presence and in absence of BF15 and BF8 at either 100 or 
200 µM. The fluorescent signals were corrected for cell density by dividing with OD600 of cell 
culture. Error bar is standard error of the mean from 4 replicates. 
5.2.8 Production of virulence factor, elastase B by P. aeruginosa is inhibited by brominated 
furanones 
 
P. aeruginosa deploys many virulence factors either openly or covertly for attacking host 
systems and causing infections. Some of these prominent P. aeruginosa virulence factors are 
secretion of alginate, lipopolysaccharides, rhamnolipids, proteases, phospholipases and 
exoproteases.275 Elastase B (LasB), which is a 33 kDa protein, is one such exoprotease secreted 
by P. aeruginosa  and its expression is controlled by the lasB gene.276 The mode of action of 
LasB is through  the hydrolysis of cellular extracellular matrix and attack on intercellular tight 
junctions.277, 278 One important function of LasB reported under laboratory setting is the 
degradation of components of the innate immune system like surfactant proteins -A and D.279  
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Therefore, brominated furanones were further tested for their ability to inhibit production 
of LasB by P. aeruginosa. Colorimetric assays were used to determine the amount of LasB in the 
cultures grown with or without BFs. Both BF15 and BF8 at 200 µM inhibited the production of 
LasB by almost 50 % (Figure 5.16). Inhibition of LasB along with quorum sensing gene reporter 
assays suggested that brominated furanones antagonistically interfere with las system of P. 
aeruginosa.    
 
Figure 5.16 LasB produced by P. aeruginosa PAO1 in the absence (control) and presence of 200 
µM of BF15 or BF8. Error bar is standard error of the mean from 4 replicates.  
5.3 Conclusion 
 
Four structurally related synthetic BFs showed similar trends in inhibiting the bacterial 
growth and biofilm formed by both E. coli and P. aeruginosa. Methyl substitution at C2 and C5 
positions were important for observing nonmicrobicidal biofilm inhibition. Among all the 
synthetic brominated furanones tested, BF8 was the most effective at inhibiting the biofilm, 
suggesting that methyl substitution at C2 position is optimum for maximum activity. Three 
bioassays, crystal violet dye-based, confocal microscopy-based and scanning electron 
microscopy-based assays gave consistent results that brominated furanones showed higher 
activity for wild type E. coli than its sdiA mutant strain, AY1297. Results suggest that inhibition 
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of quorum sensing by brominated furanones in E.coli is dependent on its sdiA gene and 
therefore, the SdiA protein could be a potential receptor for BFs.  
The quorum sensing gene reporter assay for P. aeruginosa suggested that BFs were 
antagonistic to the LasR in las system but agonistic to the RhlR in rhl system. This could be one 
of the reasons of low inhibition activities of brominated furanones against the biofilm formed by 
P. aeruginosa. Another reason could be the low binding affinity between the receptor protein 
LasR and BFs. Hence there is a further scope to modulate the structure of brominated furanones 
such that they will be antagonistic to both the QS systems which will increase their biofilm 
inhibition activity. Interestingly both SdiA and LasR (autoinducer receptor in las system) are 
homologous to the luxR type receptors that bind AHLs.  
5.4 Materials and Methods  
 
Chemistry 
The synthesis of BF15 was executed under an atmosphere of argon in flame dried 
glassware. 4-Oxohexanoic acid and anhydrous CH2Cl2 ( > 99 % with sure seal) was purchased 
from Sigma Aldrich. HRMS was obtained through positive ESI on Bruker 12 Tesla APEX-QE 
FTICR-MS with an Apollo II ion source at Cosmic instrumentation center, Virginia. TLC 
visualization was done under UV light (254 nm). Solvents were removed in vacuo using Bűchi 
rotary evaporator below 40oC. EMD silica gel 60 F254 pre-coated plates (0.25-mm thickness) 
were used for TLC. Column chromatography was performed using Silicycle, silia-P flash silica 
gel with 40-63μ mesh size. 1H and 13CNMR spectra were recorded on 300 MHz and 75 MHz 
Bruker instruments respectively. 1H chemical shifts are reported in ppm relative to CDCl3 δ 
 
 
7.27. 13C chemical shifts are reported in ppm relative to CDCL3 δ 77.0. FTIR was recorded on 
Nicolet IR 200 FTIR instrument (Thermo Scientific)  
Synthesis of brominated furanones (BF15) 
OHO
O
OHO
O
Br
Br
 Br2, CH2Cl2
OO
Brrt, 1 h
i) P4O10 (1.2 eq),
  CH2Cl2, 0 °C    reflux
  1h
ii) NEt3, (1.03 eq),
  CH2Cl2, 0 °C    reflux
  1h1A 1B BF15  
Step 1: 4-oxohexanoic acid (1A) (100 mg, 0.768 mmol) dissolved in dichloromethane 
(CH2Cl2) (2 mL) with 1 drop of HBr (40% v/v in water) was added to a flame dried round 
bottom flask under argon. Bromine (79 µL, 2 eq) was then added drop-wise. After complete 
addition of bromine the mixture was allowed to stir at room temperature for 1 h. After complete 
consumption of reactants (monitored by TLC, hexane : ethyl acetate, 2:1), the mixture was 
diluted with CH2Cl2  (4 mL), then successively washed with 1 N Na2S2O3 (5 mL), brine (5 mL) 
and dried over anhydrous Na2SO4. The solvent was evaporated in vacuo to obtain a viscous 
yellow oily crude product 1B (dibromo-oxohexanoic acid, 0.150 g). This crude product was used 
in step 2 without any further purification. 
Step 2: Step 1 crude product (1B) (0.150 g, 0.52 mmol) was dissolved in CH2Cl2 (1.5 
mL) in an oven dried round bottom flask under argon. The reaction mixture was cooled to 0 ̊C 
and P4O10 (0.177 g, 0.62 mmol) was added. After stirring at 0 ̊C for 30 min the solution was 
allowed to warm to room temperature and then further heated at reflux for 1.5 h. The reaction 
mixture was then cooled to room temperature and transferred into a test tube and centrifuged (5 
min, Metpath analytical centrifuge). The supernatant was decanted to yield a solid intermediate. 
The solid intermediate was dissolved in CH2Cl2 (2.0 mL) and transferred into an oven dried 
 
 
round bottom flask and cooled to 0 ̊C. Et3N (0.79 µL, 1.5 mmol) was then added and the reaction 
mixture was allowed to stir at 0 ̊C for 1 h. The reaction mixture was then warmed to room 
temperature and later heated at reflux for 1 h. Further, the reaction mixture was allowed to cool 
to room temperature and aqueous NH4Cl (1.5 mL) was added. The aqueous phase was extracted 
with EtOAc (6 × 2 mL). The organic layers were combined and dried over anhydrous Na2SO4, 
and the solvent removed in vacuo. The impure compound was purified by column 
chromatography using a gradient of 20:1 to 10:1 of hexane : EtOAc to give title compound as a 
pale white solid (BF15) (yield – 0.065 g, 45 % (2 steps), Rf – 0.51( 2:1, Hexane : EtOAc, mp 
116-118 ̊C). 1H NMR (300 MHz, CDCl3): δ 7.61 (d, J = 4.8 Hz, 1H), 6.28 (d, J = 5.1 Hz, 1H), 
2.53 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 168.9, 147.7, 138.1, 119.5, 108.7, 22.4. HRMS calcd 
for (C6H5BrO2)Na+ = 210.9365, found = 210.9365, difference <  - 1.0 ppm (Positive ESI on 
Bruker 12 Tesla APEX-QE FTICR-MS with an Apollo II ion source). IR (KBr pellet): ῡ = 3130, 
3105, 1777, 1753, 1658, 1546, 1261, 1132, 902, 820, 712 cm-1. The Z configuration of exo-
cyclic double bond was determined by the noe observed at H-3 (δ 7.61) while irradiating at H-6 
(δ 2.53).  
 
Bacteria strains and growth media   
E. coli RP437 and E. coli RP437 (pRSH103) (constitutively expresses red fluorescence proteins) 
were provided by Dr. Dacheng Ren (Syracuse University). 10 µg/mL of tetracycline was added 
to maintain the plasmid pRSH103 in all the bacterial cultures. Plasmids plasI-LVAgfp and prhlI-
LVAgfp were provided by Dr. Hiroaki Suga (The University of Tokyo). 300 µg/mL of 
carbenicillin was added to maintain the plasmids of PAO1-GFP, PAO1 (plasI-LVAgfp), PAO1 
(prhlI-LVAgfp). All the bacterial strains were grown in Luria-Bertani (LB) medium containing 
 
 
10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl at 37 oC. Single trial values reported for 
each experiment (Figures 1, 2, 4, 5, 6, S2) were similar to values obtained from replicate (3 or 
more) experiments.  
Construction of AY1297 (E. coli RP437 but ∆sdiA)   
Deletion of the sdiA gene in E. coli RP437 chromosome was achieved by P1 
transduction. To prepare the donor P1 lysate, overnight culture of the donor strain (JW1901) was 
diluted 1:100 into 5 ml fresh LB medium. The culture was grown at 37°C aerobically with 
shaking at 220 rpm till the OD600 reached 0.1~0.2. 50 μl of 1 M CaCl2 and 100 μl P1vir stock 
were added and the bacterial culture was continued to shaken continuously for ~3 hrs until cells 
lysed. After lysis, 1 drop of chloroform was added and the cell culture was subject to continuous 
shaking for 10 min. 1 ml of this suspension was removed and subject to centrifugation for 2 min 
at maximum speed (16000 rcf). The supernatant was collected and a few drops of chloroform 
were added. This P1 vir lysate was stored at 4°C.  
To perform P1 transduction, overnight culture of the recipient strain (E. coli RP437) was 
diluted 1:100 into 5 ml fresh LB medium. The culture was grown at 37°C with shaking at 220 
rpm till the OD600 reaches 0.7. 50 μl of 1M CaCl2 was added to the culture followed by 
continuous shaking for 15 min. Then 200 μl of the recipient cells were transferred to a sterile 1.5 
ml eppendorf tube. P1 lysate from the donor strain prepared as above was added into the 
recipient cells with varying volumes. Following P1 vir infection of the recipient cells, the tubes 
carrying recipient cells were shaken at 37°C for 20 min. 100 μl 30% citrate was added to stop the 
infection and 500 μl fresh LB medium was added for cell recovery. The culture was incubated 
for 1 hr at 37°C with aeration. The cells were then spun down, resuspended in 30 μL 30% citrate 
and 70 μL LB and spread on LB plates containing antibiotic (kanamycin) and 4 mM citrate. 
 
 
Transductants were streaked twice on LB plates containing antibiotic and 4 mM citrate to 
completely remove the P1vir. Single colonies were selected and positive transductants were 
screened by colony PCR and subsequently verified by DNA sequencing. 
Electroporation method for transferring plasmid   
Plasmid in E.coli RP437 (pRSH103) was extracted using Qiagen plasmid extraction kit 
and was then transferred to E.coli AY1297 (∆sdiA mutant) by electroporation. Briefly, overnight 
culture of AY1297 was sub-cultured in 25 mL LB broth and was grown to reach an OD600 of 0.5 
to 0.8 by shaking the culture at 37 °C. Flask containing subculture was cooled on ice for 30 min. 
Cell pellet was obtained by centrifugation at 4500 rpm for 5 min. Supernatant was removed and 
cell pellet was resuspended in 20 mL ice-cold 10 % glycerol. Cells were centrifuged at 4500 rpm 
for 5 min. Supernatant was discarded and the cell pellet was resuspended in 1 mL ice-cold 10 % 
glycerol. Cell suspension was transferred to a new 1.5 mL ice-cold microcentrifuge tube and 
spun down at 13,000 rpm for 30 sec. Supernatant was discarded and the cell pellet was 
resuspended in 500 µL ice-cold 10 % glycerol. The last time, cells were spun down at 13,000 
rpm for 30 sec. After removal of the supernatant, cell pellet was resuspended in 100 µL ice-cold 
10 % glycerol. 50 µL of the competent cell suspension along with 1 µL of plasmid DNA in TE 
buffer was transferred to the cold 0.1 cm electroporation cuvette. Electroporator was set to Ec1 
and pulse was passed through the cells. LB medium (1 mL) was immediately added to the 
electroporator cuvette and cell suspension was transferred to a sterile microcentrifuge tube and 
incubated for 1 h at 37 °C with shaking at 180 rpm. Cells were then spread on the LB plates 
supplemented with respective antibiotics and incubated over night at 37 °C. Plasmids plasI-
LVAgfp and prhlI-LVAgfp were transferred to the PAO1 using the same electroporation method 
except that glycerol was replaced by sucrose in the preparation of competent cells.  
 
 
 
Stock solution of brominated furanones   
Stock solutions of all brominated furanones (10 mM) were prepared in DMSO, sterilized 
by filtering through 0.2 µm syringe filter, and stored at -20 °C in sealed vials. Appropriate 
amount of DMSO was added to controls in all assays to eliminate solvent effect.  
Antimicrobial activities of BF against planktonic growth 
Optical density was measured using Biotek ELx800 TM absorbance microplate reader 
(BioTek Instruments, Inc., Winooski, VT) using Gen5TM data analysis software. The OD values 
were taken in sterile conditions at 0, 2, 4, 6, 8, 10, 12, and 24 h. 
Crystal violet-based biofilm inhibition assay 
Inhibitory effect of four brominated furanones on biofilm formation by E.coli and its sdiA 
knockout mutant was determined by biofilm inhibition assays. Overnight culture of both the 
E.coli strains was sub cultured to an OD600 of 0.01 into the Luria-Bertani (LB) media.280 200 µL 
of the sub culture was aliquoted into the wells of 96 well PVC microtiter plate when it reached 
the OD600 of 0.05. Stock solutions of all the test compounds were made in DMSO (biology 
grade, autoclaved). Predetermined concentrations of the test compounds were then added to the 
respective wells of 96 well plate containing sub culture. Sample plates were wrapped in GLAD 
Press n’ Seal® followed by incubation under stationary conditions for 24 h at 37 °C. After 
incubation the media was discarded and the plates were washed with water. The sample plates 
were then stained with 200 μL of 0.1% aqueous solution of crystal violet (CV) and then 
incubated at ambient temperature for 30 min.281 The CV stain was then discarded and the plates 
were washed with water. The remaining stain was solubilized with 200 μL of 95% ethanol. After 
 
 
the stain was dissolved (15 minutes) 100 μL of the solubilized CV was transferred from each 
well into the corresponding wells of a polystyrene microtiter dish. Biofilm inhibition was 
quantified by measuring the OD540 of each well in which a negative control lane, wherein no 
biofilm was formed, served as a background and was subtracted out. The percent inhibition was 
calculated by the comparison of the OD540 for biofilm grown in the absence of compound 
(control) versus biofilm grown in the presence of compound under identical conditions. 
Confocal laser scanning microscopy (CLSM) 
Biofilms were grown by inoculating the bacteria on 316 L stainless steel coupons (ca. 3/8 
in. × 3/8 in., from McMaster-Carr) with or without BFs in a 24-well microtiterplate. Saran 
wrapped plate was then incubated at 37 oC for 24 h without shaking. Each steel coupon was then 
washed gently by dipping into 0.85 w/v% aqueous NaCl solutions 3 times (fresh NaCl solution 
was used for each dipping) and then placed upside down on a microscope cover glass (50 x 
24mm, No. 2, Fisher Scientific, Pittsburgh, PA). The biofilms were visualized using a Zeiss LSM 
710 Confocal Laser Scanning Microscope (Carl Zeiss, Jena, Germany). A 488 nm laser line was 
used to visualize biofilms formed by PAO1-GFP. Z-stacks from four randomly picked spots 
were taken for each steel coupon. Quantification of analysis of biomass, mean thickness, and 
surface area of the biofilms formed in the absence and presence of brominated furanones were 
obtained from fluorescence image using COMSTAT software. Values are normalized to that of 
the brominated furanone-free control.  
 
 
 
 
 
Visual semi-quantification of biofilm on SAM patterned gold slides using scanning electron 
microscopy 
Semitransparent gold film of thickness ~ 280 Å was deposited onto the piranha-cleaned 
glass substrates with an electron beam evaporation system from Thermionics (Port Townsend, 
WA). About 80 Å of titanium was deposited before depositing gold to enhance the adhesion of 
gold on glass substrate (angle of deposition - 45°, rate of deposition - 0.2 Å/s). Gold slides were 
soaked in 2mM solution of (1-Mercapto-n-yl)-(triethylene glycols) for 15 h after microcontact 
printing 1-pentadecanethiol using (PDMS) stamp. Gold slides were taken out of solution, washed 
with ethanol and dried with nitrogen gas before placing them in bacterial cell culture. 
  Gold slides with circular patterns of 1-pentadecanethiol surrounded with (1-Mercapto-n-
yl)-(triethylene glycols) SAM were placed in a 24 well plate containing cultures of either E.coli 
RP437 or E.coli AY1297 (OD600 =0.05) with 200 µM BF8 for 24 h at 37 °C. Control 
experiments for both the bacterial strains were carried out under the same conditions but without 
BF8. 24 well plates were covered and wrapped in GLAD Press n’ Seal® followed by incubation 
under stationary conditions for 24 h at 37 °C. Biofilm on gold slides was fixed with 4% 
paraformaldehyde solution, dehydrated with sequential soaking in solutions containing 10%, 
30%, 50%, 70%, 90% ethanol, and pure ethanol, and sputter coated with gold-palladium alloy. 
Topographic features of the patterned biofilm on gold surface and effect of BF8 were examined 
under a JEOL JSM-5800LV Scanning Electron Microscope (SEM). 
 
 
 
 
 
 
Gene reporter assays for las and rhl quorum sensing systems of P. aeruginosa 282   
GFP used in this study is LVAgfp. LVAgfp is a modified form of GFP which is unstable 
(estimated half-life of 40–60 min) as compared to native GFP (estimated half life of one day).250 
The short half life of LVAgfp makes the real time detection of gene expression possible.  Since 
modified GFP (LVAgfp) has an excitation wavelength of 501 nm (excitation wavelength for 
wild type GFP is 395 nm) and emission wavelength of 511 nm (similar to wild type GFP).59 
An overnight culture of P. aeruginosa PAO1/plasI-LVAgfp in LB broth (supplemented 
with 300 µg/mL of carbenicillin) was grown from a single colony from an LB agar plate 
supplemented with 300 µg/mL carbenicillin. The overnight culture was diluted and grown to 
OD600 of 0.1 in LB broth containing 300 µg/mL of carbenicillin. Bacteria culture (200 µL) was 
added to each well of a polystyrene 96-well microplate (Costar 3370) containing appropriate 
amount of brominated furanones or DMSO as a control. The plate was incubated at 37 °C for 24 
h in a rotary shaking incubator (250 rpm). The culture from each well was then transferred to a 
flat-bottom, 96-well plate with black wall (µClear, Greiner-One 655096). The fluorescence and 
OD absorbance in each well was measured by Synergy 2 multi-mode microplate reader with 
Gen5 data analysis software. Background signals from LB broth were deducted from all samples. 
Fluorescence was measured at an excitation wavelength of 500 nm and an emission wavelength 
of 540 nm. 
 
 
 
 
  
 
 
Elastase B assay 
  Elastase B activity in P. aeruginosa was measured as previously reported,251 with some 
modifications: Bacteria were grown overnight in LB media (10 g/liter tryptone, 5 g/liter yeast 
extract, and 10 g/liter NaCl) at 37 oC, diluted and grown to midlog phase, and subcultured to LB 
at OD600 of 0.05. The culture was then aliquoted to test tubes containing brominated furanones to 
give the desired final concentrations. The tubes were incubated for 24 h at 37 °C with shaking 
(250 rpm). Culture supernatants were recovered by centrifugation at 3000 rpm (Galaxy 5D 
centrifuge, VWR) for 10 min at room temperature and then passed through a 0.45 µm PVDF 
syringe filter (Santa Cruz Biotechnology). A 100 µL aliquot of the supernatant was added to 900 
µL of Elastin-Congo red (ECR) buffer (100 mM Tris-HCl, 1 mM CaCl2, pH 7.2) containing 4.5 
mg of Elastin-Congo red (Sigma-Aldrich) and incubated for 24 h at 37 oC with shaking (250 
rpm). After incubation, 0.2 mL of 0.12 M EDTA was added to stop the reaction. Insoluble ECR 
was removed by centrifugation and the absorbance of the supernatant (OD490) was measured. 
Elastase B activity was measured by OD490 of the samples treated with brominated furanones 
after subtracting the OD490 of the samples incubated in the absence of cell culture filtrate.   
 
 
 
 
 
 
O O 
B r
 
 
 
 
 
 
 
 
References 
1. Shapiro, J. A., Thinking about bacterial populations as multicellular organisms. Ann. Rev. 
Microbiol. 1998, 52, (1), 81-104. 
2. Shapiro, J. A., Bacteria as multicellular organisms. Scientific American 1988, 258, (6), 
82-89. 
3. WAKSMAN, S. A., Sergei Nikolaevitch Winogradsky: The Story of a Great 
Bacteriologist. Soil Sci. 1946, 62, (3), 197-226. 
4. Bassler, B. L.; Losick, R., Bacterially speaking. Cell 2006, 125, 237-246. 
5. Schauder, S.; Bassler, B. L., The Languages of Bacteria. Genes Dev. 2001, 15, 1468-
1480. 
6. Kempner, E.; Hanson, F., Aspects of light production by Photobacterium fischeri. J. 
Bacteriol. 1968, 95, (3), 975-979. 
7. Nealson, K.; Hastings, J. W., Bacterial bioluminescence: its control and ecological 
significance. Microbiol. Rev. 1979, 43, (4), 496. 
8. Hastings, J.; Nealson, K., Bacterial bioluminescence. Ann. Rev. Microbiol. 1977, 31, (1), 
549-595. 
9. Eberhard, A., Inhibition and activation of bacterial luciferase synthesis. J. Bacteriol. 
1972, 109, (3), 1101-1105. 
10. Eberhard, A.; Burlingame, A.; Eberhard, C.; Kenyon, G.; Nealson, K.; Oppenheimer, N., 
Structural identification of autoinducer of Photobacterium fischeri luciferase. Biochemistry 1981, 
20, (9), 2444-2449. 
11. Engebrecht, J.; Nealson, K.; Silverman, M., Bacterial bioluminescence: isolation and 
genetic analysis of functions from Vibrio fischeri. Cell 1983, 32, (3), 773-781. 
 
 
12. Engebrecht, J.; Silverman, M., Identification of genes and gene products necessary for 
bacterial bioluminescence. Proc. Natl. Acad. Sci. 1984, 81, (13), 4154-4158. 
13. Engebrecht, J.; Silverman, M., Nucleotide sequence of the regulatory locus controlling 
expression of bacterial genes for bioluminescence. Nucleic Acids Res. 1987, 15, (24), 10455-
10467. 
14. Fuqua, W. C.; Winans, S. C.; Greenberg, E. P., Quorum sensing in bacteria: the LuxR-
LuxI family of cell density-responsive transcriptional regulators. J. Bacteriol. 1994, 176, (2), 
269. 
15. Meighen, E. A., Genetics of bacterial bioluminescence. Annual Rev. Genet. 1994, 28, (1), 
117-139. 
16. Sitnikov, D. M.; Schineller, J. B.; Baldwin, T. O., Transcriptional regulation of 
bioluminesence genes from Vibrio fischeri. Mol. Microbiol. 1995, 17, (5), 801-812. 
17. Xavier, K. B.; Bassler, B. L., LuxS quorum sensing: more than just a numbers game. 
Curr. Opin. Microbiol. 2003, 6, (2), 191-197. 
18. Ahmer, B. M. M., Cell-to-cell signalling in Escherichia coli and Salmonella enterica. 
Mol. Microbiol. 2004, 52, (4), 933-945. 
19. Chen, X.; Schauder, S.; Potier, N.; Van Dorsselaer, A.; Pelczer, I.; Bassler, B. L.; 
Hughson, F. M., Structural identification of a bacterial quorum-sensing signal containing boron. 
Nature 2002, 415, (6871), 545-549. 
20. Gambello, M. J.; Iglewski, B. H., Cloning and characterization of the Pseudomonas 
aeruginosa lasR gene, a transcriptional activator of elastase expression. J. Bacteriol. 1991, 173, 
(9), 3000-3009. 
 
 
21. Miller, M. B.; Bassler, B. L., Quorum sensing in bacteria. Annu. Rev. Microbiol. 2001, 
55, 165-199. 
22. Fuqua, C.; Parsek, M. R.; Greenberg, E. P., Regulation of gene expression by cell-to-cell 
communication: acyl-homoserine lactone quorum sensing. Ann. Rev. Genet. 2001, 35, (1), 439-
468. 
23. Kleerebezem, M.; Quadri, L. E.; Kuipers, O. P.; De Vos, W. M., Quorum sensing by 
peptide pheromones and two‐component signal‐transduction systems in Gram‐positive bacteria. 
Mol. Microbiol. 1997, 24, (5), 895-904. 
24. Jayaraman, A.; Wood, T. K., Bacterial quorum sensing: signals, circuits, and implications 
for biofilms and disease. Annu. Rev. Biomed. Eng. 2008, 10, 145-167. 
25. Galloway, W. R.; Hodgkinson, J. T.; Bowden, S. D.; Welch, M.; Spring, D. R., Quorum 
sensing in Gram-negative bacteria: small-molecule modulation of AHL and AI-2 quorum 
sensing pathways. Chem. Rev. 2010, 111, (1), 28-67. 
26. Richards, J. J.; Melander, C., Small molecule approaches toward the non-microbicidal 
modulation of bacterial biofilm growth and maintenance. Anti-Infect. Agents Med. Chem. 2009, 
8, (4), 295-314. 
27. Costerton, J.; Stewart, P. S.; Greenberg, E., Bacterial biofilms: a common cause of 
persistent infections. Science 1999, 284, (5418), 1318-1322. 
28. Rasmussen, T. B.; Givskov, M., Quorum-sensing inhibitors as anti-pathogenic drugs. Int. 
J. Med. Microbiol. 2006, 296, (2), 149-161. 
29. Davies, D., Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug 
Discov. 2003, 2, (2), 114-122. 
 
 
30. Gadsby, D. C.; Vergani, P.; Csanady, L., The ABC protein turned chloride channel 
whose failure causes cystic fibrosis. Nature 2006, 440, 477-483. 
31. Riordan, J. R.; Rommens, J. M.; Kerem, B. S.; Alon, N.; Rozmahel, R.; Grzelczak, Z.; 
Zielenski, J.; Lok, S.; Plavsic, N.; et, a., Identification of the cystic fibrosis gene: cloning and 
characterization of complementary DNA. Science 1989, 245, 1066-1073. 
32. Davies, J. C.; Stern, M.; Dewar, A.; Caplen, N. J.; Munkonge, F. M.; Pitt, T.; Sorgi, F.; 
Huang, L.; Bush, A.; Geddes, D. M.; Alton, E. W. F. W., CFTR gene transfer reduces the 
binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium. Am. J. Respir. Cell 
Mol. Biol. 1997, 16, 657-663. 
33. Bjarnsholt, T.; Jensen, P. O.; Jakobsen, T. H.; Phipps, R.; Nielsen, A. K.; Rybtke, M. T.; 
Tolker-Nielsen, T.; Givskov, M.; Hoeiby, N.; Ciofu, O., Quorum sensing and virulence of 
Pseudomonas aeruginosa during lung infection of cystic fibrosis patients. PLoS One 2010, 5, 
e10115. 
34. Davies, J. C., Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. 
Paediatr. Respir. Rev. 2002, 3, 128-134. 
35. Singh, P. K.; Schaefer, A. L.; Parsek, M. R.; Moninger, T. O.; Welsh, M. J.; Greenberg, 
E. P., Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial 
biofilms. Nature 2000, 407, 762-764. 
36. Oliver, A.; Canton, R.; Campo, P.; Baquero, F.; Blazquez, J., High frequency of 
hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000, 288, 
1251-1253. 
37. Hall-Stoodley, L.; Costerton, J. W.; Stoodley, P., Bacterial biofilms: From the natural 
environment to infectious diseases. Nat. Rev. Microbiol. 2004, 2, (2), 95-108. 
 
 
38. McDougald, D.; Rice, S. A.; Barraud, N.; Steinberg, P. D.; Kjelleberg, S., Should we stay 
or should we go: mechanisms and ecological consequences for biofilm dispersal. Nat. Rev. 
Microbiol. 2012, 10, 39-50. 
39. Costerton, J. W.; Lewandowski, Z.; Caldwell, D. E.; Korber, D. R.; Lappin-Scott, H. M., 
Microbial biofilms. Ann. Rev. Microbiol. 1995, 49, (1), 711-745. 
40. Donlan, R. M., Biofilms: microbial life on surfaces. Emerg. Infect. Dis. 2002, 8, (9), 881-
890. 
41. Breidenstein, E. B. M.; de la Fuente-Núñez, C.; Hancock, R. E. W., Pseudomonas 
aeruginosa: all roads lead to resistance. Trends. Microbiol. 2011, 19, (8), 419-426. 
42. Ofek, I.; Doyle, R. J., Principles of bacterial adhesion. In Bacterial adhesion to cells and 
tissues, Springer: 1994; pp 1-15. 
43. Monroe, D., Looking for chinks in the armor of bacterial biofilms. PLoS biology 2007, 5, 
(11), e307. 
44. Bordi, C.; de Bentzmann, S., Hacking into bacterial biofilms: a new therapeutic 
challenge. Ann. Intensive Care 2011, 1, (1), 1-8. 
45. Jonas, K.; Edwards, A. N.; Simm, R.; Romeo, T.; Römling, U.; Melefors, Ö., The RNA 
binding protein CsrA controls cyclic di‐GMP metabolism by directly regulating the expression of 
GGDEF proteins. Mol. Microbiol. 2008, 70, (1), 236-257. 
46. Antoniani, D.; Bocci, P.; Maciąg, A.; Raffaelli, N.; Landini, P., Monitoring of 
diguanylate cyclase activity and of cyclic-di-GMP biosynthesis by whole-cell assays suitable for 
high-throughput screening of biofilm inhibitors. Appl. Microbiol. Biotechnol. 2010, 85, (4), 
1095-1104. 
 
 
47. Hammer, B. K.; Bassler, B. L., Distinct sensory pathways in Vibrio cholerae El Tor and 
classical biotypes modulate cyclic dimeric GMP levels to control biofilm formation. J. Bacteriol. 
2009, 191, (1), 169-177. 
48. Audette, G. F.; Delbaere, L. T.; Xiang, J., Mapping protein: carbohydrate interactions. 
Curr. Protein Pept. Sci. 2003, 4, (1), 11-20. 
49. Chevolot, Y.; Zhang, J.; Meyer, A.; Goudot, A.; Rouanet, S.; Vidal, S.; Pourceau, G.; 
Cloarec, J.-P.; Praly, J.-P.; Souteyrand, E., Multiplexed binding determination of seven 
glycoconjugates for Pseudomonas aeruginosa Lectin I (PA-IL) using a DNA-based carbohydrate 
microarray. Chem. Commun. 2011, 47, (31), 8826-8828. 
50. Doig, P.; Todd, T.; Sastry, P. A.; Lee, K.; Hodges, R. S.; Paranchych, W.; Irvin, R., Role 
of pili in adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells. Infect. 
Immu. 1988, 56, (6), 1641-1646. 
51. Sharon, N., Carbohydrates as future anti-adhesion drugs for infectious diseases. Biochim. 
Biophys. Acta 2006, 1760, (4), 527-537. 
52. Giltner, C. L.; Van Schaik, E. J.; Audette, G. F.; Kao, D.; Hodges, R. S.; Hassett, D. J.; 
Irvin, R. T., The Pseudomonas aeruginosa type IV pilin receptor binding domain functions as an 
adhesin for both biotic and abiotic surfaces. Mol. Microbiol. 2006, 59, (4), 1083-1096. 
53. Lindhorst, T. K.; Bruegge, K.; Fuchs, A.; Sperling, O., A bivalent glycopeptide to target 
two putative carbohydrate binding sites on FimH. Beilstein J. Org. Chem. 2010, 6, (1), 801-809. 
54. Pieters, R. J., Intervention with bacterial adhesion by multivalent carbohydrates. Med. 
Res. Rev. 2007, 27, (6), 796-816. 
 
 
55. Han, Y.; Hou, S.; Simon, K. A.; Ren, D.; Luk, Y.-Y., Identifying the important structural 
elements of brominated furanones for inhibiting biofilm formation by Escherichia coli. Bioorg. 
Med. Chem. Lett. 2008, 18, (3), 1006-1010. 
56. Ren, D.; Sims, J. J.; Wood, T. K., Inhibition of biofilm formation and swarming of 
Escherichia coli by (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone. Environ. 
Microbiol. 2001, 3, (11), 731-736. 
57. Zang, T.; Lee, B. W. K.; Cannon, L. M.; Ritter, K. A.; Dai, S.; Ren, D.; Wood, T. K.; 
Zhou, Z. S., A naturally occurring brominated furanone covalently modifies and inactivates 
LuxS. Bioorg. Med. Chem. Lett. 2009, 19, (21), 6200-6204. 
58. Lee, J.; Bansal, T.; Jayaraman, A.; Bentley, W. E.; Wood, T. K., Enterohemorrhagic 
Escherichia coli biofilms are inhibited by 7-hydroxyindole and stimulated by isatin. Appl. 
Environ. Microbiol. 2007, 73, (13), 4100-4109. 
59. Frei, R.; Breitbach, A. S.; Blackwell, H. E., 2-Aminobenzimidazole Derivatives Strongly 
Inhibit and Disperse Pseudomonas aeruginosa Biofilms. Angew. Chem., Int. Ed. 2012, 51, 5226-
5229. 
60. Richards, J. J.; Ballard, T. E.; Melander, C., Inhibition and dispersion of Pseudomonas 
aeruginosa biofilms with reverse amide 2-aminoimidazole oroidin analogues. Org Biomol. 
Chem. 2008, 6, 1356-1363. 
61. Smith, K. M.; Bu, Y.; Suga, H., Library Screening for Synthetic Agonists and 
Antagonists of a Pseudomonas aeruginosa Autoinducer. Chem. Biol. 2003, 10, (6), 563-571. 
62. Geske, G. D.; Wezeman, R. J.; Siegel, A. P.; Blackwell, H. E., Small Molecule Inhibitors 
of Bacterial Quorum Sensing and Biofilm Formation. J. Am. Chem. Soc. 2005, 127, (37), 12762-
12763. 
 
 
63. Smith, K. M.; Bu, Y.; Suga, H., Induction and Inhibition of Pseudomonas aeruginosa 
Quorum Sensing by Synthetic Autoinducer Analogs. Chem. Biol. 2003, 10, (1), 81-89. 
64. Che, Y.; Sanderson, K.; Roddam, L. F.; Kirov, S. M.; Reid, D. W., Iron-binding 
compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic 
conditions. J. Med. Microbiol. 2009, 58, (6), 765-773. 
65. Moreau-Marquis, S.; O'Toole, G. A.; Stanton, B. A., Tobramycin and FDA-approved 
iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. Am. J. Respir. 
Cell Mol. Biol. 2009, 41, (3), 305. 
66. Bandyopadhyay, D.; Prashar, D.; Luk, Y.-Y., Anti-Fouling Chemistry of Chiral 
Monolayers: Enhancing Biofilm Resistance on Racemic Surface. Langmuir 2011, 27, (10), 6124-
6131. 
67. Dwyer, A. In Surface‐Treated Catheters—A Review, Seminars in dialysis, 2008; Wiley 
Online Library: 2008; 542-546. 
68. Shetye, G. S.; Singh, N.; Gao, X.; Bandyopadhyay, D.; Yan, A.; Luk, Y.-Y., Structures 
and biofilm inhibition activities of brominated furanones for Escherichia coli and Pseudomonas 
aeruginosa. MedChemComm 2013. 
69. Barraud, N.; Hassett, D. J.; Hwang, S.-H.; Rice, S. A.; Kjelleberg, S.; Webb, J. S., 
Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa. J. Bacteriol. 2006, 
188, (21), 7344-7353. 
70. Lu, T. K.; Collins, J. J., Dispersing biofilms with engineered enzymatic bacteriophage. 
Proc. Natl. Acad. Sci. 2007, 104, (27), 11197-11202. 
71. Wood, T. K.; Hong, S. H.; Ma, Q., Engineering biofilm formation and dispersal. Trends 
Biotechnol. 2011, 29, (2), 87-94. 
 
 
72. Verstraeten, N.; Braeken, K.; Debkumari, B.; Fauvart, M.; Fransaer, J.; Vermant, J.; 
Michiels, J., Living on a surface: swarming and biofilm formation. Trends Microbiol. 2008, 16, 
(10), 496-506. 
73. Caiazza, N. C.; Merritt, J. H.; Brothers, K. M.; O'Toole, G. A., Inverse regulation of 
biofilm formation and swarming motility by Pseudomonas aeruginosa PA14. J. Bacteriol. 2007, 
189, 3603-3612. 
74. Harshey, R. M., Bacterial motility on a surface: many ways to a common goal. Annu. 
Rev. Microbiol. 2003, 57, (1), 249-273. 
75. McCarter, L. L., Dual flagellar systems enable motility under different circumstances. J. 
Mol. Microbiol. Biotechnol. 2004, 7, (1-2), 18-29. 
76. Butler, M. T.; Wang, Q.; Harshey, R. M., Cell density and mobility protect swarming 
bacteria against antibiotics. Proc. Natl. Acad. Sci. 2010, 107, (8), 3776-3781. 
77. Ochsner, U. A.; Reiser, J., Autoinducer-mediated regulation of rhamnolipid biosurfactant 
synthesis in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 1995, 92, 6424-6428. 
78. Toguchi, A.; Siano, M.; Burkart, M.; Harshey, R. M., Genetics of swarming motility in 
Salmonella enterica serovar Typhimurium: critical role for lipopolysaccharide. J. Bacteriol. 
2000, 182, (22), 6308-6321. 
79. Ohnishi, M.; Golparian, D.; Shimuta, K.; Saika, T.; Hoshina, S.; Iwasaku, K.; Nakayama, 
S.-i.; Kitawaki, J.; Unemo, M., Is Neisseria gonorrhoeae initiating a future era of untreatable 
gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. 
Antimicrob. Agents Chemother. 2011, 55, (7), 3538-3545. 
 
 
80. Carmeli, Y.; Troillet, N.; Eliopoulos, G. M.; Samore, M. H., Emergence of antibiotic-
resistant Pseudomonas aeruginosa: comparison of risks associated with different 
antipseudomonal agents. Antimicrob. Agents Chemother. 1999, 43, (6), 1379-1382. 
81. Foster, T. J., The Staphylococcus aureus “superbug”.  J. Clin. Invest. 2004, 114, (12), 
1693-1696. 
82. Nordmann, P.; Naas, T.; Fortineau, N.; Poirel, L., Superbugs in the coming new decade; 
multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. 
and Pseudomonas aeruginosa in 2010. Curr. Opin. Microbiol. 2007, 10, (5), 436-440. 
83. Wright, G. D., Resisting resistance: new chemical strategies for battling superbugs. 
Chem. Biol. 2000, 7, (6), R127-R132. 
84. Botzenhart, K.; Döring, G., Ecology and epidemiology of Pseudomonas aeruginosa. In 
Pseudomonas aeruginosa as an Opportunistic Pathogen, Springer: 1993; pp 1-18. 
85. McDougald, D.; Klebensberger, J.; Tolker‐Nielsen, T.; Webb, J. S.; Conibear, T.; Rice, 
S. A.; Kirov, S. M.; Matz, C.; Kjelleberg, S., Pseudomonas aeruginosa: a model for biofilm 
formation. Pseudomonas: Model Organism, Pathogen, Cell Factory 2008, 215-253. 
86. Bodey, G. P.; Bolivar, R.; Fainstein, V.; Jadeja, L., Infections caused by Pseudomonas 
aeruginosa. Rev. Infect. Dis. 1983, 5, 279-313. 
87. Wagner, V. E.; Iglewski, B. H., P. aeruginosa biofilms in CF infection. Clin. Rev. Allergy 
Immunol. 2008, 35, 124-134. 
88. Davies, D., Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug 
Discovery 2003, 2, 114-122. 
89. Govan, J. R.; Deretic, V., Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas 
aeruginosa and Burkholderia cepacia. Microbiol. Rev. 1996, 60, (3), 539-574. 
 
 
90. Singh, P. K.; Schaefer, A. L.; Parsek, M. R.; Moninger, T. O.; Welsh, M. J.; Greenberg, 
E. P., Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial 
biofilms. Nature 2000, 407, 762-764. 
91. Drenkard, E., Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microb. 
Infect. 2003, 5, (13), 1213-1219. 
92. Nicas, T.; Hancock, R., Pseudomonas aeruginosa outer membrane permeability: isolation 
of a porin protein F-deficient mutant. J. Bacteriol. 1983, 153, (1), 281-285. 
93. Hancock, R. E., Resistance mechanisms in Pseudomonas aeruginosa and other 
nonfermentative gram-negative bacteria. Clin. Infect. Dis. 1998, 27, S93-S99. 
94. Bax, R.; Mullan, N.; Verhoef, J., The millennium bugs - the need for and development of 
new antibacterials. Int. J. Antimicrob. Agents 2000, 16, 51-59. 
95. Taga, M. E.; Bassler, B. L., Chemical communication among bacteria. Proc. Natl. Acad. 
Sci. U. S. A. 2003, 100, 14549-14554. 
96. Lowery, C. A.; Dickerson, T. J.; Janda, K. D., Interspecies and interkingdom 
communication mediated by bacterial quorum sensing. Chem. Soc. Rev. 2008, 37, (7), 1337-
1346. 
97. Fegan, M.; Francis, P.; Hayward, A.; Davis, G.; Fuerst, J. A., Phenotypic conversion of 
Pseudomonas aeruginosa in cystic fibrosis. J. Clin. Microbiol. 1990, 28, (6), 1143-1146. 
98. Berry, A.; DeVault, J. D.; Chakrabarty, A., High osmolarity is a signal for enhanced algD 
transcription in mucoid and nonmucoid Pseudomonas aeruginosa strains. J. Bacteriol. 1989, 171, 
(5), 2312-2317. 
99. Pritt, B.; O’Brien, L.; Winn, W., Mucoid Pseudomonas in cystic fibrosis. J. Clin. Pathol. 
2007, 128, (1), 32-34. 
 
 
100. Govan, J.; Harris, G., Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial 
adaptation and pathogenesis. Microbiol. sci. 1986, 3, (10), 302. 
101. Hentzer, M.; Teitzel, G. M.; Balzer, G. J.; Heydorn, A.; Molin, S.; Givskov, M.; Parsek, 
M. R., Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. 
J. Bacteriol. 2001, 183, (18), 5395-5401. 
102. Hengzhuang, W.; Wu, H.; Ciofu, O.; Song, Z.; Høiby, N., Pharmacokinetics / 
pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas 
aeruginosa biofilms. Antimicrob. Agents Chemother. 2011, 55, (9), 4469-4474. 
103. Tielen, P.; Rosenau, F.; Wilhelm, S.; Jaeger, K.-E.; Flemming, H.-C.; Wingender, J., 
Extracellular enzymes affect biofilm formation of mucoid Pseudomonas aeruginosa. 
Microbiology 2010, 156, (7), 2239-2252. 
104. Singh, V.; Arora, V.; Alam, M. J.; Garey, K. W., Inhibition of Biofilm Formation by 
Esomeprazole in Pseudomonas aeruginosa and Staphylococcus aureus. Antimicrob. Agents 
Chemother. 2012, 56, (8), 4360-4364. 
105. DRAKE, D.; MONTIE, T. C., Flagella, motility and invasive virulence of Pseudomonas 
aeruginosa. J. Gen. Microbiol. 1988, 134, (1), 43-52. 
106. Pedersen, S.; Høiby, N.; Espersen, F.; Koch, C., Role of alginate in infection with mucoid 
Pseudomonas aeruginosa in cystic fibrosis. Thorax 1992, 47, (1), 6-13. 
107. Zulianello, L.; Canard, C.; Köhler, T.; Caille, D.; Lacroix, J.-S.; Meda, P., Rhamnolipids 
are virulence factors that promote early infiltration of primary human airway epithelia by 
Pseudomonas aeruginosa. Infect. Immun. 2006, 74, (6), 3134-3147. 
108. Banin, E.; Vasil, M. L.; Greenberg, E. P., Iron and Pseudomonas aeruginosa biofilm 
formation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, (31), 11076-11081. 
 
 
109. McDermott, C.; Chess-Williams, R.; Grant, G. D.; Perkins, A. V.; McFarland, A. J.; 
Davey, A. K.; Anoopkumar-Dukie, S., Effects of Pseudomonas aeruginosa virulence factor 
pyocyanin on human urothelial cell function and viability. J. Urol. 2012, 187, (3), 1087-1093. 
110. Ołdak, E.; Trafny, E. A., Secretion of proteases by Pseudomonas aeruginosa biofilms 
exposed to ciprofloxacin. Antimicrob. Agents Chemother. 2005, 49, (8), 3281-3288. 
111. Wretlind, B.; Pavlovskis, O. R., Pseudomonas aeruginosa elastase and its role in 
pseudomonas infections. Rev. Infect. Dis. 1983, 5, S998-S1004. 
112. Adonizio, A.; Kong, K.-F.; Mathee, K., Inhibition of quorum sensing-controlled 
virulence factor production in Pseudomonas aeruginosa by South Florida plant extracts. 
Antimicrob. Agents Chemother. 2008, 52, (1), 198-203. 
113. Hauser, A. R., The type III secretion system of Pseudomonas aeruginosa: infection by 
injection. Nat. Rev. Microbiol. 2009, 7, (9), 654-665. 
114. Frei, R.; Breitbach, A. S.; Blackwell, H. E., 2-Aminobenzimidazole Derivatives Strongly 
Inhibit and Disperse Pseudomonas aeruginosa Biofilms. Angew. Chem., Int. Ed. 2012, 51, 5226-
5229. 
115. Bunders, C. A.; Minvielle, M. J.; Worthington, R. J.; Ortiz, M.; Cavanagh, J.; Melander, 
C., Intercepting bacterial indole signaling with flustramine derivatives. J. Am. Chem. Soc. 2011, 
133, (50), 20160-20163. 
116. De, K. T. R.; Gillis, R.; Marx, S.; Brown, C.; Iglewski, B. H., Quorum-sensing genes in 
Pseudomonas aeruginosa biofilms: their role and expression patterns. Appl. Environ. Microbiol. 
2001, 67, 1865-1873. 
 
 
117. Pearson, J. P.; Gray, K. M.; Passador, L.; Tucker, K. D.; Eberhard, A.; Iglewski, B. H.; 
Greenberg, E. P., Structure of the autoinducer required for expression of Pseudomonas 
aeruginosa virulence genes. Proc. Natl. Acad. Sci. U. S. A. 1994, 91, 197-201. 
118. Pearson, J. P.; Passador, L.; Iglewski, B. H.; Greenberg, E. P., A second N-
acylhomoserine lactone signal produced by Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. 
S. A. 1995, 92, 1490-1494. 
119. Suga, H.; Smith, K. M., Molecular mechanisms of bacterial quorum sensing as a new 
drug target. Curr. Opin. Chem. Biol. 2003, 7, (5), 586-591. 
120. Geske, G. D.; O’Neill, J. C.; Blackwell, H. E., Expanding dialogues: from natural 
autoinducers to non-natural analogues that modulate quorum sensing in Gram-negative bacteria. 
Chem. Soc. Rev. 2008, 37, (7), 1432-1447. 
121. Jarvis, F. G.; Johnson, M. J., A glycolipide produced by Pseudomonas aeruginosa. J. Am. 
Chem. Soc. 1949, 71, 4124-4126. 
122. Edwards, J. R.; Hayashi, J. A., Structure of a rhamnolipid from Pseudomonas aeruginosa. 
Arch. Biochem. Biophys. 1965, 111, (2), 415-421. 
123. Abdel-Mawgoud, A. M.; Lepine, F.; Deziel, E., Rhamnolipids: diversity of structures, 
microbial origins and roles. Appl. Microbiol. Biotechnol. 2010, 86, 1323-1336. 
124. Lequette, Y.; Greenberg, E. P., Timing and localization of rhamnolipid synthesis gene 
expression in Pseudomonas aeruginosa biofilms. J. Bacteriol. 2005, 187, 37-44. 
125. Soberon-Chavez, G.; Lepine, F.; Deziel, E., Production of rhamnolipids by Pseudomonas 
aeruginosa. Appl. Microbiol. Biotechnol. 2005, 68, 718-725. 
126. Déziel, E.; Lépine, F.; Milot, S.; Villemur, R., rhlA is required for the production of a 
novel biosurfactant promoting swarming motility in Pseudomonas aeruginosa: 3-(3-
 
 
hydroxyalkanoyloxy) alkanoic acids (HAAs), the precursors of rhamnolipids. Microbiology 
2003, 149, (8), 2005-2013. 
127. Ochsner, U. A.; Fiechter, A.; Reiser, J., Isolation, characterization, and expression in 
Escherichia coli of the Pseudomonas aeruginosa rhlAB genes encoding a rhamnosyltransferase 
involved in rhamnolipid biosurfactant synthesis. J. Biol. Chem. 1994, 269, 19787-19795. 
128. Rahim, R.; Ochsner, U. A.; Olvera, C.; Graninger, M.; Messner, P.; Lam, J. S.; Soberon-
Chavez, G., Cloning and functional characterization of the Pseudomonas aeruginosa rhlC gene 
that encodes rhamnosyltransferase 2, an enzyme responsible for di-rhamnolipid biosynthesis. 
Mol. Microbiol. 2001, 40, 708-718. 
129. Davey, M. E.; Caiazza, N. C.; O'Toole, G. A., Rhamnolipid surfactant production affects 
biofilm architecture in Pseudomonas aeruginosa PAO1. J. Bacteriol. 2003, 185, 1027-1036. 
130. Davey, M. E.; Caiazza, N. C.; O'Toole, G. A., Rhamnolipid surfactant production affects 
biofilm architecture in Pseudomonas aeruginosa PAO1. J. Bacteriol. 2003, 185, 1027-1036. 
131. Irie, Y.; O'Toole, G. A.; Yuk, M. H., Pseudomonas aeruginosa rhamnolipids disperse 
Bordetella bronchiseptica biofilms. FEMS Microbiol. Lett. 2005, 250, 237-243. 
132. Ofek, I.; Hasty, D. L.; Sharon, N., Anti-adhesion therapy of bacterial diseases: prospects 
and problems. FEMS Immunol. Med. Microbiol. 2003, 38, 181-191. 
133. Pieters, R. J., Intervention with bacterial adhesion by multivalent carbohydrates. Med. 
Res. Rev. 2007, 27, 796-816. 
134. Doig, P.; Smith, N. R.; Todd, T.; Irvin, R. T., Characterization of the binding of 
Pseudomonas aeruginosa alginate to human epithelial cells. Infect. Immun. 1987, 55, 1517-1522. 
135. McEachran, D. W.; Irvin, R. T., Adhesion of Pseudomonas aeruginosa to human buccal 
epithelial cells: evidence for two classes of receptors. Can. J. Microbiol. 1985, 31, (6), 563-569. 
 
 
136. Giltner, C. L.; van, S. E. J.; Audette, G. F.; Kao, D.; Hodges, R. S.; Hassett, D. J.; Irvin, 
R. T., The Pseudomonas aeruginosa type IV pilin receptor binding domain functions as an 
adhesin for both biotic and abiotic surfaces. Mol. Microbiol. 2006, 59, 1083-1096. 
137. Irvin, R.; Doig, P.; Lee, K.; Sastry, P.; Paranchych, W.; Todd, T.; Hodges, R., 
Characterization of the Pseudomonas aeruginosa pilus adhesin: confirmation that the pilin 
structural protein subunit contains a human epithelial cell-binding domain. Infect. Immun. 1989, 
57, (12), 3720-3726. 
138. Lee, K.; Sheth, H.; Wong, W.; Sherburne, R.; Paranchych, W.; Hodges, R.; Lingwood, 
C.; Krivan, H.; Irvin, R., The binding of Pseudomonas aeruginosa pili to glycosphingolipids is a 
tip‐associated event involving the C‐terminal region of the structural pilin subunit. Mol. 
Microbiol. 1994, 11, (4), 705-713. 
139. KRIVAN, H.; GINSBURG, V.; ROBERTS, D., Pseudomonas aeruginosa and 
Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to 
gangliotetraosylceramide (Asialo GM1) and gangliotriaosylceramide (Asialo GM2). Arch. 
Biochem. Biophys. 1988, 260, (1), 493-496. 
140. Sheth, H. B.; Lee, K. K.; Wong, W. Y.; Srivastava, G.; Hindsgaul, O.; Hodges, R. S.; 
Paranchych, W.; Irvin, R. T., The pili of Pseudomonas aeruginosa strains PAK and PAO bind 
specifically to the carbohydrate sequence βGalNAc(1–4)βGal found in glycosphingolipids 
asialo-GM1 and asialo-GM2. Mol. Microbiol. 1994, 11, (4), 715-723. 
141. Lee, K.; Paranchych, W.; Hodges, R., Cross-reactive and strain-specific antipeptide 
antibodies to Pseudomonas aeruginosa PAK and PAO pili. Infect. Immun. 1990, 58, (9), 2727-
2732. 
 
 
142. Irvin, R. T., Adherence of Pseudomonas aeruginosa. In Pseudomonas, Wiley-VCH 
Verlag GmbH & Co. KGaA: 2008; pp 45-83. 
143. Schweizer, F.; Jiao, H.; Hindsgaul, O.; Wong, W. Y.; Irvin, R. T., Interaction between the 
pili of Pseudomonas aeruginosa PAK and its carbohydrate receptor β-D-GalNAc(1->4) β-D-Gal 
analogs. Can. J. Microbiol. 1998, 44, (3), 307-311. 
144. Dusane, D.; Rajput, J.; Kumar, A.; Nancharaiah, Y.; Venugopalan, V.; Zinjarde, S., 
Disruption of fungal and bacterial biofilms by lauroyl glucose. Lett. Appl. Microbiol. 2008, 47, 
(5), 374-379. 
145. Houari, A.; Di Martino, P., Effect of chlorhexidine and benzalkonium chloride on 
bacterial biofilm formation. Lett. Appl. Microbiol. 2007, 45, (6), 652-656. 
146. Mireles, J. R.; Toguchi, A.; Harshey, R. M., Salmonella enterica serovar Typhimurium 
swarming mutants with altered biofilm-forming abilities: surfactin inhibits biofilm formation. J. 
Bacteriol. 2001, 183, (20), 5848-5854. 
147. Toutain-Kidd, C. M.; Kadivar, S. C.; Bramante, C. T.; Bobin, S. A.; Zegans, M. E., 
Polysorbate 80 inhibition of Pseudomonas aeruginosa biofilm formation and its cleavage by the 
secreted lipase LipA. Antimicrob. Agents Chemother. 2009, 53, (1), 136-145. 
148. Wang, J.; Yu, B.; Tian, D.; Ni, M., Rhamnolipid but not motility is associated with the 
initiation of biofilm seeding dispersal of Pseudomonas aeruginosa strain PA17. J. Biosci. 2013, 
38, (1), 149-156. 
149. Zezzi do Valle Gomes, M.; Nitschke, M., Evaluation of rhamnolipid and surfactin to 
reduce the adhesion and remove biofilms of individual and mixed cultures of food pathogenic 
bacteria. Food Control 2012, 25, (2), 441-447. 
 
 
150. Koto, S.; Hirooka, M.; Tashiro, T.; Sakashita, M.; Hatachi, M.; Kono, T.; Shimizu, M.; 
Yoshida, N.; Kurasawa, S.; Sakuma, N.; Sawazaki, S.; Takeuchi, A.; Shoya, N.; Nakamura, E., 
Simple preparations of alkyl and cycloalkyl α-glycosides of maltose, cellobiose, and lactose. 
Carbohydr. Res. 2004, 339, 2415-2424. 
151. Shetye, G. S.; Singh, N.; Gao, X.; Bandyopadhyay, D.; Yan, A.; Luk, Y.-Y., Structures 
and biofilm inhibition activities of brominated furanones for Escherichia coli and Pseudomonas 
aeruginosa. Med. Chem. Comm. 2013, 4, 1079-1084. 
152. Beuth, J.; Ko, H.-L.; Schroten, H.; Sölter, J.; Uhlenbrock, G.; Pulverer, G., Lectin 
mediated adhesion of Streptococcus pneumoniae and its specific inhibition in vitro and in vivo. 
Zbl. Hyg. Umweltmed. 1987, 265, (1), 160-168. 
153. Pera, N. P.; Pieters, R. J., Towards bacterial adhesion-based therapeutics and detection 
methods. Med. Chem. Comm.  2014. 
154. Geske Grant, D.; Mattmann Margrith, E.; Blackwell Helen, E., Evaluation of a focused 
library of N-aryl L-homoserine lactones reveals a new set of potent quorum sensing modulators. 
Bioorg. Med. Chem. Lett. 2008, 18, (22), 5978-5981. 
155. Yang, S.; Abdel-Razek, O. A.; Cheng, F.; Bandyopadhyay, D.; Shetye, G. S.; Wang, G.; 
Luk, Y.-Y., Bicyclic brominated furanones: A new class of quorum sensing modulators that 
inhibit bacterial biofilm formation. Bioorg. Med. Chem. 2014, 22, (4), 1313-1317. 
156. Caron, D., Inorganic nutrients, bacteria, and the microbial loop. Microb. Ecol. 1994, 28, 
(2), 295-298. 
157. Romanı, A. M.; Giorgi, A.; Acuna, V.; Sabater, S., The influence of substratum type and 
nutrient supply on biofilm organic matter utilization in streams. Limnol. Oceanogr. 2004, 49, 
1713-1721. 
 
 
158. Autar, R.; Khan, A. S.; Schad, M.; Hacker, J.; Liskamp, R. M. J.; Pieters, R. J., Adhesion 
Inhibition of F1C-Fimbriated Escherichia coli and Pseudomonas aeruginosa PAK and PAO by 
Multivalent Carbohydrate Ligands. Chem. Bio. Chem. 2003, 4, (12), 1317-1325. 
159. Caiazza, N. C.; Shanks, R. M. Q.; O'Toole, G. A., Rhamnolipids modulate swarming 
motility patterns of Pseudomonas aeruginosa. J. Bacteriol. 2005, 187, (21), 7351-7361. 
160. Wagner, C. E.; Wang, Q.; Heathcock, C. H. In Synthesis and biological evaluation of 
analogs of Altohyrtin C (Spongistatin 2), Tetrahedron 2008, 124-136. 
161. Wagner, C. E.; Wang, Q.; Melamed, A.; Fairchild, C. R.; Wild, R.; Heathcock, C. H., 
Synthesis and biological evaluation of analogs of altohyrtin C (spongistatin 2). Tetrahedron 
2008, 64, (1), 124-136. 
162. Krishnan, R.; Gopidas, K. R., β-Cyclodextrin as an End-to-End Connector. J. Phys. 
Chem. Lett. 2011, 2, 2094-2098. 
163. Harshey, R. M., Bees aren't the only ones: swarming in Gram‐negative bacteria. Mol. 
Microbiol. 1994, 13, (3), 389-394. 
164. Belas, R.; Simon, M.; Silverman, M., Regulation of lateral flagella gene transcription in 
Vibrio parahaemolyticus. J. Bacteriol. 1986, 167, (1), 210-218. 
165. Henrichsen, J., Bacterial surface translocation: a survey and a classification. Bacteriol. 
Rev. 1972, 36, (4), 478. 
166. Kearns, D. B., A field guide to bacterial swarming motility. Nat. Rev. Microbiol. 2010, 8, 
(9), 634-644. 
167. Kohler, T.; Curty, L. K.; Barja, F.; Van, D. C.; Pechere, J.-C., Swarming of Pseudomonas 
aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili. J. Bacteriol. 2000, 
182, 5990-5996. 
 
 
168. Martínez-Solano, L.; Macia, M. D.; Fajardo, A.; Oliver, A.; Martinez, J. L., Chronic 
Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin. Infect. Dis. 
2008, 47, (12), 1526-1533. 
169. Jarrell, K. F.; McBride, M. J., The surprisingly diverse ways that prokaryotes move. Nat. 
Rev. Microbiol. 2008, 6, (6), 466-476. 
170. Stoodley, P.; Sauer, K.; Davies, D. G.; Costerton, J. W., Biofilms as complex 
differentiated communities. Annu. Rev. Microbiol. 2002, 56, 187-209. 
171. Sauer, K.; Camper, A. K.; Ehrlich, G. D.; Costerton, J. W.; Davies, D. G., Pseudomonas 
aeruginosa displays multiple phenotypes during development as a biofilm. J. Bacteriol. 2002, 
184, 1140-1154. 
172. Rashid, M. H.; Kornberg, A., Inorganic polyphosphate is needed for swimming, 
swarming, and twitching motilities of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. 2000, 97, 
(9), 4885-4890. 
173. Ren, D.; Sims, J.; Wood, T., Inhibition of biofilm formation and swarming of Bacillus 
subtilis by (5Z)‐4‐bromo‐5‐(bromomethylene)‐3‐butyl‐2 (5H)‐furanone. Lett. Appl. Microbiol. 
2002, 34, (4), 293-299. 
174. de la Fuente-Núñez, C.; Korolik, V.; Bains, M.; Nguyen, U.; Breidenstein, E. B.; 
Horsman, S.; Lewenza, S.; Burrows, L.; Hancock, R. E., Inhibition of bacterial biofilm formation 
and swarming motility by a small synthetic cationic peptide. Antimicrob. Agents Chemother. 
2012, 56, (5), 2696-2704. 
175. Chow, S.; Gu, K.; Jiang, L.; Nassour, A., Salicylic acid affects swimming, twitching and 
swarming motility in Pseudomonas aeruginosa, resulting in decreased biofilm formation. J. Exp. 
Microbiol. Immunol. 2011, 15, 22-29. 
 
 
176. Tremblay, J.; Déziel, E., Improving the reproducibility of Pseudomonas aeruginosa 
swarming motility assays. J. Basic Microbiol. 2008, 48, (6), 509-515. 
177. Jones, B. V.; Young, R.; Mahenthiralingam, E.; Stickler, D. J., Ultrastructure of Proteus 
mirabilis swarmer cell rafts and role of swarming in catheter-associated urinary tract infection. 
Infect. Immun. 2004, 72, (7), 3941-3950. 
178. Toutain, C. M.; Zegans, M. E.; O'Toole, G. A., Evidence for two flagellar stators and 
their role in the motility of Pseudomonas aeruginosa. J. Bacteriol. 2005, 187, (2), 771-777. 
179. Daniels, R.; Vanderleyden, J.; Michiels, J., Quorum sensing and swarming migration in 
bacteria. FEMS Microbiol. Rev. 2004, 28, (3), 261-289. 
180. Lindum, P. W.; Anthoni, U.; Christophersen, C.; Eberl, L.; Molin, S.; Givskov, M., N-
Acyl-L-homoserine lactone autoinducers control production of an extracellular lipopeptide 
biosurfactant required for swarming motility of Serratia liquefaciens MG1. J. Bacteriol. 1998, 
180, (23), 6384-6388. 
181. Ren, D.; Sims, J. J.; Wood, T. K., Inhibition of biofilm formation and swarming of 
Bacillus subtilis by (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone. Lett. Appl. 
Microbiol. 2002, 34, 293-299. 
182. Matsuyama, T.; Nakagawa, Y., Surface-active exolipids: analysis of absolute chemical 
structures and biological functions. J. Microbiol. Methods 1996, 25, (2), 165-175. 
183. Hoeniger, J., Cellular changes accompanying the swarming of Proteus mirabilis: I. 
Observations of living cultures. Can. J. Microbiol. 1964, 10, (1), 1-9. 
184. Hoeniger, J. F., Development of flagella by Proteus mirabilis. J. Gen. Microbiol. 1965, 
40, (1), 29-42. 
 
 
185. Matsuyama, T.; Takagi, Y.; Nakagawa, Y.; Itoh, H.; Wakita, J.; Matsushita, M., Dynamic 
aspects of the structured cell population in a swarming colony of Proteus mirabilis. J. Bacteriol. 
2000, 182, (2), 385-393. 
186. Patrick, J. E.; Kearns, D. B., Laboratory strains of Bacillus subtilis do not exhibit 
swarming motility. J. Bacteriol. 2009, 191, (22), 7129-7133. 
187. Julkowska, D.; Obuchowski, M.; Holland, I. B.; Séror, S. J., Branched swarming patterns 
on a synthetic medium formed by wild-type Bacillus subtilis strain 3610: detection of different 
cellular morphologies and constellations of cells as the complex architecture develops. 
Microbiology 2004, 150, (6), 1839-1849. 
188. Zorzano, M.-P.; Hochberg, D.; Cuevas, M.-T.; Gómez-Gómez, J.-M., Reaction-diffusion 
model for pattern formation in E. coli swarming colonies with slime. Phys. Rev. E 2005, 71, (3), 
031908. 
189. Daniels, R.; Reynaert, S.; Hoekstra, H.; Verreth, C.; Janssens, J.; Braeken, K.; Fauvart, 
M.; Beullens, S.; Heusdens, C.; Lambrichts, I., Quorum signal molecules as biosurfactants 
affecting swarming in Rhizobium etli. Proc. Natl. Acad. Sci. 2006, 103, (40), 14965-14970. 
190. Du, H.; Xu, Z.; Anyan, M.; Kim, O.; Leevy, W. M.; Shrout, J. D.; Alber, M., High 
Density Waves of the Bacterium Pseudomonas aeruginosa in Propagating Swarms Result in 
Efficient Colonization of Surfaces. Biophys. J. 2012, 103, (3), 601-609. 
191. Matar, O. K.; Troian, S. M., The development of transient fingering patterns during the 
spreading of surfactant coated films. Phys. Fluids 1999, 11, (11), 3232-3246. 
192. Tuval, I.; Cisneros, L.; Dombrowski, C.; Wolgemuth, C. W.; Kessler, J. O.; Goldstein, R. 
E., Bacterial swimming and oxygen transport near contact lines. Proc. Natl. Acad. Sci. U. S. A. 
2005, 102, (7), 2277-2282. 
 
 
193. Ben‐Jacob, E., Learning from bacteria about natural information processing. Ann. N. Y. 
Acad. Sci. 2009, 1178, (1), 78-90. 
194. Ben-Jacob, E.; Schochet, O.; Tenenbaum, A.; Cohen, I., Generic modelling of 
cooperative growth patterns in bacterial colonies. Nature 1994, 368, (6466), 46-49. 
195. Tremblay, J.; Richardson, A.-P.; Lepine, F.; Deziel, E., Self-produced extracellular 
stimuli modulate the Pseudomonas aeruginosa swarming motility behavior. Environ. Microbiol. 
2007, 9, 2622-2630. 
196. Chen, G., Interaction decay of nonionic surfactants at water surfaces. Chem. Phys. Lett. 
2003, 376, (5), 758-760. 
197. Zhang, R.; Zhang, L.; Somasundaran, P., Study of mixtures of n-dodecyl-β-D-maltoside 
with anionic, cationic, and nonionic surfactant in aqueous solutions using surface tension and 
fluorescence techniques. J. Colloid Interface Sci. 2004, 278, 453-460. 
198. Geng, T.; Teng, X.-G.; Li, Q.-X.; Jiang, Y.-J.; Li, G.-J., Synthesis and properties of long-
chain quaternary ammonium hydroxides. Chin. Chem. Lett. 2013, 24, (6), 494-496. 
199. Pieters, R. J., Maximising multivalency effects in protein–carbohydrate interactions. Org. 
Biomol. Chem. 2009, 7, (10), 2013-2025. 
200. Burlatsky, S. F.; Atrazhev, V. V.; Dmitriev, D. V.; Sultanov, V. I.; Timokhina, E. N.; 
Ugolkova, E. A.; Tulyani, S.; Vincitore, A., Surface tension model for surfactant solutions at the 
critical micelle concentration. J. Colloid Interface Sci. 2013, 393, 151-160. 
201. Lenz, P.; Søgaard-Andersen, L., Temporal and spatial oscillations in bacteria. Nat. Rev. 
Microbiol. 2011, 9, (8), 565-577. 
202. Caiazza, N. C.; Shanks, R. M. Q.; O'Toole, G. A., Rhamnolipids modulate swarming 
motility patterns of Pseudomonas aeruginosa. J. Bacteriol. 2005, 187, 7351-7361. 
 
 
203. Jacobs, M. A.; Alwood, A.; Thaipisuttikul, I.; Spencer, D.; Haugen, E.; Ernst, S.; Will, 
O.; Kaul, R.; Raymond, C.; Levy, R., Comprehensive transposon mutant library of Pseudomonas 
aeruginosa. Proc. Natl. Acad. Sci. 2003, 100, (24), 14339-14344. 
204. Beveridge, T. J., Structures of gram-negative cell walls and their derived membrane 
vesicles. J. Bacteriol. 1999, 181, (16), 4725-4733. 
205. Ryan, K.; Ray, C.; Ahmad, N.; Drew, W.; Plorde, S. J., Medical Microbiology. 5th 
Edition ed.; The McGraw Hill Companies, Inc.: 2010. 
206. Otto, M., Quorum‐sensing control in Staphylococci–a target for antimicrobial drug 
therapy? FEMS Microbiol. Lett. 2004, 241, (2), 135-141. 
207. Prabhakara, R.; Foreman, O.; De Pascalis, R.; Lee, G. M.; Plaut, R. D.; Kim, S. Y.; 
Stibitz, S.; Elkins, K. L.; Merkel, T. J., Epicutaneous model of community-acquired 
staphylococcus aureus skin infections. Infect. Immun. 2013, 81, (4), 1306-1315. 
208. Tzianabos, A. O.; Wang, J. Y.; Lee, J. C., Structural rationale for the modulation of 
abscess formation by Staphylococcus aureus capsular polysaccharides. Proc. Natl. Acad. Sci. 
2001, 98, (16), 9365-9370. 
209. Corey, G. R., Staphylococcus aureus bloodstream infections: definitions and treatment. 
Clin. Infect. Dis. 2009, 48, S254-S259. 
210. Rubinstein, E.; Kollef, M. H.; Nathwani, D., Pneumonia caused by methicillin-resistant 
Staphylococcus aureus. Clin. Infect. Dis. 2008, 46, S378-S385. 
211. Jamart, S.; Denis, O.; Deplano, A.; Tragas, G.; Vandergheynst, A.; De Bels, D.; 
Devriendt, J., Methicillin-resistant Staphylococcus aureus toxic shock syndrome. Emerg. infect. 
dis. 2005, 11, (4), 636. 
 
 
212. Chambers, H. F.; DeLeo, F. R., Waves of resistance: Staphylococcus aureus in the 
antibiotic era. Nat. Rev. Microbiol. 2009, 7, (9), 629-641. 
213. Goffin, C.; Ghuysen, J.-M., Multimodular penicillin-binding proteins: an enigmatic 
family of orthologs and paralogs. Microbiol. Mol. Biol. Rev. 1998, 62, (4), 1079-1093. 
214. Talbot, G. H.; Bradley, J.; Edwards, J. E.; Gilbert, D.; Scheld, M.; Bartlett, J. G., Bad 
bugs need drugs: an update on the development pipeline from the Antimicrobial Availability 
Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis. 2006, 42, (5), 657-
668. 
215. Boucher, H. W.; Talbot, G. H.; Bradley, J. S.; Edwards, J. E.; Gilbert, D.; Rice, L. B.; 
Scheld, M.; Spellberg, B.; Bartlett, J., Bad bugs, no drugs: no ESKAPE! An update from the 
Infectious Diseases Society of America. Clin. Infect. Dis. 2009, 48, (1), 1-12. 
216. Zhang, R.; Turner, L.; Berg, H. C., The upper surface of an Escherichia coli swarm is 
stationary. Proc. Natl. Acad. Sci. 2010, 107, (1), 288-290. 
217. Kaito, C.; Sekimizu, K., Colony spreading in Staphylococcus aureus. J. Bacteriol. 2007, 
189, (6), 2553-2557. 
218. Williams, P.; Camara, M.; Hardman, A.; Swift, S.; Milton, D.; Hope, V. J.; Winzer, K.; 
Middleton, B.; Pritchard, D. I.; Bycroft, B. W., Quorum sensing and the population-dependent 
control of virulence. Phil. Trans. R. Soc. B. 2000, 355, (1397), 667-680. 
219. Ji, G.; Beavis, R. C.; Novick, R. P., Cell density control of staphylococcal virulence 
mediated by an octapeptide pheromone. Proc. Nat. Acad. Sci. 1995, 92, (26), 12055-12059. 
220. Cirioni, O.; Ghiselli, R.; Minardi, D.; Orlando, F.; Mocchegiani, F.; Silvestri, C.; 
Muzzonigro, G.; Saba, V.; Scalise, G.; Balaban, N., RNAIII-inhibiting peptide affects biofilm 
 
 
formation in a rat model of staphylococcal ureteral stent infection. Antimicrob. Agents 
Chemother. 2007, 51, (12), 4518-4520. 
221. Giacometti, A.; Cirioni, O.; Gov, Y.; Ghiselli, R.; Del Prete, M. S.; Mocchegiani, F.; 
Saba, V.; Orlando, F.; Scalise, G.; Balaban, N., RNA III inhibiting peptide inhibits in vivo 
biofilm formation by drug-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 
2003, 47, (6), 1979-1983. 
222. Abraham, W.-R., Controlling biofilms of gram-positive pathogenic bacteria. Curr. Med. 
Chem. 2006, 13, (13), 1509-1524. 
223. Chan, W. C.; Coyle, B. J.; Williams, P., Virulence Regulation and Quorum Sensing in 
Staphylococcal Infections: Competitive AgrC Antagonists as Quorum Sensing Inhibitors. J. 
Med. Chem. 2004, 47, (19), 4633-4641. 
224. DebRoy, C.; Maddox, C. W., Identification of virulence attributes of gastrointestinal 
Escherichia coli isolates of veterinary significance. Anim. Health Res. Rev. 2001, 2, (02), 129-
140. 
225. Bentley, R.; Meganathan, R., Biosynthesis of vitamin K (menaquinone) in bacteria. 
Microbiol. Rev. 1982, 46, (3), 241. 
226. Hudault, S.; Guignot, J.; Servin, A., Escherichia coli strains colonising the 
gastrointestinal tract protect germfree mice againstSalmonella typhimuriuminfection. Gut 2001, 
49, (1), 47-55. 
227. Besser, R. E.; Lett, S. M.; Weber, J. T.; Doyle, M. P.; Barrett, T. J.; Wells, J. G.; Griffin, 
P. M., An outbreak of diarrhea and hemolytic uremic syndrome from Escherichia coli O157: H7 
in fresh-pressed apple cider. Jama 1993, 269, (17), 2217-2220. 
 
 
228. Jacobsen, S.; Stickler, D.; Mobley, H.; Shirtliff, M., Complicated catheter-associated 
urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin. Microbiol. Rev. 2008, 
21, (1), 26-59. 
229. Smith, J. L.; Fratamico, P. M.; Yan, X.-H., Eavesdropping by Bacteria: The Role of SdiA 
in Escherichia coli and Salmonella enterica Serovar Typhimurium Quorum Sensing. Foodborne 
Pathog. Dis. 2011, 8, 169-178. 
230. Sharma, V. K.; Bearson, S. M. D.; Bearson, B. L., Evaluation of the effects of sdiA, a 
luxR homologue, on adherence and motility of Escherichia coli O157: H7. Microbiology 2010, 
156, (5), 1303-1312. 
231. Soulère, L.; Frezza, M.; Queneau, Y.; Doutheau, A., Exploring the active site of acyl 
homoserine lactones-dependent transcriptional regulators with bacterial quorum sensing 
modulators using molecular mechanics and docking studies. J. Mol. Graphics Modell. 2007, 26, 
(2), 581-590. 
232. Beloin, C.; Roux, A.; Ghigo, J. M., Escherichia coli Biofilms. In Bacterial Biofilms, 
Romeo, T., Ed. Springer Berlin Heidelberg: 2008; 322, 249-289. 
233. Yao, Y.; Martinez-Yamout, M.; Dickerson, T.; Brogan, A.; Wright, P.; Dyson, H., 
STRUCTURE OF THE ESCHERICHIA COLI QUORUM SENSING PROTEIN SDIA: 
ACTIVATION OF THE FOLDING SWITCH BY ACYL HOMOSERINE LACTONES. J. Mol. 
Biol. 2006, 355, (2), 262-273. 
234. Wang, X.; de Boer, P. A.; Rothfield, L., A factor that positively regulates cell division by 
activating transcription of the major cluster of essential cell division genes of Escherichia coli. 
EMBO J. 1991, 10, (11), 3363. 
 
 
235. Lee, J.; Maeda, T.; Hong, S. H.; Wood, T. K., Reconfiguring the quorum-sensing 
regulator SdiA of Escherichia coli to control biofilm formation via indole and N-acylhomoserine 
lactones. Appl. Environ. Microbiol. 2009, 75, (6), 1703-1716. 
236. Smith, J. L.; Fratamico, P. M.; Yan, X.-H., Eavesdropping by Bacteria: The Role of SdiA 
in Escherichia coli and Salmonella enterica Serovar Typhimurium Quorum Sensing. Foodborne 
Pathog. Dis. 2011, 8, (2), 169-178. 
237. Lee, J.; Jayaraman, A.; Wood, T. K., Indole is an inter-species biofilm signal mediated by 
SdiA. BMC Microbiol. 2007, 7, (1), 42. 
238. Surette, M. G.; Miller, M. B.; Bassler, B. L., Quorum sensing in Escherichia coli, 
Salmonella typhimurium, and Vibrio harveyi: a new family of genes responsible for autoinducer 
production. Proc. Natl. Acad. Sci. 1999, 96, (4), 1639-1644. 
239. Surette, M. G.; Bassler, B. L., Quorum sensing in Escherichia coli and Salmonella 
typhimurium. Proc. Natl. Acad. Sci. 1998, 95, (12), 7046-7050. 
240. Lee, J. H.; Lee, J., Indole as an intercellular signal in microbial communities. FEMS 
Microbiol. Rev. 2010, 34, (4), 426-444. 
241. Stewart, V.; Yanofsky, C., Evidence for transcription antitermination control of 
tryptophanase operon expression in Escherichia coli K-12. J. Bacteriol. 1985, 164, (2), 731-740. 
242. Li, G.; Young, K. D., Indole production by the tryptophanase TnaA in Escherichia coli is 
determined by the amount of exogenous tryptophan. Microbiology 2013, 159, (Pt 2), 402-410. 
243. Lee, J.; Zhang, X.-S.; Hegde, M.; Bentley, W. E.; Jayaraman, A.; Wood, T. K., Indole 
cell signaling occurs primarily at low temperatures in Escherichia coli. ISME J. 2008, 2, (10), 
1007-1023. 
 
 
244. Bansal, T.; Englert, D.; Lee, J.; Hegde, M.; Wood, T. K.; Jayaraman, A., Differential 
effects of epinephrine, norepinephrine, and indole on Escherichia coli O157: H7 chemotaxis, 
colonization, and gene expression. Infect. Immun. 2007, 75, (9), 4597-4607. 
245. Hirakawa, H.; Inazumi, Y.; Masaki, T.; Hirata, T.; Yamaguchi, A., Indole induces the 
expression of multidrug exporter genes in Escherichia coli. Mol. Microbiol. 2005, 55, (4), 1113-
1126. 
246. Vega, N. M.; Allison, K. R.; Khalil, A. S.; Collins, J. J., Signaling-mediated bacterial 
persister formation. Nat. Chem. Biol. 2012, 8, (5), 431-433. 
247. Hirakawa, H.; Kodama, T.; Takumi-Kobayashi, A.; Honda, T.; Yamaguchi, A., Secreted 
indole serves as a signal for expression of type III secretion system translocators in 
enterohaemorrhagic Escherichia coli O157: H7. Microbiology 2009, 155, (2), 541-550. 
248. Davies, D. G.; Parsek, M. R.; Pearson, J. P.; Iglewski, B. H.; Costerton, J. W.; Greenberg, 
E. P., The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science  
1998, 280, 295-298. 
249. Pesci, E.; Pearson, J. P.; Seed, P. C.; Iglewski, B. H., Regulation of las and rhl quorum 
sensing in Pseudomonas aeruginosa. J. Bacteriol. 1997, 179, 3127-3132. 
250. Andersen, J. B.; Sternberg, C.; Poulsen, L. K.; Bjørn, S. P.; Givskov, M.; Molin, S., New 
Unstable Variants of Green Fluorescent Protein for Studies of Transient Gene Expression in 
Bacteria. Appl. Environ. Microbiol. 1998, 64, (6), 2240-2246. 
251. Pearson, J. P.; Pesci, E. C.; Iglewski, B. H., Roles of Pseudomonas aeruginosa las and rhl 
quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes. J. Bacteriol. 
1997, 179, 5756-5767. 
 
 
252. Glansdorp, F. G.; Thomas, G. L.; Lee, J. K.; Dutton, J. M.; Salmond, G. P.; Welch, M.; 
Spring, D. R., Synthesis and stability of small molecule probes for Pseudomonas aeruginosa 
quorum sensing modulation. Org. Biomol. Chem. 2004, 2, (22), 3329-3336. 
253. Pettus Jr, J. A.; Wing, R. M.; Sims, J. J., Marine Natural Products XII Isolation of a 
Family of Multihalogenated Gamma-Methylene Lactones from the Red Seaweed Delisea 
fimbriata. Tetrahedron Lett. 1977, 18, (1), 41-44. 
254. Beechan, C. M.; Sims, J. J., The first synthesis of fimbrolides, a novel class of 
halogenated lactones naturally occurring in the red seaweed Delisea fimbriata 
(Bonnemaisoniaceae). Tetrahedron Lett. 1979, (19), 1649-1652. 
255. Kazlauskas, R.; Murphy, P. T.; Quinn, R. J.; Wells, R. J., A new class of halogenated 
lactones from the red alga delisea fimbriata (bonnemaisoniaceae). Tetrahedron Lett. 1977, 18, 
(1), 37-40. 
256. Ren, D.; Sims, J. J.; Wood, T. K., Inhibition of biofilm formation and swarming of 
Bacillus subtilis by (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone. Lett. Appl. 
Microbiol. 2002, 34, (4), 293-299. 
257. Hentzer, M.; Riedel, K.; Rasmussen, T. B.; Heydorn, A.; Andersen, J. B.; Parsek, M. R.; 
Rice, S. A.; Eberl, L.; Molin, S.; Høiby, N., Inhibition of quorum sensing in Pseudomonas 
aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 2002, 148, (1), 
87-102. 
258. Janssens, J. C.; Steenackers, H.; Robijns, S.; Gellens, E.; Levin, J.; Zhao, H.; Hermans, 
K.; De Coster, D.; Verhoeven, T. L.; Marchal, K., Brominated furanones inhibit biofilm 
formation by Salmonella enterica serovar Typhimurium. Appl. Environ. Microbiol. 2008, 74, 
(21), 6639-6648. 
 
 
259. Back, A.; Holmstrom, C.; Kjelleberg, S.; Steinberg, P. D., Inhibition of gram positive 
bacteria. In Google Patents:1999. 
260. Hume, E.; Baveja, J.; Muir, B.; Schubert, T.; Kumar, N.; Kjelleberg, S.; Griesser, H.; 
Thissen, H.; Read, R.; Poole-Warren, L., The control of Staphylococcus epidermidis biofilm 
formation and in vivo infection rates by covalently bound furanones. Biomaterials 2004, 25, 
(20), 5023. 
261. Lönn‐Stensrud, J.; Petersen, F.; Benneche, T.; Scheie, A. A., Synthetic bromated 
furanone inhibits autoinducer‐2‐mediated communication and biofilm formation in oral 
streptococci. Oral microbiol. Immun. 2007, 22, (5), 340-346. 
262. Duo, M.; Zhang, M.; Luk, Y.-Y.; Ren, D., Inhibition of Candida albicans growth by 
brominated furanones. Applied microbiology and biotechnology 2010, 85, (5), 1551-1563. 
263. Pan, J.; Ren, D., Structural effects on persister control by brominated furanones. Bioorg. 
Med. Chem. Lett. 2013, 23, (24), 6559-6562. 
264. Manefield, M.; De Nys, R.; Kumar, N.; Read, R.; Givskov, M.; Steinberg, P.; Kjelleberg, 
S., Evidence that halogenated furanones from Delisea pulchra inhibit acylated homoserine 
lactone (AHL)-mediated gene expression by displacing the AHL signal from its receptor protein. 
Microbiology  1999, 145, (2), 283-291. 
265. Manefield, M.; Rasmussen, T. B.; Henzter, M.; Andersen, J. B.; Steinberg, P.; Kjelleberg, 
S.; Givskov, M., Halogenated furanones inhibit quorum sensing through accelerated LuxR 
turnover. Microbiology 2002, 148, (4), 1119-1127. 
266. Gram, L.; de Nys, R.; Maximilien, R.; Givskov, M.; Steinberg, P.; Kjelleberg, S., 
Inhibitory Effects of Secondary Metabolites from the Red Alga Delisea pulchra on Swarming 
Motility of Proteus mirabilis. Appl. Environ. Microbiol. 1996, 62, (11), 4284-4287. 
 
 
267. Manefield, M.; Welch, M.; Givskov, M.; Salmond, G. P.; Kjelleberg, S., Halogenated 
furanones from the red alga, Delisea pulchra, inhibit carbapenem antibiotic synthesis and 
exoenzyme virulence factor production in the phytopathogen Erwinia carotovora. FEMS 
Microbiol. Lett. 2001, 205, (1), 131-138. 
268. Manefield, M.; Harris, L.; Rice, S. A.; de Nys, R.; Kjelleberg, S., Inhibition of 
luminescence and virulence in the black tiger prawn (Penaeus monodon) pathogen Vibrio 
harveyi by intercellular signal antagonists. Appl. Environ. Microbiol. 2000, 66, (5), 2079-2084. 
269. Givskov, M.; de Nys, R.; Manefield, M.; Gram, L.; Maximilien, R.; Eberl, L.; Molin, S.; 
Steinberg, P. D.; Kjelleberg, S., Eukaryotic interference with homoserine lactone-mediated 
prokaryotic signalling. J. Bacteriol. 1996, 178, (22), 6618-6622. 
270. Hentzer, M.; Wu, H.; Andersen, J. B.; Riedel, K.; Rasmussen, T. B.; Bagge, N.; Kumar, 
N.; Schembri, M. A.; Song, Z.; Kristoffersen, P., Attenuation of Pseudomonas aeruginosa 
virulence by quorum sensing inhibitors. The EMBO journal 2003, 22, (15), 3803-3815. 
271. Iskander, G.; Zhang, R.; Chan, D. S.-H.; Black, D. S.; Alamgir, M.; Kumar, N., An 
efficient synthesis of brominated 4-alkyl-2(5H)-furanones. Tetrahedron Lett. 2009, 50, (32), 
4613-4615. 
272. Hentzer, M.; Riedel, K.; Rasmussen, T. B.; Heydorn, A.; Andersen, J. B.; Parsek, M. R.; 
Rice, S. A.; Eberl, L.; Molin, S.; Hoiby, N.; Kjelleberg, S.; Givskov, M., Inhibition of quorum 
sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. 
Microbiology  2002, 148, (1), 87-102. 
273. Manny, A. J.; Kjelleberg, S.; Kumar, N.; de Nys, R.; Read, R. W.; Steinberg, P., 
Reinvestigation of the sulfuric acid-catalyzed cyclization of brominated 2-alkyllevulinic acids to 
3-alkyl-5-methylene-2(5H)-furanones. Tetrahedron 1997, 53, (46), 15813-15826. 
 
 
274. Sorg, A.; Siegel, K.; Brueckner, R., Stereoselective syntheses of dihydroxerulin and 
xerulinic acid, anti-hypocholesterolemic dyes from the fungus Xerula melanotricha. Chem.Eur. 
J. 2005, 11, (5), 1610-1624. 
275. Kuang, Z.; Hao, Y.; Walling, B. E.; Jeffries, J. L.; Ohman, D. E.; Lau, G. W., 
Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the 
pulmonary surfactant protein-A. PLoS One 2011, 6, (11), e27091. 
276. McIver, K. S.; Kessler, E.; Ohman, D. E., Identification of residues in the Pseudomonas 
aeruginosa elastase propeptide required for chaperone and secretion activities. Microbiology 
2004, 150, (12), 3969-3977. 
277. Azghani, A. O., Pseudomonas aeruginosa and epithelial permeability: role of virulence 
factors elastase and exotoxin A. Am. J. Respir. Cell Mol. Biol. 1996, 15, (1), 132-140. 
278. de Bentzmann, S.; Polette, M.; Zahm, J.-M.; Hinnrasky, J.; Kileztky, C.; Bajolet, O.; 
Klossek, J.-M.; Filloux, A.; Lazdunski, A.; Puchelle, E., Pseudomonas Aeruginosa Virulence 
Factors Delay Airway Epithelial Wound Repair by Altering the Actin Cytoskeleton and Inducing 
Overactivation of Epithelial Matrix Metalloproteinase–2. Laboratory investigation 2000, 80, (2), 
209-219. 
279. Alcorn, J. F.; Wright, J. R., Degradation of pulmonary surfactant protein D by 
Pseudomonas aeruginosa elastase abrogates innate immune function. J. Biol. Chem. 2004, 279, 
(29), 30871-30879. 
280. Sambrook, J. F.; Russell, D. W.; Editors, Molecular cloning: A laboratory manual, third 
edition. 2000; p 2300. 
 
 
281. Kanamaru, H.; Yoshida, O., Assessment of in vitro lymphokine activated killer (LAK) 
cell activity against renal cancer cell lines and its suppression by serum factor using crystal violet 
assay. Urol Res 1989, 17, (4), 259-264. 
282. Frei, R.; Breitbach, A. S.; Blackwell, H. E., 2-Aminobenzimidazole derivatives strongly 
inhibit and disperse Pseudomonas aeruginosa biofilms. Angew. Chem. Int. Ed. 2012, 51, (21), 
5226-5229. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Curriculum Vitae 
Name of the Author: Gauri S. Shetye 
Date and Place of Birth: September 27, 1985, Mumbai, India 
Language proficiency: English, Hindi, Marathi 
 
Degrees Awarded 
 
• Ph.D., Chemistry, Advisor: Professor Yan-Yeung Luk (Degree expected Dec, 2014)          
• M. Phil., Chemistry, Advisor: Professor Yan-Yeung Luk (Aug 2009-May 2011)                        
• Master of Science (M.Sc.), Organic Chemistry (Aug 2006-May 2008) 
• Bachelor of Science (B.Sc.), Chemistry (Aug 2003-May 2006) 
RESEARCH EXPERIENCE 
Syracuse University, Syracuse, NY (Aug 2009 – present)                                                               
Research Assistant, Department of Chemistry,                                                                                        
PhD. Program, Advisor: Professor Yan-Yeung Luk   
TEACHING EXPERIENCE 
Syracuse University, Syracuse, NY (Aug 2009 – Present)                                                                          
Teaching Assistant, Department of Chemistry, PhD. Program 
• Taught general chemistry to undergraduate students at Syracuse University 
PUBLICATIONS 
1. Karen Simon, Gauri S. Shetye, Ulrich Englich, Lei Wu, Yan-Yeung Luk; “Noncovalent 
Polymerization of Mesogens Crystallizes Lysozyme: Correlation between Nonamphiphilic 
Lyotropic Liquid Crystal Phase and Protein Crystal Formation” Langmuir, 2011, 27, 10901- 
10906. 
2.  Nisha Varghese, Gauri S. Shetye,  Debjyoti Bandyopadhyay, Nemal Gobalasingham, JinAm 
Seo, Jo-Han Wang, Barbara Theiler, Yan-Yeung Luk; “Emulsion of Aqueous-Based 
Nonspherical Droplets in Aqueous Solutions by Single-Chain Surfactants: Templated Assembly 
by Nonamphiphilic Lyotropic Liquid Crystals in Water” Langmuir 2012, 28, 10797-10807 
3. Gauri S. Shetye, Nischal Singh, Gao, X.; Bandyopadhyay, D.; Yan, A.; Luk, Y.-Y., Structures 
and biofilm inhibition activities of brominated furanones for Escherichia coli and Pseudomonas 
aeruginosa. Med. Chem. Comm, 2013, 4, (7), 1079-1084. 
4. Nisha Varghese, Gauri S. Shetye, Sijie Yang, Stephan Wilkens, Robert P. Smith, Yan-Yeung 
Luk, The ability of single-chain surfactants to emulsify an aqueous-based liquid crystal oscillates 
with odd–even parity of alkyl-chain length, J. Colloid Interface Sci., 2013, 412, 95-99.  
5. Gauri S. Shetye, Nischal Singh, Changqing Qia, Chan D. K. Nguyen, Guirong Wang, Yan-
Yeung Luk; Disaccharide Hydrocarbons Reactivate Swarming Motility of Nonswarming Mutant 
 
 
and Inhibit Bacterial Adhesion and Biofilm Formation by Pseudomonas aeruginosa, Chem. Bio. 
Chem, 2014, 15 (10), 1514-1523.  
6. Sijie Yang, Abdel-Razek, O. A., Cheng, F., Bandyopadhyay, D., Gauri S. Shetye, Wang, G., and 
Luk, Y.-Y. Bicyclic Brominated Furanones: A New Class of Quorum Sensing Modulators that 
Inhibit Bacterial Biofilm Formation, Bioorg. Med. Chem, 2014, 22, 1313-1317. 
7. Nischal Singh, Gauri S Shetye, Guirong Wang, Yan-Yeung Luk; Structure Activity Study of 
Polyol-derivatized Hydrocarbons in Inhibition and Dispersion of P. aeruginosa Biofilm. 
(Manuscript in preparation) 
PATENT                                                                                                                                                  
Gauri S. Shetye, Nischal Singh, Yan-Yeung Luk; “Disugar hydrocarbons for controlling bacterial 
behaviors”; (Manuscript in preparation) 
PRESENTATIONS AND CONFERENCES 
1. Gauri S. Shetye, Nischal Singh,  Xiang Gao, Debjyoti Bandyopadhyay, Aixin Yan, Yan-Yeung 
Luk; “Inhibition of Pseudomonas aeruginosa and E.coli biofilm formation by brominated 
furanones and the interfering of their quorum sensing pathways” Abstracts of Papers, 245th ACS 
National Meeting, New Orleans, LA, United States, April 7-11, 2013. 
2. Gauri S. Shetye; Nischal Singh; Guirong Wang; Yan-Yeung Luk; “Non-microbicidal inhibition 
and dispersion of mucoid Pseudomonas aeruginosa biofilm by polyol-derivatized hydrocarbons” 
Abstracts of Papers, 245th ACS National Meeting, New Orleans, LA, United States, April 7-11, 
2013. 
3. Gauri S. Shetye; Nischal Singh; Guirong Wang; Yan-Yeung Luk; “Non-microbicidal inhibition 
and dispersion of mucoid Pseudomonas aeruginosa biofilm by polyol-derivatized hydrocarbon” 
Abstracts of Papers, 245th ACS National Meeting, New Orleans, LA, United States, April 7-11, 
2013. 
4. Gauri S. Shetye, Yan-Yeung Luk; “Redesigning Biosurfactants for Selective Inhibition and 
Dispersion of Pseudomonas aeruginosa Biofilm: A New Therapeutic Target for Infectious 
Diseases” Biochem Journal Club, Department of Chemistry, Syracuse University, Dec 29-2012. 
5. Nischal Singh; Gauri S. Shetye; Guirong Wang; Yan-Yeung Luk; “Structure-activity study of 
polyol-derivatized hydrocarbons in inhibition and dispersion of Pseudomonas 
aeruginosa biofilm” Abstracts of Papers, 245th ACS National Meeting, New Orleans, LA, 
United States, April 7-11, 2013. 
6. Nisha Varghese, Gauri S. Shetye; Debjyoti Bandyopadhyay, Robert P. Smith, Stephan Wilkens, 
Yan-Yeung Luk; “Emulsification of aqueous−based liquid crystals by single−chain surfactants 
and effect of odd−even parity of alkyl−chain on droplet formation” Abstracts of Papers, 245th 
ACS National Meeting, New Orleans, LA, United States, April 7-11, 2013. 
7. Karen A. Simon, Gauri S. Shetye, Erik A. Burton, Dacheng Ren, Yan-Yeung Luk;  “Anti-
Fouling Chemistry and Bioactive Gels with Controlled Structure” Syracuse Biomaterials 
Institute, 2011. 
